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ABSTRACT 
KUN LU: Molecular Binding of Formaldehyde to DNA and Proteins 
(Under the direction of Dr. James A Swenberg) 
 
Formaldehyde is produced worldwide on a large scale (21 million tons in 
2000) and used in a wide spectrum of applications. Its toxicity and carcinogenic 
effects have evoked numerous public health concerns. According to the International 
Agency on Research on Cancer (IARC),  formaldehyde is classified as a known 
animal and human carcinogen, causing nasal cancer. More limited epidemiologic 
evidence suggests that formaldehyde can also induce leukemia in humans, however, 
this is controversial. In this dissertation, we have designed an integrated bottom-up 
approach to address critical issues to better understand formaldehyde’s carcinogenic 
potential.  
Specifically, the N-terminus of histone and lysine residues located in both 
the histone N-terminal tail and the globular fold domain were identified as binding 
sites for formaldehyde in the current study. We also found that formaldehyde-
induced lysine adducts could inhibit the formation of post translational 
modifications on histone, raising the possibility that formaldehyde might alter 
epigenetic regulation.  We have also elucidated the structures of DNA-protein cross-
links induced by formaldehyde. Detailed characterization of the formaldehyde-
derived linkage of single amino acids with nucleosides by NMR and mass
 iv
spectrometry established that these amino acids all form cross-links involving 
formation of a formaldehyde-derived methylene bridge. Our results also 
demonstrated that Lys-dG cross-links are the most common DNA-protein cross-
links induced by formaldehyde, however, they are very labile. The finding that Cys-
CH2-dG cross-links could be initiated by the S-hydroxymethyl group of cysteine 
residue lead to the identification of a novel dG-CH2-GSH adduct. This adduct is 
unique because of the involvement of S-hydroxymethylglutathione, a key player in 
the detoxification of formaldehyde. After our extensive work on biomarker 
discovery and validation involving DNA monoadducts and DNA-DNA cross-links, 
we applied these methods to analyze DNA samples from rats exposed to [13CD2]-
formaldehyde for 1 day and 5 days. The results show that exogenous formaldehyde 
induced N2-hydroxymethyl-dG monoadducts and dG-dG cross-links in DNA from 
rat nasal mucosa, but did not form [13CD2]-adducts in distant tissues despite 
analyzing 5 times more DNA than for nasal epithelium. These data provide strong 
evidence supporting a genotoxic and cytotoxic mode of action for inhaled 
formaldehyde in the target tissue for carcinogenesis, but do not support the 
biological plausibility that inhaled formaldehyde causes leukemia in rats.   
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CHAPTER 1 
1. INTRODUCTION 
 
Formaldehyde is the simplest aldehyde, with the formula CH2O. 
Formaldehyde is produced worldwide on a large scale (21 million tons in 2000) and a 
chemical with a wide spectrum of applications and important economic impact. 
However, formaldehyde’s toxicity and carcinogenic effects have evoked numerous 
health concerns. Recently, associations between residents’ sickness and formaldehyde 
in FEMA trailers raised additional public concern for adverse effects of formaldehyde 
exposure (http://www.cdc.gov/nceh/ehhe/trailerstudy). Formaldehyde is classified as a 
known animal and human carcinogen according to International Agency on Research 
on Cancer (IARC), causing nasal cancer (1).  IARC also considered there was “strong 
but not sufficient evidence for a causal association between leukemia and 
occupational exposure to formaldehyde”. In this chapter, we will briefly introduce its 
production and use, occurrence, toxicity and carcinogenesis, with the emphasis on the 
association between formaldehyde inhalation exposure and the induction of nasal 
cancer and leukemia.  At the end of this chapter, we will raise the critical issues to be 
addressed in this dissertation to better understand formaldehyde toxicity and 
carcinogenesis.  
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1.1 Production and use 
Formaldehyde has been produced since 1889 through the catalytic oxidation of 
methanol. Among many available methods, the silver catalyst process and the metal 
oxide catalyst process are currently widely used in the formaldehyde industry(1). The 
commercially available product is primarily 37% formaldehyde solution and its 
worldwide annual production and consumption is approximately 21 million tons in 
2000(1).  
Formaldehyde is used in a variety of industries.  Formaldehyde is extensively 
used in the production of resins with urea, phenol and melamine and other resins. 
These formaldehyde-resins have diverse downstream applications in the production of 
wood product, pulp and paper, synthetic fiber, plastics, coatings and textile.  
Formaldehyde is also widely used as an important intermediate chemical for the 
synthesis of many other compounds. Formaldehyde is also used as a disinfect and to 
preserve biological samples in medical laboratories and facilities. It is also common to 
find formaldehyde present in cosmetics products, acting as an antimicrobial agent. 
Given the large quantity of formaldehyde production and its wide applications, 
occupational exposure to formaldehyde occurs in many occupations and related 
industries. This list includes: manufacture of formaldehyde, formaldehyde-based 
resins and other chemical products; histopathology and disinfection in hospitals; 
embalming and anatomy laboratories; manufacture of wood products and paper; 
building and construction industry; manufacture of textiles and garments; foundries; 
synthetic fiber production; plastics production; firefighters; automobile and engine 
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exhausts; offices and public buildings.  It is estimated that more than 2 million U.S. 
workers are occupationally exposed to formaldehyde (2).  
 
1.2 Occurrence 
Formaldehyde is a ubiquitous environmental pollutant from many outdoor and 
indoor sources.  Outdoor sources of formaldehyde primarily come from automobile 
exhaust emissions, plants and manufacturing facilities, combustion, while indoor 
sources of formaldehyde are primarily released from building materials, consumer 
products and tobacco smoke.  Formaldehyde is also found in various foods, which 
could be the consequence of both the natural occurrence of formaldehyde and 
pollution(3). The formaldehyde contamination in foods is emerging as an important 
issue in some developing countries, which may be another exposure route under 
certain circumstances.  
In addition to the exogenous formaldehyde coming from the environment, 
formaldehyde is an essential intermediate in all living cells. It is endogenously 
generated from serine, glycine, methionine and choline and also produced from some 
metabolites and proteins by demethylation(1). The endogenous concentration of 
formaldehyde in the blood of human subjects is about 0.1mM(4;5).  
Formaldehyde can also be formed in our bodies after metabolizing various 
compounds, such as nitrosamines(6-8), and certain types of drugs(9;10) following 
metabolism.  Therefore, both endogenous and exogenous formaldehyde is present in 
all human cells.  
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1.3 Fate and metabolism  
As mentioned before, both endogenous and exogenous formaldehyde can enter 
or form in our body (also shown in Figure 1.1). The major detoxification of 
formaldehyde is through glutathione-dependent enzyme systems, with ADH3 as a 
primary enzyme. Formaldehyde rapidly reacts with glutathione, forming S-
hydroxymethyl-glutathione. S-hydroxymethyl-glutathione is further converted into S-
formylglutathione and eventually formate, regenerating glutathione.  Other minor 
pathways include the metabolism by ALDH1A1 and ALDH2. In addition to the 
spontaneous reaction between formaldehyde and glutathione, as well as other minor 
pathways, formaldehyde induces diverse adducts with DNA and proteins, including 
protein adducts, DNA-protein cross-links (DPC), DNA adducts and DNA-DNA 
cross-links. We will discuss all of these formaldehyde-induced damage in the 
following chapters of this dissertation.  
 
1.4 Nasal cancer and formaldehyde exposure 
1.4.1 Animal data  
The induction of nasal squamous-cell carcinomas in rats was first found after 
inhalation of at least 6 ppm formaldehyde for up to two years(11).  In the interim 
report of this study, 120 male and 120 female rats were exposed by inhalation to 0, 2, 
5.6, or 14.3 ppm formaldehyde (6 hr/day, 5 days/week) for 18 months of a 24-month 
study. Squamous cell carcinomas were observed in the nasal cavities of 36 rats 
 5
exposed to 14.3 ppm formaldehyde after 18 months. The exposure period was 
followed by up to 6 months of nonexposure. Squamous cell  carcinomas were 
observed in the nasal cavities of 103 rats (52 females and 51 males), but only in 2 rats 
(one male and one female) exposed to 5.6 ppm of formaldehyde(12), indicating the 
incidence of nasal cancer was highly concentration dependent.  
 
1.4.2 Human data  
Formaldehyde was classified as a human carcinogen by IARC based on 
“sufficient epidemiological evidence that formaldehyde causes nasopharyngeal 
cancer in humans”, which arises from six major cohort studies of industrial workers 
and seven case–control studies of nasopharyngeal cancer(13). IARC especially 
emphasized the statistically significant excess of deaths from nasopharyngeal cancer 
observed in the National Cancer Institute (NCI) cohort(14). A statistically significant 
exposure-response relationship for both peak and cumulative exposure was identified 
in this study. The NCI cohort was the largest cohort study of industrial works and 
considered most informative by IARC. In addition, an excess of deaths due to 
nasopharyngeal cancer was also found in a proportionate mortality analysis of the 
largest U.S. cohort of embalmers(15), and in a Danish study of proportionate cancer 
incidence among workers(16). Five of seven case-control studies found elevated risk 
for overall exposure to formaldehyde or in higher exposure categories(17-24).  The 
IARC working group considered that the positive finding in the NCI cohort study of 
industrial works, coupled with largely positive results from other studies, supported 
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that formaldehyde caused nasopharyngeal cancer in humans with sufficient 
epidemiological evidence.  
However, the fact that 6 of 10 nasopharyngeal cancer deaths observed in the 
NCI study occurred in only one plant (Plant 1) and the remaining four cases occurred 
individually in the other nine plants studied casts a question about the validity of 
NCI’s suggested causal association(25-29).  The reanalysis provided little evidence to 
support NCI’s suggestion of a causal association between formaldehyde exposure and 
mortality from nasopharyngeal cancer(30). NCI’s conclusion of a possible causal 
association was driven heavily by anomalous findings in one study plant (Plant 1). An 
independent nested case–control study of 7345 workers employed at a plastics-
producing plant (Plant 1 in NCI cohort) suggested that the influence of external 
employment in the ferrous and non-ferrous metal industry, instead of formaldehyde 
exposure may account for the large nasopharyngeal cancer mortality excess found in 
Plant 1 in NCI cohort(31). Possible suspected risk factors for nasal cancer in the local 
area included sulfuric acid mists, mineral acid, metal dusts and heat. Thesse could be 
responsible for the higher nasopharyngeal cancer mortality and may explain why the 
NCI cohort had unique pattern nasopharyngeal cancer in Plant 1.  
 
1.5 Leukemia and formaldehyde exposure  
1.5.1 Epidemiology data  
Compared with the incidence and mortality rates of nasopharyngeal cancer 
(0.7 and 0.2 per 100,000), leukemia has much higher incidence and mortality rates at 
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12.3 and 7.5 per 100,000 in U.S. population, respectively(2). Thus, if formaldehyde 
causes leukemia, the number of cancers caused by formaldehyde should increase due 
to this more common and lethal cancer. Therefore, epidemiology studies may have 
better power and higher chance to detect an excess of deaths from leukemia.  In the 
past 5 years, studies on this possible association and the mechanisms underlying this 
association have attracted more and more attention from academic, industry and 
regulatory agencies due to the potential significance on this high volume chemical on 
public health. So far, however, IARC considered the data “strong but not sufficient 
evidence for a causal association between leukemia and occupational exposure to 
formaldehyde”.  
The positive association between leukemia and formaldehyde exposure was 
based on epidemiology studies including case–control study in the general population, 
proportionate mortality studies of professionals such as embalmers, funeral workers, 
pathologists and anatomists, and cohort studies of industrial workers (1). Among three 
major types of studies, cohorts in industrial works have provided the largest sample 
size and best quality for assessing causation between the induction of leukemia and 
formaldehyde exposure. Two of the three cohorts in industrial works found positive 
associations between formaldehyde exposure and leukemia, but one failed to find any 
association. 
The first large cohort in industrial workers was performed in the United 
Kingdom (32). It included 14,014 workers in chemical factories associated with either 
use or production of formaldehyde. Comparisons with a local populations, no 
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association was observed between leukemia and formaldehyde exposure (in either 
employment in the factories, or work in the high exposure group (> 2ppm)).  IARC 
considered this British cohort a high-quality study due to adequate size and 
sufficiently long follow-up. Therefore, this study should have reasonable chance to 
detect an excess of deaths from leukemia if there is any. This study did not examine 
the response to peak exposure, however, previous studies of garments and 
professionals in USA found positive findings with the same absence of evaluation of 
peak exposure.  In addition, this study did not examine the specific risk of myeloid 
leukemia, which was shown to be the primary type of leukemia in other cohort 
studies.  
The second industrial cohort was conducted by National Institute for 
Occupational Safety and Health (NIOSH) to evaluate the mortality of 11,039 workers 
exposed to formaldehyde for three months or more in three garment plants (33).The 
mean time weighted average formaldehyde exposure at the plants in the early 1980s 
was 0.15 ppm according to an exposure assessment involving 594 randomly selected 
employees, but past exposures could have been substantially higher. In this study, 
mortality from myeloid leukemia was greatest among workers first exposed when 
exposures were presumably higher although the real exposure was unknown. 
Mortality for myeloid leukemia was also high among workers with 10 or more years 
of exposure.  The result from this cohort supported a possible association between 
formaldehyde exposure and mortality arising from myeloid leukemia. 
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The third study was conducted by the NCI and included 25,619 industrial 
workers (34). They used different exposure metrics including peak exposure, average 
exposure intensity, cumulative exposure, and duration of exposure. The study 
identified positive associations between formaldehyde exposure and leukemia overall, 
but the stronger associations were seen for myeloid leukemia. Also, this strong 
association was only observed when peak exposure was used as a metric. A recent 
update of this cohort still found similar positive association between leukemia and 
formaldehyde exposure (35).  
 
1.6 Mechanistic considerations  
1.6.1 Carcinogenesis of formaldehyde   
Numerous previous studies show that formaldehyde is genotoxic, inducing 
both DNA damage such as DNA adducts and DNA-protein crosslinks (DPC) and 
chromosome changes including chromosomal aberrations (CA), sister chromatid 
exchanges (SCEs), and micronuclei (MN). These alterations have been demonstrated 
by a large number of studies using in vitro systems or exposed animals, but the results 
are inconsistent from study to study.(36-58). 
Currently available data indicate that both genotoxicity and cytoxicity play 
important role in formaldehyde’s carcinogenesis at the site of contact. Formation of 
DPC is considered a primary genotoxic effect. Earlier studies of Heck and Casanova 
demonstrated a linear response between 6, 10 and 15 ppm formaldehyde exposures 
for DPC, with a reduced number of DPC per ppm formaldehyde at 2 and 0.7 ppm due 
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to depletion of glutathione in the nasal epithelium at 6 ppm and higher exposures to 
formaldehyde(59-61). They also demonstrated that there was no accumulation of DPC 
with exposure, which was attributed to rapid repair of DPC(62).  
Marked and sustained increases in cell proliferation in the noses of rats has 
been observed after exposure to more than 6 ppm (10 ppm or higher) formaldehyde 
(63;64), which is thought to greatly amplify the genotoxic effects of formaldehyde at 
the site of contact.  
In humans, elevated DPC in peripheral mononuclear cells of formaldehyde-
exposed workers was reported (65;66), however, this study has been questioned due 
to an abnormally high background of DPC in the controls(67). Recently, the Hecht 
Lab reported clear differences in formaldehyde-DNA adducts between smokers and 
non-smokers in leukocyte DNA samples(68). This study provided the first evidence of 
formaldehyde-DNA adducts in humans, however, it may not be directly related to the 
effects of inhaled formaldehyde, since formaldehyde could be released during 
metabolism of various compounds present in tobacco.  
 
1.6.2 Leukemia  
The limited evidence for causation of leukemia concluded by IARC, is at least, 
partially based on the inability of the IRAC working group to identify a mechanism 
for the induction of leukemia in humans (1;69-71). Generally, leukemia arises from 
damage to early stem or progenitor cells in the bone marrow. Hematotoxicty or 
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genotoxicity occurs following exposure to all established chemical leukemogens(72-
81). All known leukemogens act on the bone marrow, causing marrow toxicity.  
Zhang et al. have hypothesized three mechanisms for leukemia(2;82): (1) 
Targeting bone marrow hematopoietic stem cells. This could be achieved by 
converting inhaled formaldehyde gas to hydrated methanediol which  may reach bone 
marrow and cause damage; (2) Targeting blood stem cells and progenitors.  In this 
case, formaldehyde needs to enter into the blood, after reaching the nasal/oral 
passages and lung, and induce mutations or pre-mutagenic lesions in circulating 
hematopoietic stem cells.  Then, the damaged cells are postulated to return to the bone 
marrow and undergo mutational changes leading to leukemia. (3) Targeting 
pluripotent nasal/oral stem cells.  Under this scenario, formaldehyde directly induces 
mutations or pre-mutagenic lesions in primitive pluripotent stem cells residing in the 
oral or nasal passages. Then, the damaged stem cells are released from the nasal 
passages by either normal trafficking or enhanced trafficking associated with 
formaldehyde-induced cytotoxicity, circulate through the blood, and migrate to the 
bone marrow where they divide, develop a mutation and progress toward leukemia.  
Although these proposed mechanisms are possible, they remain speculative 
since there are no data supporting the second and third mechanisms by any known 
chemicals. Therefore, these mechanisms must be backed up with scientific data.  
Based on established mechanisms by other known leukemogens and the first proposed 
mechanism by Zhang et al, formaldehyde needs to travel to the bone marrow to cause 
damage if it is to cause leukemia.  According to the second and third possible 
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mechanisms of Zhang et al, stem cells damaged in blood or nasal/oral passage need to 
migrate to bone marrow, undergo cell division and mutate. Under these situations, 
formaldehyde-induced damage needs to have a relatively long half-life to undergo 
such processes. In any of the cases mentioned above, there is a critical need to provide 
mechanistic data on the ability of formaldehyde to induce leukemia.  
 
1.7 Remaining challenges 
Overall, after almost 30 years of extensive study on formaldehyde toxicity and 
carcinogenesis, the results continue to raise additional questions.  Understanding these 
issues is confusing and frustrating, but also offers unique research opportunities. 
Several of these critical challenges will be addressed step by step in this dissertation.  
 
1.7.1 Challenge 1: To generate structural information on DPC  
DPC are considered a primary genotoxic effect and have been used as a 
biomarker to evaluate formaldehyde exposure in animals. However, before this study, 
there was little structural information about formaldehyde-induced DPC, even though 
the formation of DPC had been known for decades.  The absence of structural 
information greatly hinders our understanding on formaldehyde toxicity and 
carcinogenesis. It is not clear whether DPC are initiated by formaldehyde-induced 
protein damage or DNA lesions. It is not clear which residues of protein are involved 
in the formation of DPC. It is not clear which specific DNA bases are cross-linked 
with protein. It is not clear what the stability of DPC are and what the corresponding 
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half-lives are.  It is not clear if chemical-specific biomarkers based on DPC can be 
established. All these unknown, yet intriguing questions rely on strict structural 
elucidation and relevant studies, which will be discussed in Chapters 2 and 3.  
 
1.7.2 Challenge 2: No specific DNA biomarkers are available for formaldehyde 
inhalation exposure 
DPC were used as biomarkers to evaluate formaldehyde exposure in animals 
and to establish exposure-responses following inhalation exposure. However, all 
available methodologies on DPC are based on physical chemistry, which use either 
the different solvbility of DNA, protein and DPC in organic/aqueous phase 
(Interfacial method used by Heck et al.) or the precipitation of DPC in potassium 
solution (SDS/K method developed by Zhitkovich et al)(83;84). None of these 
methods represent a chemical-specific approach that needs to be established using 
rigorous structure elucidation and unambiguous signal assignment. If additional 
protein damage or DNA lesions occurred at other positions in addition to cross-
linking sites, the general resolution of these approaches does not allow the 
differentiation between them and DPC. Therefore, the quantitative data based on these 
non-specific methods are not rigorous and do not represent ideal data sets for use in 
risk assessment. To date,  no formaldehyde DNA adducts have been identified in 
animals exposed by inhalation. Recently, the Hecht laboratory reported increased 
amounts of formaldehyde-induced N6-HOCH2-dA in multiple tissues of rats treated 
with N-nitrosodimethylamine (NDMA) or 4-(methylnitrosamino)-1-(3-pyridyl)-1-
 14
butanone (NNK), which was attributed to the production of formaldehyde during the 
metabolism of NDMA and NNK . However, it is still not clear whether or not this 
DNA biomarker could be used to evaluate formaldehyde exposure through inhalation. 
Therefore, additional biomarker discovery research and validation needs to be done. 
The identification and application of  formaldehyde DNA biomarkers will be found in 
Chapters 4 and 5.  
 
1.7.3 Challenge 3: Differentiating endogenous and exogenous formaldehyde 
As we mentioned before, formaldehyde is a ubiquitous environment pollutant. 
Of equal importance, formaldehyde is an essential metabolic intermediate in all 
human cells. The endogenous concentration of formaldehyde in the blood of human 
subjects is about 0.1mM. Thus, the ability to distinguish DNA damage caused by 
exogenous formaldehyde from substantial background endogenous formaldehyde-
induced lesions is crucial.  Accurate molecular dosimetry of both endogenous and 
inhaled formaldehyde is essential for the science-based risk assessment of 
formaldehyde exposure. It is also critical to determine the plausibility of inhaled 
formaldehyde to induce leukemia. Currently, there are no available studies providing 
molecular dosimetry for both endogenous and exogenous formaldehyde. We will 
address this paramountly important issue by using highly sensitive mass spectrometry, 
coupled with the utilization of [13CD2]-formaldehyde in animal exposures. This 
unique approach allows us to differentiate DNA damage originating from both 
endogenous and inhaled [13CD2]-formaldehyde and to quantify corresponding DNA 
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adducts.  The application of this approach and results will be demonstrated in Chapter 
5.  
 
1.7.4 Challenge 4: Whether or not formaldehyde has distant genotoxic effects  
The critical issue concerning the ability of formaldehyde to induce leukemia is 
whether or not formaldehyde has distant genotoxic effects. All established 
leukemogens act on the bone marrow, causing marrow toxicity.  Formation of DNA 
adducts is thought to be a key event of significance in initiating cancer. Therefore, 
valuable information on this question will be provided by examining the formation of 
formaldehyde-induced DNA adducts at site of contact and distant tissues, such as 
bone marrow. In addition, the use of [13CD2]-formaldehyde in animal exposures 
coupled with mass spectrometry will unambiguously identify DNA damage arising 
from endogenous and inhaled sources. The molecular dosimetry data generated in this 
study will provide critical evidence for science-based risk assessment of 
formaldehyde exposure. More importantly, the tissue distribution of exogenous 
formaldehyde-induced DNA damage will provide strong evidence about the 
biological plausibility of formaldehyde to induce leukemia. The data toward this end 
are demonstrated in Chapter 5.  
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Figure 1.1. Fate and metabolism of formaldehyde 
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CHAPTER 2 
2. FORMALDEHYDE-INDUCED HISTONE MODIFICATIONS IN VITRO 
 
This paper has been published and therefore is reproduced with permission 
from [Kun Lu, Gunnar Boysen, Lina Gao, Leonard B. Collins and James A. 
Swenberg. Formaldehyde-Induced Histone Modifications in Vitro. Chem. Res. 
Toxicol., 2008, 21 (8), pp 1586–1593] Copyright [2008] American Chemical Society.  
 
2.1 Abstract 
Numerous experiments have demonstrated the genotoxic and mutagenic 
effects of formaldehyde, including DNA-protein crosslinks (DPC). Histone was 
reported to be involved in the formation of DPC in which the epsilon-amino groups of 
lysine and exocyclic amino groups of DNA were thought to be cross-linked through 
multiple step reactions. Using mass spectrometry, the N-terminus of histone and 
lysine residues located in both the histone N-terminal tail and the globular fold 
domain were identified as binding sites for formaldehyde in the current study. The 
observation that only lysine residues without post-translational modification (PTM) 
can be attacked by formaldehyde indicates that PTM blocks the reaction between 
lysine and formaldehyde. Additionally, we found that formaldehyde-induced Schiff 
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based on lysine residues could inhibit the formation of PTM on histone, raising the 
possibility that formaldehyde might alter epigenetic regulation. 
 
2.2 Introduction 
 Formaldehyde is produced worldwide on a large scale and is widely used in 
the manufacture of resins, particle board, plywood, leather goods, paper, 
pharmaceuticals and other products (1). Therefore, occupational and environmental 
exposures to formaldehyde are quite common. Previous research has demonstrated 
that formaldehyde is genotoxic and mutagenic to mammalian cells, as well as to 
bacteria and lower eukaryotes (1-6). Exposure to formaldehyde results in the 
formation of DNA-protein crosslinks (DPC) as a primary genotoxic effect (2-7), and 
histones are reported to be cross-linked to DNA (7, 8).  The formation of DPC, in 
which the epsilon-amino groups of lysine and exocyclic amino groups of DNA are 
thought to be involved (9, 10), proceeds in multiple-step reactions, with formaldehyde 
initiating an attack on the amino groups of protein, followed by DPC formation.  
 Core histones are located in the nucleosome, the fundamental repeating unit of 
chromatin, and contain a histone 3 (H3) /histone 4 (H4) tetramer flanked by 2 histone 
2A (H2A) /histone 2B (H2B) dimers, around which 147 base pairs of DNA are 
wrapped (11). The highly conserved structure of histone includes a folded core and an 
unstructured tail. The histone core is a globular fold domain with a helix-loop-helix-
loop-helix motif, which facilitates dimerization through a hand-shaking motion (12). 
However, the crystal structure reveals that histone tails do not have any defined 
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conformation. Many conserved amino acid residues such as lysine are subject to a 
broad spectrum of post-translational modifications (PTM) including methylation and 
acetylation. These modifications impact biological actions such as gene expression by 
acting as markers for the specific recruitment of regulatory complexes and by 
changing the structure of the chromatin between heterochromatin and euchromatin, 
which is usually referred to as epigenetic regulation (13).  
 It has been shown that the lysine residues of histones are probably involved in 
DPC. However, the accessibility of amino acids, which is controlled not only by 
reactive ability but also the conformation states of the residues (14), has not been 
evaluated. In addition, a wealth of post-translational modifications on histone raises 
the question whether the PTM on histone have any influence on the reaction with 
formaldehyde. Another very important question is whether formaldehyde-induced 
modifications impact the formation of PTM on histone lysine residues.  In this 
investigation, histone 4 was chosen as our model histone protein due to its 
indispensable role in epigenetic regulation. Using mass spectrometry, we have now 
identified the residues of histone 4 which are accessible to formaldehyde binding. We 
have also demonstrated that PTM on lysine residues block the reaction between 
formaldehyde and the epsilon-amino groups of lysine residues. In addition, we found 
that formaldehyde-induced Schiff bases on lysine can inhibit the formation of PTM.  
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2.3 Materials and Methods  
2.3.1 Chemicals and Reagents 
Potassium phosphate, ammonium bicarbonate, glycine, trifluoroacetic acid, 
formic acid, acetonitrile, sodium cyanoborohydride (NaCNBH3), acetyl coenzyme A 
trilithium salt (acetylCoA) and endoproteinase Asp-N were purchased from Sigma 
(St. Louis, MO). Modified sequencing grade trypsin and chymotrypsin were from 
Promega (San Luis Obispo, CA) and PrinSep (Adelphia, NJ), respectively. The 
histone 4 isolated from calf thymus was purchased from Roche Applied Science 
(Indianapolis, IN) and human recombinant histone 4 expressed in E.coli, active PCAF 
enzyme and 5X histone acetylation (HAT) assay buffer (250 mM Tris-base, pH=8.0, 
50% glycerol, 0.5 mM EDTA and 5 mM dithiothreitol) were obtained from Millipore 
(Billerica, MA). 20% formaldehyde in water was procured from Tousimis (Rockville, 
MD), while stable isotope-labeled formaldehyde, 13CH2O, was obtained from 
Cambridge Isotope Laboratories (Andover, MA). The peptides were synthesized by 
Genscript Corporation (Piscatway, NJ). All chemicals were used as received unless 
otherwise stated.  
 
2.3.2 Experimental Methods 
The analytical approach used in this study is illustrated in Scheme 2.1. First, 
the reaction of histone 4 with formaldehyde was performed, followed by reduction 
with NaCNBH3. 20 µg of histone 4 was dissolved in 50 µL 10 mM potassium 
phosphate buffer (pH=7.2).  Formaldehyde then was added to a final concentration of 
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either 5 mM or 50µM. After a 10 min of reaction between formaldehyde and histone, 
reduction was performed with NaCNBH3 at a final concentration of 5 mM. The 
reaction solution was further incubated for 3 hours. Excessive formaldehyde and other 
small chemicals were removed using Millipore Microcon YM-3 spin columns with a 
3000 molecular weight cutoff (MWCO). Two identical reactions were prepared using 
either native formaldehyde (12CH2O) or 13C labeled formaldehyde (13CH2O). After 
proteolysis, equimolar amounts of 12CH2O-treated and 13CH2O-treated histone 4 
desalted digestion solutions were mixed for further mass spectrometry analyses. In 
addition, the resultant histone 4 from the formaldehyde and NaCNBH3 treatment was 
further treated separately with formaldehyde or formaldehyde plus equimolar glycine.  
In these reactions, the final concentration of formaldehyde or glycine varied from 5 
mM to 100 mM and the reaction time ranged from 3 hours to 2 weeks.  
 
2.3.3 Digestion by Enzymes 
Untreated histone 4 and formaldehyde-treated histone 4 were digested with 
trypsin, chymotrypsin, and endoproteinase Asp-N, individually. For the trypsin 
digestion, 20 µg of histone was dissolved in 50 mM NH4HCO3 (pH=7.8), and 0.4 µg 
of trypsin was added. The solution was incubated for 3 hours at 37 °C. For 
chymotrypsin cleavage, 0.4 µg of chymotrypsin was mixed with 20 µg of histone 
dissolved in 50 mM Tris HCl (pH=8.0) and 1 mM CaCl2. The digestion mixture was 
incubated for 3 hours at 30 °C. Endoproteinase Asp-N digestion was performed in 
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100 mM NH4HCO3 (pH=8.5) at a 1:50 enzyme to substrate ratio for 18 hours at 37 
°C.  
 
2.3.4 Histone Acetylation Assay 
5 µg of synthetic histone 4 N-terminal peptide (amino acid 1-23) and 500 ng 
of active PCAF enzyme were dissolved in 1X HAT assay buffer. AcetylCoA was 
added to a final concentration of 0.2 mM and the solutions were incubated for 1 hour 
at 30 °C with shaking. The resultant reaction mixtures were analyzed by liquid 
chromatography-mass spectrometry. In parallel, 10 µg of histone 4 synthetic peptide 
was treated with 50 mM formaldehyde at room temperature for 3 hours. The 
formaldehyde-modified peptide was dried using a speed vacuum. Then the 
formaldehyde-modified peptide was incubated with active PCAF enzyme for the HAT 
assay, followed by mass spectrometry analysis.  
 
2.3.5 Liquid Chromatography-Mass Spectrometry (LC-MS) 
LC-MS analyses were performed on an ion trap mass spectrometer LCQ-Deca 
(Thermo Electron, Waltham, MA) operating in full scan as well as dependent scan 
mode. Analytes were separated by reverse phase chromatography using a 250 mm × 
2.5mm analytical column from Grace Vydac (Hesperia, CA). The mobile phase 
consisted of 0.1% formic acid in water (solvent A) and acetonitrile (solvent B). A 
linear gradient was started from 5% acetonitrile to 55% in 15 min. The flow rate of 
the mobile phase was set as 200 µL/min. An electrospray ionization (ESI) source was 
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used to analyze peptide samples. For the fragmentation of precursor ions, the 
normalized collision energy varied from 30% to 35%, depending on the structures of 
peptides. The activation time was set at 30 msec.  
 
2.3.6 Matrix-Assisted Laser Desorption/Ionization Tandem Time-of-Flight Mass 
Spectrometry (MALDI-TOF MS) 
MALDI-TOF mass spectrometric analyses were performed on a 4700 
Proteomics Analyzer (Applied Biosystems, Framingham, MA) operating in reflectron 
mode. Most of the tandem mass spectrometric experiments were performed on the 
MALDI-TOF/TOF mass spectrometer using air as the collision gas at a medium 
pressure setting (4e-007 torr) and a laser intensity of 5400 ABI units (Nd-Yag laser, 
355 nm wavelength, 3–7 ns pulse, >12 µJ pulse energy.). The matrix applied for 
peptide analysis was α-cyano-4-hydroxy-cinnamic acid. The MS-Digest or MS-Fit 
program (Protein Prospector, University of California at San Francisco) was used to 
automatically assign the peptides. The MS/MS fragment ion spectra were manually 
matched to the predicted peptide fragmentation generated by Data Explorer software.  
 
2.4 Results  
2.4.1 Characterization of Histone 4 
Two different types of histone 4 were used in this study. Histone 4 with PTM 
was isolated from calf thymus tissues, while unmodified human recombinant H4 was 
purified after expression in E.coli cells. The sequences of the both proteins were 
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identical. Prior to the formaldehyde reaction, the purity and molecular weight of 
histone 4 were examined by LC-MS. Histone 4 was digested with trypsin and 
chymotrypsin to improve the coverage for peptide mapping, yielding 6 and 11 
detectable fragments for trypsin and chymotrypsin proteolysis, respectively, as listed 
in Table 1.   
 By combining the peptides from independent trypsin and chymotrypsin 
digestion, all the residues located in the histone fold domain could be covered. 
However, neither trypsin nor chymotrypsin was able to provide any information about 
the histone N-terminal tail. To obtain this data, endoproteinase Asp-N was utilized to 
produce N-terminal peptides. This protease cleaves proteins at the amino side of 
aspartic acid. In theory, this will result in 4 non-overlapping peptides in complete 
digestion. The largest predicted fragment at 5004.91 Da is over the cutoff of the 
MALDI-TOF mass spectrometer operating at reflectron mode, so only 3 peptides 
were observed, as listed in Table 1. In addition, after the Asp-N digestion of histone 4 
with PTM, two abundant peptides with PTM were detected, as shown in Table 1.  
 
2.4.2 Evaluation of the Accessibility of Lysine Residues 
The reaction between formaldehyde and amine involves a nucleophilic attack 
of amine on the carbonyl group of formaldehyde, followed by rapid proton transfer 
resulting in methylol groups. Subsequently, labile Schiff bases are produced after 
dehydration of methylol. These two reactions are both reversible, thus they can not be 
easily detected. Therefore, a reduction approach with sodium cyanoborohydride was 
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chosen to reduce the Schiff base to a detectable dimethylamino structure. The reaction 
mechanism is shown in Scheme 2.2.  First, a Schiff base formed from formaldehyde 
attack is quickly reduced to a secondary amine, which is relatively more reactive than 
a primary amine. The secondary amine then reacts with another formaldehyde 
molecule and is further reduced to form a dimethylamino group (15).  
 In addition to 12CH2O, stable isotope-labeled formaldehyde, 13CH2O, was used 
to treat histone 4. Mixing equal ratios of 12CH2O- and 13CH2O- peptides results in the 
formation of doublets in a mass spectrum. The mass difference between a doublet 
allows us to calculate how many formaldehyde molecules were incorporated into each 
peptide. For instance, if the mass difference between the peptide pair equals 2, this 
indicates that 2 formaldehyde units reacted with the residue and, consequently, 1 
lysine residue is reactive with formaldehyde. Thus the general formula is n=∆m/2, 
where n is the number of reactive lysines and ∆m corresponds to the mass difference 
between the doublet.  
 The accessibility of each lysine residue by formaldehyde was confirmed by 
either MALDI-TOF or LC-MS. A good match of mass increase after formaldehyde 
treatment or MS/MS fragmentation pattern of formaldehyde-modified peptides 
permitted the identification of the exact reactive sites with high confidence. The 
formaldehyde-modified histones were digested with 3 different enzymes, and the 
resulting peptides were analyzed by MALDI-TOF mass spectrometry to determine the 
mass increases of individual peptide sequences upon formaldehyde treatment (Table 
2). 
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 There were 5 detectable tryptic peptides by MALDI-TOF mass spectrometry, 
with three of them having the corresponding doublets when 13C labeled formaldehyde 
was used, as listed in Table 2. Figure 2.1A shows a typical doublet (∆m=2 Da) arising 
from the application of 12CH2O and 13CH2O. It is very straightforward to assign the 
peptide at 1353.85 Da as the dimethylated product of original tryptic peptide at 
1325.77 Da ( 24DNIQGITKPAIR35 ) after observing the 28 Da mass increase and a 
doublet separated by 2 Da. The specific sequence and exact reaction sites were 
confirmed by MS/MS sequencing with MALDI TOF/TOF and the MS/MS 
fragmentation pattern of the precursor ion of 1353.82 Da is given in Figure 2.1B. 
 According to the doublets resulting from 13C labeled formaldehyde, the 
fragments at 1414.96 and 1651.07 Da were identified as having 1 and 2 lysine 
residues accessible to formaldehyde. Their structures were determined to be 
56GVLK2meVFLENVIR67 and 79K2meTVTAMDVVYALK2meR92, respectively. It is 
interesting to note that two expected tryptic peptides at 989.57 and 1310.70 Da 
disappeared after the reaction with formaldehyde. However, no direct formaldehyde-
induced precursor ions could be attributed to them. Increased cleavage resistance from 
the dimethylation at K59 and K91 after NaCNBH3 reduction could be responsible for 
their absence. 
 Two unique fragments at 1297.87 Da and 1905.10 Da (shown in Figure 2.1C) 
were identified as 38ARRGGVK2meRISGL49 and 
73TEHAK2meRK2meTVTAMDVVY88 after chymotrypsin proteolysis, suggesting that 
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K44 and K77 are two additional residues in the fold domain that can be attacked by 
formaldehyde.  
 
The accessibility of lysine residues along the N-terminal tail was evaluated 
after endoproteinase Asp-N cleavage, which liberated the N-terminal peptide 
consisting of the first 23 amino acids. According to the mass difference (∆m=12 Da) 
between the resulting doublet, 12 formaldehyde units were incorporated into the 5 
lysine residues and the N-terminus, resulting in 168 Da mass increases (∆M=168 Da) 
compared with the untreated N-terminal peptide (shown in Figure 2.1D). Therefore, 
all the lysine residues located in the globular fold domain and the N-terminal tail 
coupled with the end amino group of the N-terminus are accessible to formaldehyde, 
providing a total of 12 potential reactive sites. The reactive sites identified by mass 
spectrometry are visualized in a structural model, as shown in Figure 2.1E.  
 In addition to the high concentration formaldehyde used in this study, a 
physiological level of formaldehyde (50 µM) was also used to treat histone 4. The 
binding sites we identified were consistent with those found based on the experiment 
using the higher formaldehyde treatment (5mM) (data not shown here). The 
concentration of formaldehyde only influenced the percentage of modified histone, as 
shown in Figure 2.2.  Figure 2.2A shows the molecular weight of unmodified histone 
4 (11236 Da), which was determined after deconvoluting the peaks from ESI-MS. 
Figure 2.2B gives the deconvoluted spectrum for the 5mM formaldehyde-treated 
histone sample. The most intense peak was attributed to modified histone and its 
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molecular weight was determined to be 11574 Da.  The mass increase (about 338 Da) 
resulted from the formation of dimethyl groups on 11 lysine residues as well as the N-
terminal amino group.  Figure 2.2C shows the deconvoluted mass spectrum of histone 
treated with 50 µM formaldehyde.  Two major peaks were found and assigned as 
unmodified histone 4 (11236 Da) and formaldehyde-modified histone 4 (11574 Da). 
Compared with Figure 2.2B, the percentage of modified histone is much lower than 
that of the higher formaldehyde-treated sample.  
 In theory, other amino acids including arginine, glutamine, tyrosine, histidine, 
cystine, and asparagines could also potentially react with formaldehyde (14). 
However neither the formaldehyde, nor the formaldehyde-glycine treatment described 
in the experimental section yielded any detectable modifications on these residues 
using the current analytical approach. Remarkably, we found that a 1 hour reaction at 
37 °C with 5 mM formaldehyde can induce obvious intermolecular crosslinks, but no 
such crosslinks could be observed even with a 2 week, 100 mM formaldehyde 
treatment once these lysine residues of histone were blocked by dimethylation (data 
not shown). These results may further highlight the higher reactivity and importance 
of lysine in forming intermolecular crosslinks.  
 
2.4.3 Influence of PTM on the Reaction 
Prior to formaldehyde treatment, H4 with PTM was cleaved by endoproteinase 
Asp-N, and the resultant abundant N-terminal peptides are shown in Figure 2.3 
(Control panel). The peptide fragment at 2430.54 Da was assigned to the peptide 
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1SGRGKGGKGLGKGGAKRHRKVLR23 with dimethylation on K20 and one 
acetylation on the N-terminus, while the peptide observed at 2472.55 Da had an 
additional acetylation on lysine, resulting in 42 Da mass increases compared with the 
fragment at 2430.54 Da. These assignments are consistent with previous 
identifications of histone acetylation isomers (16).   
 Figure 2.3 (Treatment panel) shows the mass spectrum of formaldehyde-
treated histone 4 after Asp-N digestion. Two relatively abundant fragments were 
observed at 2542.71 Da and 2556.68 Da corresponding to the formaldehyde-modified 
products of untreated peptides at 2430.54 Da and 2472.55 Da (∆M equals 112 and 84 
Da, respectively). Although unmodified histone offers 5 lysine residues and the N-
terminus as potential reactive sites along the N-terminal tail, the number of reactive 
lysine residues was determined to be 4 and 3 for the fragments at 2542.71 Da and 
2556.68 Da, respectively. The observation that only the lysine residues void of PTM 
could be attacked by formaldehyde clearly shows that PTM inhibits the reaction 
between formaldehyde and lysine.     
 
2.4.4 Impact of Formaldehyde-Induced Modifications on PTM Formation 
Figure 2.4A shows the ESI spectrum of a synthetic H4 N-terminal peptide, 
which was used as the substrate of histone acetyltransferases for the histone 
acetylation assay. The precursor ion at 1181.45 m/z is the doubly charged form of H4 
N-terminal peptide. Figure 2.4B shows the ESI mass spectrum of histone 
acetyltransferase (PCAF)-treated H4 N-terminal peptide, which was obtained after 
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incubating H4 N-terminal peptide with PCAF enzyme in the presence of acetylCoA 
for 1 hour at 30 °C. Doubly charged ions at 1202.24 m/z and 1223.84 m/z are 
monoacetylated (m/z increase=21 Da) and diacetylated (m/z increase=42 Da) H4 N-
terminal peptides.  
 Figure 2.4C shows the ESI mass spectrum of a formaldehyde-modified H4 N-
terminal tail. The m/z shift is about 36 Da for a doubly charged ion, which is 
attributed to the formation of 6 Schiff bases on lysine residues as well as the N-
terminus. Figure 2.4D shows the ESI mass spectrum of a formaldehyde-modified H4 
N-terminal peptide after a histone acetyltransferase treatment. It was generated by 
incubating formaldehyde-modified H4 N-terminal peptide with PCAF enzyme in the 
presence of acetylCoA for 1 hour at 30 °C. Compared with the formaldehyde-
modified H4 N-terminal peptide shown in Figure 2.4C, no mass increase upon further 
histone acetyltransferase treatment could be observed, which clearly shows that 
formaldehyde-induced Schiff bases inhibit the formation of PTM in vitro. 
 
2.5 Discussion  
 One of the goals of this study was to evaluate the reactivity of histone residues 
towards formaldehyde using mass spectrometry. We have unambiguously 
demonstrated that all the lysine residues located in both the globular fold domain and 
the unstructured N-terminal tail are accessible to formaldehyde. We also found that 
PTM on histone residues inhibited the attack of formaldehyde. Additionally, we 
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demonstrated that formaldehyde-induced lysine modifications inhibited the formation 
of PTM in vitro.  
 One question may be raised by the observation that PTM on residues inhibits 
the reaction between formaldehyde and lysine residues. Histones are subject to a 
variety of post- translational modifications, including methylation, acetylation and 
phosphorylation. The accessibility of DNA for many important biological events such 
as transcription, replication, recombination and repair is regulated by these 
modifications through forming either open or condensed chromatin (17). As far as the 
histone 4 tail is concerned, K5, K8, K12, K16 and the end amino group of S1 can be 
acetylated, whereas methylation occurs on K20, which can be mono-, di- or 
trimethylated on the side chain (16). Are the lysine residues still accessible to 
formaldehyde considering the widespread occurrence of PTM on histone?  It is well 
known that histone acetylation is catalyzed by histone acetyltransferases, and histone 
deacetylation is realized by histone deacetylases, making this process completely 
reversible (18). Lysine methylation was once thought to be an irreversible process, 
however enzymes identified recently are capable of demethylating histone at specific 
sites (19). Although lysine residues are protected by PTM, formaldehyde could still 
attack lysine residues provided the PTM is removed. Our finding highlights the 
importance of less modified states of histone or nascent histone, which usually is only 
diacetylated in the cytoplasm at K5 and K12 by B-type histone acetyltransferase (16). 
 The second question is how the modifications caused by formaldehyde evolve. 
There are three different structures for such modifications. The reaction between 
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formaldehyde and lysine includes the quick formation of methylol groups, followed 
by the formation of Schiff bases from partial dehydration of methylol groups. The 
final step may yield intra-molecular or inter-molecular crosslinks, depending on the 
local physical and chemical environment of reactive groups. Although methylol and 
Schiff bases are involved in reversible reactions, the existence of all three structures 
was confirmed in previous research using mass spectrometry or NMR (14). Therefore, 
these distinct structures have potential biological impact. As we have shown, Schiff 
bases induced by formaldehyde inhibit the formation of PTM on lysine in vitro. 
Clearly, additional experiments need to be done in order to track the exact structure 
occurring on individual lysine molecules and the corresponding biological influence 
in vivo.  
 Although previous studies have demonstrated the genotoxic and mutagenic 
effects of formaldehyde, the fact that all lysine residues are the targets of 
formaldehyde raises the possibility of an additional mode of action for its toxicity. 
Formaldehyde could alter epigenetic regulation in which histone modifications 
occurring on lysine play a central role. We have clearly shown that formaldehyde-
induced Schiff bases inhibit the formation of PTM on lysine. Therefore, these 
formaldehyde-induced lysine adducts on histone may impair the PTM pattern and 
possibly disturb the subsequent recruitment of specific proteins highly associated with 
the PTM pattern, triggering a series of abnormal cascade effects. Additionally, the 
balance between histone acetylation and deacetylation could be disturbed by the 
attachment of formaldehyde on lysine residues. The balance between histone 
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acetylation and deacetylation is important for normal cell growth, and an imbalance of 
acetylation in promoter regions may induce the deregulation of gene expression. 
Accumulating evidence has linked imbalances between acetylation and deacetylation 
to carcinogenesis and cancer progression (20-22). However, our finding that 
formaldehyde-induced Schiff bases inhibit the formation of PTM is based on a 
simplified in vitro model. Furthermore, the Schiff bases are generally reversible in 
nature. Therefore, additional experiments in cells or tissues will be needed to 
demonstrate that such effects occur in biology.  
 In conclusion, identification of reactive sites on histone is an initial step in 
understanding the mechanisms of formaldehyde toxicity and carcinogenicity, with 
many questions remaining to be elucidated. What is the structure and fate of 
formaldehyde-induced lysine adducts? What is the biological impact of 
formaldehyde-induced modification on each lysine residue? Where are the exact sites 
for the formation of DPC? What are the toxicological mechanisms of DPC? How are 
DPC repaired? Further in vitro and in vivo experiments should be carried out in order 
to shed light on these intriguing questions.   
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Figure 2.1.  Mass spectra of formaldehyde-modified histone 4 peptides. (A) The 
formation of a doublet separated by 2 Da after native formaldehyde and 13C labeled 
formaldehyde treatment. (B) MALDI-TOF/TOF MS/MS spectrum of the precursor 
ion at 1353.82 Da with the identified structure as 24DNIQGITK2mePAIR35. (C) 
MALDI-TOF MS spectrum of two doublets, 1297.87-1299.87 and 1905.10-1909.11, 
obtained after chymotrypsin proteolysis. (D) MALDI-TOF Mass spectrum of 
unmodified N-terminal peptide observed at 2360.68 Da after Asp-N cleavage (Control 
panel) and formaldehyde-modified N-terminal doublet separated by 12 Da after Asp-
N digestion (Treatment panel). (E) The representation of reactive sites including 
lysine and the N-terminus of histone 4. The potential reactive residues are shown with 
a sphere model, constructed based on a 1.9 Å crystal structure (PDB Code:1KX5) and 
rendered with PyMOL (DeLano Scientific LLC, Palo Alto, CA) 
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Figure 2.2.  The molecular weight of untreated histone 4 and formaldehyde-treated 
histone 4.  (A) The mass spectrum of histone 4 after deconvoluting major peaks from 
ESI-MS, showing the molecular weight of histone 4 equal to 11236 Da.   (B) The 
deconvoluted mass spectrum for the 5mM formaldehyde-treated histone 4 sample. (C) 
The deconvoluted mass spectrum for the 50 µM formaldehyde-treated histone 4 
sample.  
0
10
20
30
40
50
8000 9000 10000 11000 12000 13000 14000 15000 16000
C:\_Users\Kun\other\kun_03092008_70_702-793.dec
In
te
ns
ity
 x
 1
0^
6
Mass, Da
0
50
100
150
200
250
8000 9000 10000 11000 12000 13000 14000 15000 16000
C:\_Users\Kun\other\kun_033108_08_708-801a.dec
In
te
ns
ity
 x
 1
0^
6
Mass, Da
0
10
20
30
40
50
60
70
80
8000 9000 10000 11000 12000 13000 14000 15000 16000
C:\_Users\Kun\other\kun_033108_07_707-800a.dec
In
te
ns
ity
 x
 1
0^
6
Mass, Da
11236 Da 
      11236 Da  
11574 Da 
      11236 Da 
11574 Da 
A 
B 
C 
 48
 
 
 
 
 
 
 
Figure 2.3.  MALDI-TOF MS spectrum of two abundant histone 4 N-terminal 
peptides with PTM observed at 2430.54 and 2472.55 Da after Asp-N cleavage prior to 
formaldehyde treatment (Control panel) and MS spectrum of two formaldehyde-
modified N-terminal peptides observed at 2542.71 and 2556.68 Da after Asp-N 
digestion (Treatment panel).  
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Figure 2.4.   Impact of formaldehyde-induced modification on PTM formation. (A) 
ESI mass spectrum of a synthetic histone 4 N-terminal peptide (amino acid 1-23). A 
doubly charged ion is shown in the spectrum. (B) ESI mass spectrum of the PCAF 
enzyme-treated histone 4 N-terminal peptide. The fragments at 1202.24 m/z and 
1223.84 m/z are monoacetylated and diacetylated histone 4 N-terminal peptides. (C) 
ESI mass spectrum of the formaldehyde-modified histone 4 N-terminal peptide. The 
36 m/z increase is attributed to the formation of 6 Schiff bases on lysine and the N-
terminus. (D) ESI mass spectrum of the formaldehyde-modified histone 4 N-terminal 
peptide treated by PCAF enzyme. The precursor ion at 1217.31 m/z presents the same 
mass with formaldehyde-modified histone 4 N-terminal peptide. 
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Schemes 
 
Scheme 2.1. The analytical approach used in this study. 
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Scheme 2.2. The formation of a Schiff base and its reduction to a dimethylated group 
by NaCNBH3. 
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Tables 
Table 2.1. Peptide fragments of histone 4 observed by mass spectrometry 
No Peptide fragments Calculated  (Da) 
Measured 
(Da) ∆(ppm) 
1a 96TLYGFGG102 714.34 714.35 19.4 
2 60VFLENVIR67 989.57 989.58 10.3 
3 46ISGLIYEETR55 1180.62 1180.66 36.2 
4 68DAVTYTEHAK77 1134.54 1134.55 9.07 
5 80TVTAMDVVYALK91 1310.70 1310.71 6.71 
6 24DNIQGITKPAIR35 1325.75 1325.77 14.5 
7b 91KRQGRTLV98 1021.59 1021.63 40.5 
8 89ALKRQGRTL97 1042.64 1042.69 42.4 
9 50IYEETRGVL58 1079.57 1079.61 42.7 
10 89ALKRQGRTLY98 1205.71 1205.76 43.7 
11 38ARRGGVKRISGL49 1269.78 1269.84 45.9 
12 62LENVIRDAVTY72 1292.68 1292.74 46.4 
13 38ARRGGVKRISGLIY51 1545.93 1546.01 53.4 
14 59KVFLENVIRDAVTY72 1666.91 1667.01 57.8 
15 23RDNIQGITKPAIRRL37 1751.03 1751.12 48.9 
16 73TEHAKRKTVTAMDVVY88 1848.96 1849.07 59.7 
17 38ARRGGVKRISGLIYEETRG58 2330.34 2330.50 71.1 
18c 68DAVTYTEHAKRKTVTAM84 1921.98 1922.03 28.7 
19 85DVVYALKRQGRTLYGFGG102 2000.07 2000.11 19.7 
20 1SGRGKGGKGLGKGGAKRHRKVLR23 2360.43 2360.43 15.5 
21d 1SacGRGKGGKGLGKGGAKRHRK2meVLR23 2430.47 2430.54 28.8 
22 1SacGRGKGGKGLGKGGAKacRHRK2meVLR23 2472.48 2472.55 28.3 
a: Peptides 1-6 were obtained after trypsin digestion. 
b: Peptides 7-17 were yielded by chymotrypsin cleavage.   
c: Peptides 18-22 were observed after Asp-N proteolysis.  
d: Peptides 21-22 were obtained from histone 4 with PTM 
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Table 2.2.  Formaldehyde-modified histone 4 peptide fragments observed by MALDI-TOF mass spectrometry 
No. Observed Doublets Sequence ∆M (Da) 
∆m 
(Da) n 
1 a 1353.85 1355.86 24DNIQGITK2mePAIR35 +28 2 1 
2 1414.96 1416.96 56GVLK2meVFLENVIR67 +28 2 1 
3 1651.07 1655.08 79K2meTVTAMDVVYALK2meR92 +56 4 2 
4 b 1297.87 1299.87 38ARRGGVK2meRISGL49 +28 2 1 
5 1905.10 1909.11 73TEHAK2meRK2meTVTAMDVVY88 +56 4 2 
6 c 2528.83 2540.86 1S2meGRGK2meGGK2meGLGK2meGGAK2meRHRK2meVLR23 +168 12 6 
∆M: mass increase of peptide upon formaldehyde treatment 
∆m: mass difference between the doublets 
n: the number of reactive lysine residue and N-terminal amino group 
a: Peptides 1-3 were obtained after trypsin digestion. 
b: Peptides 4-5 were yielded by chymotrypsin cleavage. 
c: Peptide 6 were observed after Asp-N proteolysis.
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CHAPTER 3 
3. CHARACTERIZATION OF FORMALDEHYDE-INDUCED DNA-PROTEIN 
CROSS-LINKS 
3.1 Introduction  
Formaldehyde is a ubiquitous environmental contaminant, with human exposures 
occurring during use in industrial processes such as the manufacture of resins, particle 
board, plywood, leather goods, paper, and pharmaceuticals and through emission as a 
vapor over the lifetimes of these products(1). Formaldehyde also occurs endogenously as 
a normal metabolic intermediate in human cells as well as under certain pathological 
conditions such as oxidative stress. While formaldehyde is a known carcinogen and 
mutagen and has thus evoked serious health concerns(2-6), its mode of action is not well 
understood. Among the interactions of formaldehyde considered to have biological 
relevance is the induction of DNA adducts(7-13), protein modifications(14-16), inter-
strand DNA cross-links(17-19), and DNA-protein cross-links (DPCs)(20;21), with the 
formation of DPCs being considered as the primary genotoxic effect following exposure 
to formaldehyde(2-6).The two routes shown in Scheme 3.1 may be responsible for the 
formation of DPCs. In pathway A, formaldehyde addition at a nucleophilic site on a 
protein is followed by cross linking between the resulting protein methylol adduct and a 
nucleophilic site on DNA, while in pathway B, addition at a nucleophilic site on a DNA 
base is followed by cross-linking between the DNA methylol adduct and a protein
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residue. The formation of DPCs is favored by intimate interactions between DNA and 
proteins(22) and the lysine-rich DNA-binding histones have been reported to crosslink 
with DNA(20;21) in the presence of formaldehyde. 
Key to understanding the toxicity of formaldehyde is the detection and 
quantitation of the DPCs as biomarkers for formaldehyde exposure, both at sites of 
contact and at sites removed from contact. Of techniques available for this purpose, those 
based on liquid chromatography coupled with mass spectrometry have shown great 
promise in recent years(23). Selected ion monitoring (SIM), selected reaction monitoring 
(SRM), or multiple reaction monitoring (MRM) provide ideal sensitivity and specificity 
for the quantitation of DNA adducts. To take advantage of these techniques, the 
molecular structures of the DPCs must be characterized and standards generated. In a 
previous communication, we described a formaldehyde-derived cross-link formed 
between the Cys sulfhydryl group of glutathione and dG, and suggested that this reaction 
may be relevant to systemic effects of formaldehyde transported as an S-
hydroxymethylene conjugate of glutathione. In the present work, we have established that 
cross-linking reactions occur between the amino acids Lys, Cys, His and Trp and the 
nucleosides dG, dA or dC. We have characterized the nature of the cross-links formed in 
the presence of formaldehyde between the reactive amino acids and trinucleotides 
d(T1B2T3) where B2 is the target base G, A or C. We have also examined the cross links 
formed in the presence of formaldehyde between dG, dA and dC and N-terminal 
protected 8-mer peptides containing a single target residue at position 5. Finally, we have 
determined by NMR and mass spectrometric studies the structures of the cross-links 
formed between potentially cross-linking amino acids and dG, dA and dC in the presence 
of formaldehyde as shown in Chart 3.1.   
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3.2 Experimental Section 
3.2.1 Chemicals 
Potassium phosphate, ammonium bicarbonate, trifluoroacetic acid, formic acid, 
acetonitrile, methanol, Nα-(tert-butoxycarbonyl)-L-lysine, tert-butoxycarbonyl-L-
cysteine, Nα-(tert-butoxycarbonyl)-L-histidine, Nα-(tert-butoxycarbonyl)-L-tryptophan, 
Nα-(tert-butoxycarbonyl)-L-arginine, Nα-(tert-butoxycarbonyl)-L-asparagine, Nα-(tert-
butoxycarbonyl)-L-glutamine, Nα-(tert-butoxycarbonyl)-L-tyrosine, deoxyadenosine, 
deoxythymidine, deoxycytidine and deoxyguanosine were purchased from Sigma (St. 
Louis, MO). The N-terminal acetylated 8-mer peptides Ac-VEGGRGAA, Ac-
VEGGQGAA, Ac-GEGGCGAA, Ac-GEGGYGAA, Ac-VEGGKGAA, Ac-
VEGGNGAA, Ac-GEGGHGAA and Ac-GEGGWGAA were synthesized by GenScript 
Corporation (Piscataway, NJ). 20% Formaldehyde in water was purchased from Tousimis 
(Rockville, MD). 13CH2O was purchased from Cambridge Isotope Laboratories 
(Andover, MA). All chemicals were used as received unless otherwise stated.  
 
3.2.2 Instrumental methods 
Nuclear magnetic resonance (NMR) analysis. NMR Spectra were recorded on a 
Varian INOVA NMR spectrometer (Varian, Inc., Palo Alto, CA) at 500 MHz for 1H 
NMR and 125 MHz for 13C spectra with the Varian cold probe. 
Liquid Chromatography-Mass Spectrometry (LC-MS). LC-MS analyses were 
performed on a LCQ-Deca ion trap mass spectrometer (Thermo Electron, Waltham, MA) 
or a TSQ Quantum Ultra triple quadrupole mass spectrometer (Thermo Electron, 
Waltham, MA). The mass spectrometers were equipped with electrospray ionization 
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(ESI) sources. Analytes were separated by reverse phase HPLC using a 250 mm × 2.5 
mm C18 analytical column from Grace Vydac (Hesperia, CA) eluted at 200 µL/min with 
a linear gradient from 2% to 60% solvent A in B over 15 min. Solvent A consisted of 
0.1% formic acid in water and solvent B was methanol. The ion trap mass spectrometer 
was operated in full scan as well as dependent scan modes.  For the fragmentation of 
precursor ions, the normalized collision energy of the ion trap mass spectrometer varied 
from 30% to 35% depending on the adduct. The activation time was set at 30 msec. The 
triple quadrupole mass spectrometer was operated in full scan, parent mode scan, MS/MS 
scan, selected ion monitoring (SIM) or selected reaction monitoring (SRM) mode. The 
collision energy was set at 17 V for most fragmentation experiments.  High resolution 
mass spectra were obtained on an Agilent 6250 Accurate Mass Q-TOF LC/MS (Agilent 
Technologies, Santa Clara, CA) equipped with a dual spray ESI source. For liquid 
chromatography, a Hypersil Gold column (Thermo Scientific, Waltham, MA) (150 x 2.1 
mm, 3 μm particle size) was used with a linear gradient from 2% acetonitrile in 0.1% 
formic acid to 80% acetonitrile over 15 min, eluted at 200 μL/min. The ESI source was 
set as follows: gas temperature, 350 oC; drying gas, 10 L/min; Vcap, 4000 V; nebulizer, 
35 psig; fragmentor, 100 V; skimmer, 65 V. Fourier-transform ion cyclotron resonance 
mass spectra (FTICR-MS) (10 scans) were acquired on a hybrid Qe-Fourier transform ion 
cyclotron resonance mass spectrometer equipped with a 12 T actively shielded magnet 
(Apex Qe-FTICR-MS, 12.0 T AS, Bruker Daltonics, Billerica, MA, USA), and an Apollo 
II microelectrospray (µESI) source. The voltages on the µESI sprayer, interface plate, 
heated capillary exit, deflector, ion funnel and skimmer were set at 4.2 kV, 3.9 kV, 300 
V, 250 V, 175 V and 30 V, respectively. The µESI source temperature was maintained at 
180 oC.  Desolvation was carried out by using a nebulization gas flow (2 bar) and a 
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countercurrent drying gas flow. Before transfer, ion packets were accumulated inside the 
collision cell for a duration of 0.02 second. Using a syringe pump (Cole Parmer, Vernon 
Hills, IL, USA), sample solutions were infused with a 250 µL syringe (Hamilton, Reno, 
NV, USA) at 90 μL/hour. 
 
3.2.3 Formation of formaldehyde-induced cross links 
Typical reaction conditions were as follows: 10 µL each of 5 mM amino acid and 
deoxynucleoside solution were mixed in 50 µL of 10 mM potassium phosphate buffer 
(pH 7.2). Formaldehyde was added to a final concentration of 50 mM. After 48 h, the 
reaction mixtures were either separated by reverse phase chromatography or analyzed by 
LC-MS. Lys-dG coupling reactions were carried out with 5, 50 and 100 mM 
formaldehyde. Reactions using 50 mM formaldehyde were run for 48, 60, 72, and 84 h. 
The coupling reaction was repeated with 50 mM 13C-formaldehyde for 48 h. 
Formaldehyde-induced coupling between peptides and deoxynucleosides was done in 
the same manner in 50 μL reaction volumes with final concentrations of 1.5 mM peptide 
and 5 mM deoxynucleoside. For coupling between amino acids and trinucleotides in 50 
μL reaction volumes, final concentrations were 5 mM amino acid and 1 mM 
trinucleotide. 
Large scale reactions between amino acids and deoxynucleosides for structural 
characterization by NMR were run with 20 mg of deoxynucleoside and 40 mg of Nα-Boc-
amino acid in 5 mL 10 mM potassium phosphate buffer (pH 7.2) and 100mM 
formaldehyde for 12 hours to 1 week, monitored by HPLC until the chromatographic 
trace remained constant. The reaction mixtures were separated by semi-preparative 
HPLC and collected products were characterized by mass spectrometry (Table 3.2) and 
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NMR. For the Lys-dG reactions, HPLC fractions were collected on dry ice, lyophilized 
and then stored at – 80 oC until analysis. Exact masses of cross-linked products are 
tabulated in the text (Table 3.4).  MS/MS data are presented in full as Supporting 
Information. 1H and 13C shifts are tabulated below. 
 
3.2.4 NMR data of cross-links 
2-Amino-6-(10-oxo-triazino[1,2-a]purin-7-yl)hexanoic acid (TPHA-1): 1H 
NMR (500 MHz, DMSO-d6) δ 7.91 (s,1H, H2), 7.87 (s, 1H, N5H, J = 2.1 Hz), 6.74 (d, 
1H, Boc-NαH-, J = 4.7 Hz), 6.09 (dd,1H, H1′,  J = 7 .8, 5.9 Hz), 4.89 (s, 2H, C8H2), 4.33 
(m, 1H, H3′), 4.24 (bs, 2H, C6H2), 3.83 (m,1H, H4′), 3.75 (dt, 1, CαH, J = 8.1, 8.1, 4.7 
Hz), 3.54 (dd, 2H, H5′, J = 11.7, 4.5 Hz), 3.47 (dd, 2H, H5′′, J = 11.7, 4.5 Hz), ~2.47 
(CεH2 (overlaps DMSO-d6)),  ~2.50 (H2′ (overlaps DMSO-d6)), 2.18 ( ddd, 1H, H2′′-
TPHA-1, J=13.1, 5.9, 3.0 Hz), 1.34-1.48 (m, 2H, CδH2), 1.24-1.37 (m, 2H, CγH2), 1.44-
1.58 ( m, 2H, CβH2), 1.35 (s, 9H, CH3-Boc). (13C NMR, 125 MHz, DMSO-d6) δ 173.9 
COOH, 155.8 C10, 155.2 COO-Boc, 150.2 C4a, 149.0 C3a, 134.9 C2, 115.5 C10a, 87.3 
C4′, 82.1 C1′, 77.4 C-Boc 70.5 C3′, 61.4 C5′, 60.5 C8, 59.5 C6, 53.8 Cα, 49.2 Cε, 39.3 
C2′, 30.8 Cβ, 27.9 CH3-Boc, 26.6 Cδ, 22.8 Cγ. 
2-Amino-6-(5-hydroxymethyl-10-oxo-triazino[1,2-a]purin-7-yl)hexanoic acid 
(TPHA-2): (1H NMR, 500 MHz, DMSO-d6) δ 7.96 (s,1H, H2), 6.93-6.99 (m,1H, NH-
Lys), 6.19 (dd, 1H, H1′, J = 7.8, 5.9 Hz), 4.99 (d, 2H, N5CH2OH, J = 1.3 Hz), 4.95 (s, 
2H, CH28), 4.45 (s, 2H, C6H2), 4.35 (m, 1H, H3′), 3.78-3.83 (m, 1H, H4′), 3.77-3.84 (m, 
1H, CαH), 3.55 (dd, 1H, H5′, J = 11.6, 4.8 Hz), 3.49 (dd, 1H, H5, J = 11.6, 4.7 Hz), 2.58 
(ddd, 1H, H2′, J = 13.2, 7.7, 5.9 Hz), 2.49 (m, 2H, CεH2), 2.21 (ddd,1H, H2′′, J = 13.2, 
7.8, 3.1 Hz), 1.50-1.69 (m, 2H, CβH2), 1.36-1.50 (m, 2H, CδH2), 1.36 (s, 9H, CH3-t-Boc), 
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1.28-1.34 (m, 2H, CγH2). (13C NMR, 125 MHz, DMSO-d6) δ 173.9 COOH-Lys, 156.0 
C10, 155.4 COO- t-Boc, 149.4 C4a, 148.2 C3a, 136.0 C2, 115.9 C1a, 87.4 C4′, 82.3 C1′, 
77.6 C-t-Boc, 70.7 C3′, 68.5 N5CH2OH, 63.9 C6, 61.5 C5′, 61.2 C8, 53.2 Cα, 49.0 Cε, 
39.2 C2′, 30.4 Cβ, 27.9 CH3- t-Boc, 26.6 Cδ, 22.9 Cγ. 
Cys-CH2-dG: 1H NMR (500 MHz, DMSO-d6) δ 12.73 (s, 1H, COOH-Cys), 
10.82 (s, 1H, N1H-dG), 7.99 (s, 1, H8), 7.11 (bs, 1H, N2H-dG), 6.99-7.08 (m, 1H, NH-
Cys), 6.16 (ψt, 1H, H1', J = 6.8 Hz), 4.48-4.57 (m, 2H, CH2-linker, J = 10 Hz), 4.35 (td, 
1, H3′, J = 3.2, 3.2, 6.1 Hz), 4.06-4.12 (m, 1H, CαH-Cys), 3.78-3.82 (m, 1H, H4), 3.55 
(dd, 1H, H5′, J = 11.6, 4.8), 3.48 (dd, 1H, H5′′, J = 11.62, 4.8 Hz), 3.03 (dd, 1H, CβH2a, J 
= 13.5, 4.47 Hz), 2.84 (dd, 1H, CβH2b, J = 13.5, 9.19 Hz), 2.62-2.65 (m, 1H, H2′), 2.21 
(ddd, 1H, H2′′, J = 13.1, 6.8, 3.2 Hz), 1.36 (s, 9H, CH3-t-Boc. 13C NMR (125 MHz, 
DMSO-d6) δ 172.6 COOH-Cys, 156.7 C6, 155.3 COO-t-Boc, 151.9 C2, 150.0 C4, 136.1 
C8, 120.0 C5, 87.8 C4′, 82.9 C1′, 78.2 C-t-Boc, 70.5 C3′, 61.5 C5′, 53.9 Cα, 43.2 CH2-
linker, 39.3 C2′, 31.8 Cβ, 28.0 CH3-t-Boc. 
Cys-CH2-dA: (1H NMR, 500 MHz, DMSO-d6) δ 8.42 (bs, 1H, N6H), 8.37 (s, 1H, 
H8), 8.26 (s, 1H, H2), 6.35 (ψt, 1H, H1′, J = 6.8 Hz), 6.01 (d, 1H, NH-Cys, J = 5.26 Hz), 
4.66-4.77 (m, 1H, CH2a-linker), 4.50-4.61 (m, 1H, CH2b-linker), 4.40-4.44 (m, 1H, H3′), 
3.85-3.89 (m, 1H, H4′), 3.61 (dd, 1H, H5′, J = 11.9, 4.3 Hz), 3.66-3.74 (m, 1H, CHα), 
3.53 (dd, 1H, H5′′, J = 11.9, 4.3 Hz), 2.96-3.07 (m, 2H, CβH2), 2.66-2.74 (m, 1H, H2′), 
2.27 (ddd, 1H, H2′′, J = 13.1, 6.8, 3.2 Hz), 1.33 (s, 9H, CH3-t-Boc). ). (13C NMR, 125 
MHz, DMSO-d6) δ 172.2 COOH-Cys, 154.6 COO-t-Boc, 153.6 C6, 150.5 C2, 148.5 C4, 
139.9 C8, 120.2 C5, 87.3 C4′, 82.7 C1′, 78.0 C-t-Boc, 70.4 C3′, 61.5 C5′, 55.2 Cα, 43.0 
CH2-linker, 39.3 C2′, 34.7 Cβ, 27.8 CH3-t-Boc. 
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Cys-CH2-dC: (1H NMR, 500 MHz, DMSO-d6) δ 8.59 (bs, 1H, N4H), 7.83 (d, 1H, 
H6, J = 7.5 Hz), 6.11 (ψt, 1H, H1′ J = 6.9 Hz), 5.986 (d, 1H, NH-Cys, J = 4.2 Hz), 5.74 
(d, 1H, H5, J = 7.4Hz), 4.48 (dd, 1H, CH2a-linker, J = 13.4, 6.6 Hz), 4.26 (dd, 1H, CH2b- 
linker, J = 13.4 6.5 Hz), 4.20-4.24 (m, 1H, H3′), 3.71-3.74 (m, 1H, H4′), 3.64-3.69 (m, 
1H, CHα), 3.53-3.60 (m, 2H, H5′,H5′′), 2.98 (ddd, 2H, CβH2, J = 42.10, 13.5 4.3 Hz), 
2.11 (ddd, 1H, H2′, J = 12.9, 6.9, 4.4; Hz), 1.93 (td, 1H, H2′′, J =  12.9, 6.9, 6.4 Hz), 1.35 
(s, 9H, CH3-t-Boc). (13C NMR, 125 MHz, DMSO-d6) δ 171.1 COOH-Cys, 162.5 C4, 
154.7 C2, 154.3 COO-t-Boc, 140.0 C6, 94.7 C5, 87.1 C4′, 84.5 C1′, 77.2 C-t-Boc, 69.5 
C3′, 60.8 C5′, 55.2 Cα, 42.3 CH2-linker, 40.1 C2′, 35.1 Cβ, 27.8 CH3-t-Boc.  
His-CH2-dA: (1H NMR, 500 MHz, DMSO-d6) δ 8.83 (bs, 1H, NH-His), 8.42 (s, 
1H, H8), 8.34 (s, 1H, H2), 7.61 (s, 1H, Hε2-His), 6.96 (s, 1H, Hδ1-His), 6.4 (bs, 1, N6H), 
6.36 (ψt, 1H, H1′, J = 6.7 Hz), 5.59 (bs, 2H, CH2-linker), 5.32 (bs, 1H, OH3′), 5.12 (bs, 
1H, OH5′), 4.39-4.43 (m, 1H, H3′), 3.84-3.89 (m, 1H, H4′), 3.83-3.87 (m, 1H, Hα-His), 
3.48-3.65 (m, 2H, H5′,H5′′), 2.69-2.81 (m, 2H, CβH2-His), 2.70-2.75 (m, 1H, H2′), 2.27 
(ddd, 1H, H2′′, J = 12.8, 6.7, 2.8 Hz), 1.27 (s, 9H, CH3-t-Boc). (13C NMR, 125 MHz, 
DMSO-d6) δ 173.4 COOH-His, , 154.6 COO-t-Boc, 148.7 C4, 140.23 C8, 139.3 C2, 
138.2 Cγ-His, 136.1 Cε2-His, 119.5 C5, 115.5 Cδ1-His, 87.8 C4′, 83.7 C1′, 77.1 C-t-Boc, 
70.6 C3′, 61.5 C5′, 54.0 Cα-His, 49.9 CH2-linker, 39.1 C2′, 30.2 Cβ-His, 27.9 CH3-t-Boc. 
Trp-CH2-dG: (1H NMR, 500 MHz, DMSO-d6) δ  7.90 (s, 1H, H8), 7.06 (d, 1H, 
Hε3-Trp, J=7.14 Hz), 6.91-6.98 (m, 1H, Hη2-Trp), 6.50-6.58 (m, 2H, Hζ2, Hζ3-Trp), 6.14 
(ψt, 1H, H1′, J=6.8 Hz), 6.24-6.06 (m, 1H, N2H), 5.28-5.33 (bs, 2H, CH2-linker), 5.00-
4.72 (bs, OH3′ + OH5′), 4.36-4.32 (m, 1H, H3′), 4.29-4.21 (m, 1H, CHα), 3.79-3.83 (m, 
1H, H4′), 3.68-3.66 (m, 1H, CβH2a), 3.58-3.44 (m, 3H, CβH2b, + H5′,H5′′), 2.51-2.61 
(overlapping DMSO-d6), 2.17-2.25 (m, 1H, H2′′), 1.40 (s, 4H, CH3-t-Boc1), 1.34 (s, 5H, 
 66
CH3-t-Boc2). (13C NMR, 125 MHz, DMSO-d6) δ 156.3 C6, 152.8 CO2H, 150.0 C4, 150.0 
Cδ2, 135.5 C8, 129.6 Cε2, 128.1 Cη2, 122.8 Cε3, 116.9 Cζ3, 116.8 C5, 108.4 Cζ2, 87.5 C4′, 
82.8 C1′, 79.8 CH2-linker, 79.0 C-t-Boc, 70.8 C3′, 61.5 C5′, 56.4 Cα, 45.3 Cβ, 39.3 C2′, 
27.9 CH3-t-Boc. 
 
3.3 Results and discussion 
Eight amino acids previously reported to form stable adducts with formaldehyde15 
were investigated (as Nα-Boc derivatives) in coupling reactions with all four nucleosides 
to determine which would be of interest for characterization of reactions with 
oligonucleotides and oligopeptides. Results are summarized in Table 3.1. No cross-links 
could be detected with Arg, Gln, Tyr or Asn and consistent with previous studies (10-13), 
the endocyclic nitrogen of dT did not form a coupling product with any of the amino 
acids.  
The high level of cross-links formed by Lys is of particular interest because this 
residue is involved in extensive DNA-protein contacts and may therefore be considered 
highly likely to form cross-links in vivo. The second most abundant cross-link, which was 
between Cys and dG, may also have relevance for the active site of alkylguanine 
alkyltransferases(24) where a Cys residue can come into proximity with a formaldehyde 
adduct of guanine. 
 
3.3.1 Trinucleotides cross-linked to Nα-Boc-protected amino acids.  
Since dT did not form adducts (Table 3.1), we selected trinucleotides having G, A 
or C flanked by T as targets in cross-linking investigations. Elemental compositions of 
the deprotonated molecules [M – H]− of cross-linked products of the trinucleotides and 
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Nα-Boc-protected amino acids were determined by high resolution ESI-QTOF mass 
spectrometry and are given in Table 3.2. All trinucleotides yielded deprotonated 
molecules with summed masses expected for the trinucleotide + Nα-Boc protected amino 
acid + 12 mass units, consistent with formation of a methylene link between the 
trinucleotide and amino acid. The reaction of TGT with Lys and formaldehyde yielded 
two additional products: [T(TPHA-1)T], having a composition expected for the formation 
of two methylene linkages and [T(TPHA-2)T], having a composition expected for two 
methylene linkages and a hydroxymethylene adduct.  
As discussed below, NMR analysis of the products with multiple-methylene 
linkages establishes T(TPHA-1)T as T(10-oxo-triazino[1,2-a]purin-7-yl)T−substituted 2-
aminohexanoic acid and T(TPHA-2)T as the corresponding N5-hydroxymethyl adduct. 
Formation of triazinane rings has precedent in the intramolecular condensation of 
terminal amino nitrogens from two peptide residues with formaldehyde as well as from 
glycine-formaldehyde condensation with the guanidino moiety of Arg15. These products 
would be unlikely to form in vivo, due to much lower concentrations of formaldehyde. 
Fragmentation of the reaction products between trinucleotides and amino acids 
was investigated by high resolution QTOF MS/MS to confirm that the target base in the 
second position was indeed the site of the cross-linking reaction. The high resolution data 
provide elemental compositions to support structural assignments of product ions. The 
product ion nomenclature applied for describing backbone fragmentation patterns of the 
trinucleotides follows the widely used convention given in Chart 3.2. 
MS/MS spectra, acquired on an ion trap mass spectrometer, have been reported 
for all 64 possible unmodified trinucleotides25. While extensive sequential decomposition 
would be more likely in the ion trap than in the QTOF used in our work, the 
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fragmentation patterns observed for the modified trinucleotides show reaction sequences 
similar to those reported previously(25). Without exception, the cross-linked 
trinucleotides formed singly charged anions. The MS/MS spectra of the cross-linked 
trinucleotides were characterized by initial cleavage of the coupling linkage, with the 
resulting product ions undergoing backbone fragmentation. With the exception of TAT 
cross-linked with His, none of the ions containing an intact base−methylene−amino acid 
linkage was the source of backbone fragmentations. Full MS-MS spectra and assignments 
of product ions for all cross-linked trinucleotides are presented as Supporting Information 
(Figures 3.1 – 3.8). 
TGT derivatives. In addition to the w1− ion (dT-5′-P−; m/z 321), a major ion in the 
MS/MS of all of the TGT derivatives was observed at nominal mass m/z 866 [(TGT – H 
+ 12)−]. This ion corresponds in composition to the Schiff base derivative of the 
trinucleotide at G, which is possible only at the exocyclic N2 and confirms that the 
formaldehyde-induced cross-linking reactions of TGT involve the target G. The non 
sequence ion from loss of neutral TH from the Schiff base adduct of the trinucleotide is 
also common to all the MS/MS spectra of cross-linked TGT products. In the MS/MS 
spectrum of TGT—CH2—Lys, bonds on either side of the methylene linkage cleave, 
leading to a prominent ion at m/z 874 resulting from the loss of the Schiff base adduct of 
Lys in addition to the ion at m/z 886. Backbone cleavages of the product ions at m/z 874 
and 886 give rise to parallel series of sequence ions w2−, x2−, y2− and z2− separated by 12 
mass units, as expected for source ions TGT− and its Schiff base adduct at G. The 
MS/MS of TGT—CH2—Lys in Figure 3.9 is illustrative of the data obtained from QTOF 
analysis.   
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The triazino ring of T(TPHA-1)T fragments to yield the product ions TGT− and 
Schiff base adduct of the trinucleotide from which are derived the same parallel series of 
backbone fragmentations observed in the MS/MS spectrum of the singly bridged TGT-
Lys product (Figure 3.1; formation of sodium adducts of the major ions in the MS/MS 
spectrum of T(TPHA-1)T should be noted). In the MS/MS of T(TPHA-2)T, the cross-
linking structure fragments sequentially to give prominent ions corresponding to [M − H 
− hydroxymethylene]− (nominal m/z 1144) and [M − H − N-Boc − hydroxymethylene]− 
(nominal m/z 1044) in addition to the Schiff base adduct of TGT at m/z 866, which is 
progenitor of the sole series of observed sequence ions w2−, x2−, y2− and z2−. 
The MS/MS spectrum of TGT—CH2—Cys shows a single fragmentation 
pathway consistent with loss of Cys to give the Schiff base adduct of TGT at m/z 866 and 
formation of the sequence ions w2−, x2− y2− and z2− from the expected backbone 
fragmentations. The MS/MS spectrum of TGT—CH2—Trp yielded product ions in low 
abundance. The Schiff base adduct of TGT and backbone cleavage ions w2−, x2− y2− and 
z2− were present at the expected nominal mass-to-charge ratios, however the accuracy of 
mass measurements was low.  
TAT and TCT derivatives. Loss of Nα-Boc (m/z 1025) and (Nα-Boc + His) (m/z 
870) were prominent ions in the MS/MS spectrum of TAT−CH2−His. The ion at m/z 
1025 gave the non sequence ion (M − H − TH)− and sequence ions w2− and x2− ions from 
backbone fragmentation in which the cross-link is intact (the only instance of backbone 
fragmentations with an intact cross-link). The Schiff base derivative from loss of His (m/z 
870) yielded the parallel series of sequence ions w2− and x2−, fixing the point of cross link 
attachment at exocyclic N6 of adenine. The MS/MS spectrum of the deprotonated 
molecule TAT−CH2−Cys features (y2 − B2)−, w1− and T− (base peak) ions along with a 
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prominent ion at nominal mass m/z 545. However, no ion containing the Schiff base 
adduct of A was detected. The nominal mass m/z 545 corresponds to a 2′,3′-dideoxy-2′,3′-
dehydro-AMP or 2′-deoxyadenosine-5′-phosphenate linked through a methylene bridge 
to Nα-Boc-His. The exact mass differs by +10.8 ppm from that calculated for the 
composition of the proposed structures, within sufficient tolerance to support the 
methylene bridge between Cys and the target N6 of A. However, a backbone 
fragmentation pathway yielding ions of either of the proposed structures was not reported 
for any of the 64 possible unmodified trinucleotides or observed for any of the other 
cross-linked trinucleotides in this study. Thus, support for the proposed structure of the 
cross-link relies on the NMR studies of the formaldehyde-derived cross-link between dA 
and Cys discussed below. Although product ions in MS/MS spectrum of TCT−CH2−Cys 
were in low abundance, the exact mass of the base peak lies within an acceptable 
tolerance (4.1 ppm) for a composition corresponding to the Schiff base adduct of 
trinucleotide which is consistent with a methylene bridge between the C-N4 and the Cys 
sulfhydryl group. Sequence ions w2−, x2− and w1− were also present at the expected 
nominal masses, in addition to the non-sequence ion (M − H − TH)−.  
 
3.3.2 Peptides cross-linked to deoxynucleosides.  
We reacted dG, dA and dC with formaldehyde and N-terminal acetylated 8-mers 
in which position 5 contained one of the four residues which had been established as 
targets for cross-linking in the screening reactions. The exact masses of the protonated 
molecules are given in Table 3.3. As in the case of the trinucleotides, all of the 8-mers 
yielded singly charged ions with compositions corresponding to formation of a methylene 
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cross-link, and the Lys-containing 8-mers yielded two additional products consistent with 
formation of the tricyclic cross linked structures TPHA-1 and TPHA-2. 
By MS/MS, the protonated molecules undergo initial fragmentation of the 
glycosidic bond or the bridging structure, and the resulting product ions undergo 
backbone fragmentations similar to those observed for unmodified peptides, giving 
predominantly yn, an and bn ions(26). Analysis of MS/MS spectra of the protonated 
molecules definitively established the site of formaldehyde-induced cross linking for all 
of the peptides with the exception of the His-containing 8-mer cross-linked with dA. 
Backbone fragmentations in the MS/MS spectra of the Lys- and Trp-containing 8-
mers with a single methylene link to dG are derived from the intermediate product ions in 
which the cross-link has broken to yield a peptide sequence containing the Schiff base of 
Lys (Scheme 3.2) or the 2-methylene indole derivative of Trp. Figure 3.10 illustrates the 
MS/MS of the singly-bridged Lys-containing octapeptide. MS/MS spectra of the cross-
linked peptides along with identification of the fragment ions are given in Figures 3.11 − 
3.18). The mass difference between the b5 and b4 ions corresponds to the Schiff base 
adduct of the target Lys (or 2-methylene-substituted Trp) at position 5, which establishes 
the point of attachment of the methylene bridge at the predicted target residues. The 
modification of the Lys and Trp residues is further confirmed by the identification of y4 
ions, and the determination that the mass differences between (b5 + y4) and the 
intermediate product ions yielding the backbone fragmentation series (m/z 742 for the 
Lys 8-mer and 758 for the Trp 8-mer) correspond to the mass of the modified residue. 
The product ions representing loss of the Schiff base adduct of dG from the cross-linked 
peptides establishes the exocyclic N2 of dG as the second point of attachment of the 
methylene bridge, as discussed above for the cross-linked trinucleotides. 
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In the MS/MS spectrum of the Cys-containing 8-mer cross linked to dC, a series 
of low-abundance bn ions originates from the intermediate product ion (m/z 697) after 
loss of the deoxyribose from the protonated molecule. The difference in mass between 
the b5 and b4 ions of this bn series corresponds to the mass of the Cys−CH2−C unit, 
confirming that the cross link is attached to the peptide at Cys. Additional support for the 
cross link to Cys is a second series of low abundance b5, b6 and b7 ions having 
compositions consistent with backbone fragmentation of the product ion from cleavage of 
the C−S bond of methylene bridge which transforms Cys to an α-amidoacrylic acid 
residue. As required by this scheme, the difference in mass between the b5 (m/z 412) and 
b4 (m/z 343), which does not contain a modified residue, is 69 mass units, corresponding 
to α-amidoacrylic acid at position 5. Major backbone fragmentation series for the Cys-
containing 8-mers cross-linked with dA and dG originate from the product ions 
subsequent to the loss of the Schiff base derivatives of the nucleosides, and therefore are 
not informative with respect to the site of attachment of the methylene bridge to the 
peptide. However, the bn series from the intermediate product ions containing α-
amidoacrylic acid at position 5 are present in the MS/MS spectra of both cross-linked 8-
mers, fixing the methylene bridge attachment at Cys. 
The MS/MS spectrum of the Lys-containing 8-mer linked by two methylene 
groups through formation of a fused triazino ring is consistent with initial fragmentation 
of the triazino ring followed by proton transfer to give Schiff base adducts of both dG and 
the 8-mer (nominal mass, m/z 742) according to Scheme 3.3, with the charge residing 
predominantly on the 8-mer fragment. The Schiff base adduct of dG loses deoxyribose to 
give an ion at m/z 164 in low abundance. The absence of an ion corresponding to [MH – 
dG]+ (nominal mass m/z 730) accompanied by product ions from its backbone 
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fragmentation, such as observed above for a single cross-linking methylene, supports the 
triazino structure. The difference in mass between b5 and b4 ions corresponds to the Schiff 
base adduct at the terminal −NH2 of the Lys residue as required by Scheme 3.3. 
The MS/MS spectrum of the product the containing the tricyclic (TPHA-2) cross-
linking structure with an N5 hydroxymethyl-substituted triazinopurine is dominated by 
two series of ions derived from peptide backbone fragmentations of the intermediate 
product ions shown in Scheme 3.4. The y4, b4 and b5 ions can be identified for both 
series, and the compositions establish that the terminal −NH2 of Lys has been 
incorporated into the linking structure. The sequential fragmentations of the protonated 
molecule which lead to the intermediate products in Scheme 3.4 are suggested by the 
presence of product ions both at m/z 164 for the protonated N2-Schiff base adduct of G 
and at m/z 178 compatible with the protonated tricyclic base 1,N2-ethano-G.  
In the MS/MS spectrum of the His-containing 8-mer cross-linked to dA, a single 
series of backbone fragmentations arises from an intermediate product ion via loss of the 
Schiff base adduct of dA. This fragmentation pattern is not informative regarding the site 
of methylene attachment to the 8-mer, and the structure of the cross-link is inferred from 
the structures determined by NMR studies for cross-linked monomeric units 
dA−CH2−His.  
 
3.3.3 Nα-Boc-protected amino acids cross-linked to deoxynucleosides.  
Formaldehyde-induced coupling reactions between the Nα-Boc-protected amino 
acids and nucleoside monomers were investigated on a scale which allowed detailed 
structural determination of the linkages by NMR spectrometry. Table 3.4 gives the exact 
masses and corresponding elemental compositions of the cross-linked products, MS/MS 
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spectra are given in Figures 3.19 – 3.26. As observed for the trinucleotide and 8-mer, 
coupling products of Lys with dG incorporated one or two methylene groups or two 
methylenes with a hydroxymethyl adduct. All of the Lys coupling products were highly 
labile and were isolated and stored at sub-ambient temperature. The lability of the Lys 
coupling products is consistent with a recent report that formaldehyde-induced DPCs 
involving the Lys- and Arg-rich major histones are hydrolytically unstable (20). This 
observation may have a bearing on the surprising lack of Arg coupling products in this 
study. Although Arg, like Lys, is involved in a large proportion of DNA-protein contacts, 
the cross linked products may be too unstable towards hydrolysis to survive analytical 
procedures.  
 
3.3.4 Characterization of formaldehyde-induced cross-links.  
The structures of formaldehyde-induced cross-links formed between the amino 
acids and nucleosides are given in Chart 3.1.  
Lys cross-links with dG. In the presence of formaldehyde, Lys and dG formed 
three coupling products with the structures given in Chart 3.1. All three structures were 
detected in coupling reactions run at the lowest formaldehyde concentration. The 
proportion of tricyclic and N-hydroxymethyl-substituted tricyclic nucleosides increased 
with increasing formaldehyde concentration and reaction time (confirmed with 13C-
formaldehyde), consistent with progressive incorporation of formaldehyde molecules into 
the initial coupling product (Figure 3.27). As described above, the products were all 
labile at ambient temperature and required care in isolation and characterization. The 
tricyclic structures TPHA-1 and TPHA-2 were definitively established by mass 
spectrometry and NMR. Lys-CH2-dG appears to be too labile for characterization by 
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NMR and its assignment as a product of cross-linking is based on indirect evidence from 
the analyses below.  
Exact mass measurements of major ions at m/z 526, 538 and 568 in the coupling 
reaction mixture by ESI-MS in the positive ion mode were compatible with the 
protonated molecules Lys- CH2-dG, TPHA-1 and TPHA-2, respectively (Table 3.4). 
When 13C-formaldehyde was used in the coupling reaction, the protonated molecules are 
observed at m/z 527, 540 and 571, confirming formaldehyde as the origin of the 
methylene linkers and the hydroxymethylene group.  
Well-resolved peaks were collected by semi-preparative HPLC (Figure 3.28) and 
characterized by NMR. Despite the absence of any features such as tailing in the 
chromatographic trace indicative of on-column decomposition, the 1H NMR spectra 
indicated that the fractions collected at 17.2 and 26.5 min were mixtures.  
The peak eluting at 17.2 min contained a 1:1:1 dG/Lys/TPHA-1 mixture, while 
the peak at 26.5 min contained a 0.4:1 TPHA-1/ TPHA-2 mixture. In the early-eluting 
fraction, Lys and dG were readily identified by comparison of well resolved signals in 
critical regions of the spectrum with authentic standards and in the late-eluting fraction, 
signals of TPHA-1 and TPHA-2 were readily distinguished because of the difference in 
signal intensities and peak integrals. The absence of signals attributable to Lys or dG in 
the product collected at 26.5 min indicates that the triazino ring is stable under conditions 
of NMR data acquisition and thus the Lys and dG observed in the 17.2 min fraction arises 
from uncoupling of Lys-CH2-dG. Thus, the composition of the fractions may be 
explained by co-chromatography of TPHA-1 and Lys-CH2-dG at 17.2 min followed by 
uncoupling of Lys-CH2-dG post-chromatography, and by the partial loss of 
hydroxymethylene from TPHA-2 in the 26.5 min fraction. Uncoupling in the 17.2 min 
 76
fraction is supported by a strong signal in the 1H NMR spectrum attributable to 
formaldehyde or formaldehyde hydrate corresponding to ~ 0.5 mole formaldehyde/mole 
dG (Figure 3.29) from hydrolysis of the Lys-CH2-dG cross-link in accord with reported 
reversibility of formaldehyde-induced DPCs. Similarly, a formaldehyde signal of 
comparable magnitude in the 26.5 min fraction (Figure 3.32) is consistent with hydrolytic 
cleavage of the N5-hydroxymethylene group of TPHA-2. The 
formaldehyde/formaldehyde hydrate assignment is based on the appearance of a proton 
singlet below 8 ppm having unsuppressed 1-bond coupling with a carbon signal at 164.4 
ppm that has no connectivity with any component in the HMBC spectra of the mixture 
(Figures 3.29, 3.32). 
In each fraction, the signals of the components of the mixtures could be resolved, 
allowing the structures of TPHA-1 and TPHA-2 to be unambiguously assigned. Critical 
in establishing the triazine ring is the presence of two formaldehyde-derived methylenes 
and identification of the connectivities between the methylene groups, guanine and Lys 
moieties. Figures 3.33 and 3.34 show expansions of the HMBC spectra that are key to 
establishing the fused triazine linkages. In the HMBC spectrum of TPHA-1 (Figure 3.33), 
a broad two-proton singlet at 4.89 with three bond coupling to a 13C signal at 59.5 ppm 
and a second two-proton singlet at 4.24 ppm with 3JC-H coupling to a 13C signal at 60.5 
ppm are assigned to methylene groups at positions 8 and 6, respectively, of the 
triazino[1,2-a]purine framework. Unsuppressed one-bond couplings, confirmed by the 
corresponding C/H cross peaks in the HSQC spectrum (Figure 3.30), are observed for 
both methylene signals and allow assignment of the methylene carbon shifts. The protons 
attached to the methylene carbon assigned to C8 show the expected connectivities within 
the tricyclic framework between C4a at 150.2 ppm and C10 at 155.8 ppm, while the 
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methylene protons at position 6 couples only with the carbon at C4a. Attachment of the 
hexanoic acid moiety at N7 is confirmed by cross peaks between the methylene protons 
at positions 6 and 8 and a carbon signal at 49.2 ppm, which can be assigned to hexanoic 
acid Cε by virtue of unsuppressed one-bond coupling in the HMBC spectrum and the 
corresponding C/H cross peak in the HSQC spectrum. The complementary three-bond 
coupling between the methylene protons attached to Cε (overlapping with the DMSO 
signal and sugar H2′′ signals at ~ 2.5 ppm) and C6 and C8 is also observed.  
By a similar analysis of the HMBC spectrum in Figure 3.34, connectivities can be 
identified to confirm the triazino[1,2a]purine framework of TPHA-2, the major 
component of the late-eluting peak. The critical cross peaks are between C8H2 (4.95 
ppm) and C6 (63.9 ppm), C4a (149.4 ppm), C10 (156.0 ppm) and Cε (49.0 ppm); 
between C6H2 at 4.45 ppm and C8 (61.5 ppm), C5a (149.8 ppm) and Cε (49.2 ppm) and 
between CεH2 (2.5 ppm, overlapping with DMSO) and C6 and C8. A methylene proton 
signal at  4.99 ppm can be assigned to the hydroxymethylene group with the position of 
attachment fixed at N5 by virtue of cross peaks with C6 and C4a. In the 1H NMR 
spectrum (Figure 3.32), a singlet, assignable to formaldehyde by the rationale described 
above, strongly supports the conclusion that the presence of THPA-1 in the late-eluting 
fraction results from the hydrolytic elimination of the N5-hydroxymethylene substituent 
of TPHA-2. 
The mechanism proposed for the dynamic nature of formaldehyde-induced Lys-
dG cross links in Scheme 3.5 is supported by the lability of the products and the presence 
of formaldehyde in the NMR spectra of TPHA-1 and TPHA-2 which indicate that the 
condensations are reversible.  
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Cys cross links with dG, dA, dC. A single product was isolated from the cross-
linking of Cys and dG with formaldehyde. In contrast to the cross-linked products of Lys, 
the product with Cys was stable and readily isolated and purified. The exact mass 
corresponded in elemental composition to addition of one methylene group. ESI-MS/MS 
of the protonated molecule (Figure 3.22) yielded product ions from loss of deoxyribose 
and t-Boc. The base peak of the MS/MS spectrum appears at m/z 164 (Figure 3.22), in 
accord with fragmentation to a Schiff base derivative of guanine, which indicates that the 
methylene cross-link bridges N2 of guanine and the Cys sulfhydryl group.  
NMR spectrometry confirmed guanine N2 and Cys SH as the points of attachment 
of the methylene cross-link. The carbon and proton signals of formaldehyde-derived 
methylene cross-link are assigned from the HMBC spectrum on the basis of unsuppressed 
one-bond coupling between the carbon signal at 43.2 ppm and a 2-proton methylene 
multiplet centered at 4.52 ppm. Attachment at the Cys sulfhydryl is then fixed by 
coupling between the diastereotopic CβH2 protons of Cys at 2.84 and 3.03 ppm and the 
formaldehyde-derived methylene bridging carbon, while attachment at guanine N2 is 
fixed by coupling between the bridging methylene protons and C2 of guanine at 151.9 
pm. The presence of the guanine imino N1H at 10.82 ppm in the 1H NMR spectrum, 
unambiguously assigned from coupling with guanine C5 at 117 ppm in the HMBC 
spectrum (Figure 3.37), rules out attachment of the cross link at guanine N1. Attachment 
to Cys at Nα is ruled out by identification of Cys-NαH as one of two incompletely 
resolved proton signals at ~7.10 ppm based on cross peaks with Cys Cα (53.9 ppm) and 
Cβ (31.8 ppm).  
Cys formed stable cross-links with dA and dC in minor amounts. By high 
resolution mass spectrometry, both products had empirical compositions consistent with a 
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methylene bridge linking the nucleoside and Cys. For both products, critical C/H 
connectivities in the HMBC spectra (Figures 3.39, 3.41) were observed between the 
proton signals of the bridging methylene and a carbon signal of the base, and between the 
bridging methylene and Cys βCH2. In the case of Cys-CH2-dA, attachment to dA at the 
exocyclic amino group was established by coupling between the diastereotopic methylene 
protons of the bridging group at 4.56 and 4.73 ppm and C6 of dA at 153.7 ppm (Figure 
3.39). Attachment to the Cys sulfhydryl group was established by coupling between the 
diastereotopic methylene bridge protons and the Cβ signal of Cys at 34.7 ppm. 
Identification of a one-proton N6H signal confirmed the substitution at the exocyclic 
amino group of dA, while presence of the Boc-NαH proton signal ruled out attachment at 
the α-amino group of Cys. The cross link between dC and Cys was similarly determined 
to be between the exocyclic amino group of dC and the Cys sulfhydryl because of the 
observed coupling between the bridging methylene protons at 4.48 and 4.26 ppm and C4 
of dC at 162.5 ppm and between the bridging methylene protons and Cβ of Cys at 35.1 
ppm (Figure 3.41). As in the case of Cys-CH2-dA, the position of the cross link 
determined from the HMBC spectrum is supported one-proton signals attributable to N4H 
of dA and Boc-NαH. 
His cross-link with dA. A low yield of stable cross-linked product was isolated 
from the reaction of His and dA with formaldehyde incorporating one methylene linkage 
identified by accurate mass measurement. Despite the absence of C,H cross-peaks 
between the linker methylene and His, attachment at Nε1 could readily be established by 
the presence of imidazole ring C-H proton signals Hδ1 at 6.96 and Hε2 at 7.61 ppm, which 
were definitively assigned by unsuppressed one-bond coupling to carbon signals at 115.5 
and 136.1 ppm, respectively, in the HMBC spectrum (Figure 3.43). Site of attachment to 
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dA rests on the presence of a signal having an integral value of one proton assigned to 
N6H.  A broad two-proton signal at 5.59 ppm in the 1H NMR spectrum is replaced by a 
two-proton doublet centered at 5.59 ppm, 1JC-H = 153.2 Hz, when the cross-link is derived 
from 13C-formaldehyde (Figure 3.44), and can be assigned to the formaldehyde-derived 
methylene bridge. This signal has the expected NOESY interactions with the imidazole 
protons in the ROESY spectrum (Figure 3.45). 
Trp cross-link with dG. The Trp coupling product incorporated one methylene 
cross-link identified by accurate mass measurement. The site of attachment to Trp can be 
definitively fixed at C2 of the indole ring, and analogous to the reported formation of 
tetrahydro-β-carboline from Trp via intramolecular incorporation of a formaldehyde-
derived methylene when the α-amino group is unprotected(27;28). The proton signal of 
the formaldehyde-derived methylene forming the cross-link to dG is identified by a broad 
two-proton resonance at 5.30 ppm in the 1H NMR spectrum attached to a carbon having a 
signal at 79.4 ppm in the HSQC spectrum (Figure 3.46) which is also detected by 
unsuppressed one-bond coupling (1JC-H = 164.4 Hz; Figure 3.47) in the HMBC spectrum. 
Attachment of the methylene at indole C2 is supported by the detection of indole benzo-
ring carbons as the only indole carbons having attached protons in the HSQC spectrum 
and by NOESY interactions between the bridge methylene and TrpCβH2 proton signals in 
the ROESY spectrum (Figure 3.48), which would not be observed if attachment of the 
methylene were at the indole nitrogen. While the proton-bearing carbons of the Trp 
indole ring were readily identified in the HSQC spectrum, overlapping of the quaternary 
carbon signals of both indole and dG moieties precludes establishing connectivity 
between the methylene bridge and dG from the HMBC spectrum. Attachment of the 
methylene bridge at the exocyclic amino group is inferred from the absence of a 2-proton 
 81
signal assignable to an unsubstituted exocyclic amino group of guanine and the 
fragmentation of the protonated molecule to yield the Schiff base of dG as the base peak 
in the MS/MS spectrum (Figure 3.26). 
 
3.4 Conclusion   
We have investigated the formation of formaldehyde-induced cross-links between 
nucleosides and amino acids and provide the first rigorous structural characterizations of 
DNA-protein cross-links induced by coupling with formaldehyde. Eight cross-linked 
structures have been characterized. In five of these structures, the cross-linking arose via 
a methylene bridge connecting the exocyclic amino group of a nucleoside to a 
nucleophilic nitrogen or sulfur of an amino acid side chain. In the case of Trp, the points 
of attachment were the N2 exocyclic amino group of dG and C2 of the indole ring. Lys, in 
addition to forming an expected dG-N2-CH2-Nε-Lys cross-link, formed two tricyclic 
adducts with dG, a 10-oxo-triazino[1,2-a]purinyl derivative incorporating two 
formaldehyde molecules and a 5-formyl-10-oxo-triazino[1,2-a]purinyl adduct 
incorporating three formaldehyde molecules. While the formation of the tricyclic adducts 
was favored at formaldehyde levels of 50 and 100 mM, all three adducts were identified 
at the lowest levels tested (5 mM). The three Lys cross-linked products were labile in 
solution, and the cross-link formed by a single methylene bridge was too unstable for 
characterization by NMR spectrometry. The lability of the Lys-dG cross-links support the 
reported reversibility of formaldehyde-induced cross-links formed in vivo between 
histones and DNA20. Our inability to detect products with cross-links between the 
nucleobases and Arg, which along with Lys is responsible for DNA–histone contacts, 
may reflect more pronounced dynamic reversibility of cross-links involving Arg. The 
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cross-links Cys-CH2-dG, Cys-CH2-dA and Cys-CH2-dC were stable and readily isolated 
and characterized. The cross-links characterized in this work will contribute to a better 
understanding of DPC formation induced by formaldehyde and of the mode of action of 
this known human carcinogen. The stable structures identified in this study have potential 
as biomarkers for the occurrence of DPCs following formaldehyde exposure. 
Furthermore, by using [13CD2]-formaldehyde, specific exposure related exogenous cross-
links can be differentiated from endogenous cross-links. Such sophisticated methods will 
be necessary to carefully examine site of contact versus distant site adduction of 
formaldehyde to determine the plausibility of inhaled formaldehyde as a causative agent 
for leukemia.  
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Figure 3.1. MS/MS spectrum of TGT—CH2—Lys. 
 
m/z obs m/z calc ion 
886.1785 886.1816 M – H –( N-Boc) – Lys 
874.1783 874.1816 TGT 
760.1349 760.1386 –TH 
748.1359 748.1386 –TH 
662.0988 662.1018 w2 
650.0986 650.1018 w2 
644.0880 644.0913 x2 
632.0879 632.0913 x2 
582.1341 582.1355 y2 
570.1309 570.1355 y2 
564.1227 564.1250 z2 
552.1231 552.1250 z2 
401.0755 401.0755 a2 – B2 
321.0477 321.0493 w1 
195.0046 195.0064 deoxyribose-5'-phosphate 
78.9590 78.9591 PO3– 
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Figure 3.2. MS/MS spectrum of T(TPHA-1)T. 
m/z obs m/z calc ion 
908.1605 908.1635 M – H –( N-Boc) – Lys + Na 
896.1605 896.1635 TGT + Na 
886.1779 886.1816 M – H –( N-Boc) – Lys 
874.1768 874.1816 TGT 
782.1134 782.1206 – TH + Na 
770.1195 770.1206 – TH + Na 
760.1364 760.1386 – TH 
748.1353 748.1386 – TH 
684.0865 684.0838 w2 + Na 
672.0768 672.0838 w2 + Na 
662.0991 662.1018 w2 
650.0993 650.1018 w2 
644.0821 644.0913 x2 
632.0860 632.0913 x2 
582.1380 582.1355 y2 
564.1249 564.1250 z2 
552.1234 552.1250 z2 
401.0743 401.0755 a2 – B2 
321.0427 321.0493 W1 
195.0051 195.0064 deoxyribose-5'-phosphate 
78.9582 78.9591 PO3– 
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m/z obs m/z calc  Ion 
1144.3324 1144.3395 M – H – CH2OH 
1044.2822 1044.2871 M – H – CH2OH – (N-Boc) 
886.1788 886.1816 M – H – CH2OH – (N-Boc-Lys) 
760.1323 760.1386 – TH 
662.0981 662.1018 w2 
644.0918 644.0913 x2 
582.1356 582.1355 y2 
564.1261 564.1250 z2 
401.0693 401.0755 a2 – B2 
321.0476 321.0493 w1 
195.0040 195.0064 deoxyribose-5'-phosphate 
78.9593 78.9591 PO3– 
 
Figure 3.3. MS/MS spectrum of T(TPHA-2)T 
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Figure 3.4. MS/MS spectrum of TGT–CH2–Cys. 
m/z obs m/z calcd ion 
886.1777 886.1816 M – H – (N-Boc-Cys) 
760.1363 760.1386 – TH 
662.1004 662.1018 w2 
644.0850 644.0913 x2 
582.1424 582.1355 y2 
564.1232 564.1250 z2 
401.0694 401.0755 a2 – B2 
321.0488 321.0493 w1 
195.0059 195.0064 deoxyribose-5'-phosphate 
125.0352 125.0357 T– 
(M-H)—  
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m/z obs m/z calc ion 
1090.2667 1090.2714 M – H – Boc 
886.1723 886.1816 M – H – N-Boc-Trp 
760.1315 760.1386 –TH 
662.1108 662.1018 w2 
650.0996 650.1018 w2 (origin TGT) 
644.0702 644.0913 x2 
582.1255 582.1355 y2 
564.1138 564.1250 z2 
552.1118 552.1250 z2 
321.0480 321.0493 w1 
195.0073 195.0064 deoxyribose-5'-phosphate 
125.0385 125.0357 T– 
 
Figure 3.5. MS/MS spectrum of TGT–CH2–Trp. 
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m/z obs m/z calc ion 
1025.2529 1025.2561 M – H – Boc 
901.2276 901.2288 M – H – Boc – TH 
870.1830 870.1866 M – H – (N-Boc-His) 
801.1668 801.1764 w2 
783.1625 783.1658 x2 
744.1440 744.1437 M – H – (N-Boc-His) – TH 
646.1034 646.1069 w2 
628.0949 628.0964 x2 
499.0514 499.0524 w2 – B2 
401.0619 401.0755 a2 – B2 
321.0480 321.0493 w1 
195.0055 195.0064 deoxyribose-5'-phosphate 
125.0351 125.0357 T– 
 
Figure 3.6. MS/MS spectrum of TAT–CH2–His. 
 89
 
 
 
 
 
m/z obs m/z calc ion 
545.1284 545.1225 
2',3'-dideoxy-2',3'-dehydro-AMP-CH2-(N-Boc-
Cys) 
or 
dA-5'-phosphenate- CH2-(N-Boc-Cys) 
419.0853 419.0861 y2 – B2 
321.0485 321.0493 w1 
195.0056 195.0064 deoxyribose-5'-phosphate 
125.0537 125.0357 T– 
78.9592 78.9591 PO3– 
 
Figure 3.7. MS/MS spectrum of TAT–CH2–Cys. 
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m/z obs m/z calc ion 
846.1718 846.1754 M – H – (N-Boc-Cys) 
720.1192 720.1325 M – H – (N-Boc-Cys) – TH 
622.0944 622.0957 w2 
604.0830 604.0851 x2 
401.0696 401.0755 a2 – B2 
321.0488 321.0493 w1 
195.0081 195.0064 deoxyribose-5'-phosphate 
78.9584 78.9591 PO3– 
 
Figure 3.8. MS/MS spectrum of TCT–CH2–Cys. 
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Figure 3.9. ESI-QTOF-MS/MS of the deprotonated molecule TGT—CH2—Lys. 
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▬ ions containing Schiff base guanine;  ▬ ions containing unmodified guanine;    
 ▬ ions that do not contain guanine. 
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Figure 3.10. ESI-QTOF-MS/MS spectrum of the protonated molecule Acetyl-VEGG(K-
CH2-dG)GAA 
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Legend: ▬ ions containing Schiff base derivative of Lys; 
▬ ions containing unmodified Lys; 
▬ ions that do not contain residue 5. 
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Figure 3.11. MS/MS spectrum of Acetyl-VEGG(K-CH2-dG)GAA. 
m/z obs m/z calc Ion 
742.3737 742.3730 Ac-NH-VEGG-(NH-CH-CH2)4-CH=NH)-GAA+ 
(Schiff base of peptide) 
730.3738 730.3730 (Ac-NH-VEGGKGAA)+ 
724.3626 724.3624 – H2O 
653 653.3253 b7 
641.3248 641.3253 b7 
635.3145 635.3148 b7 – H2O 
625.3298 625.3304 a7 
601.2940 601.2940 y7 
582.2885 582.2882 b6 
525.2672 525.2667 b5 
513.2641 513.2667 b5 
497.2722 497.2718 a5 
472.2512 472.2514 y6 
460.2513 460.2514 y6 
385.1719 385.1718 b4 
358.2082 358.2085 y4 
346.2084 346.2085 y4 
328.1498 328.1503 b3 
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Figure 3.12. MS/MS spectrum of Acetyl-GEGG(W-CH2-dA)GAA. 
m/z obs m/z calc Ion 
909.3567 909.3598 MH – dR 
891.3452 891.3492 MH – dR– H2O 
758.3072 758.3104 MH – dG  
746.3097 746.3104 (Ac-GEGGWGAA)H+ 
728.3005 728.2998 − H2O 
669.2593 669.2627 b7 
657.2643 657.2627 b7 
598.2225 598.2256 b6 
586.2255 586.2256 b6 
541.2022 541.2041 b5 
529.2024 529.2041 b5 
416.1883 416.1928 y4 
404.1950 404.1928 y4 
343.1229 343.1248 b4 
164.0503 164.0567 Schiff base of Gua 
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Figure 3.13. MS/MS spectrum of Acetyl-GEGG(C-CH2-dC)GAA. 
m/z obs m/z calc ion 
786.2820 786.2835 MH – dR  
697.2344 697.2358 b7 
663.2392 663.2403 MH – dC=CH2 
645.2274 645.2297 − H2O 
626.1975 626.1987 b6 
611.2417 611.2420 AcGEGG-(Acr)-GAA – H2O 
574.1919 574.1926 b7 
569.1759 569.1773 b5 
564.2075 564.2082 y7 
540.1943 540.2049 AcGEGG-(Acr)-G-NH-CH(CH3)CO+ 
503.1544 503.1555 b6 
485.1415 485.1449 b6 – H2O 
469.1649 469.1678 AcGEGG-(Acr)-NH-CH2-CO+ 
446.1331 446.1340 b5 
435.1646 435.1656 y6 
428.1229 428.1234 b5 – H2O 
412.1440 412.1463 AcGEGG-NH-C(=CH2)-CO+ 
378.1426 378.1442 y5 
343.1244 343.1248 b4 
321.1218 321.1227 y4 
286.1007 286.1039 b2 
124.0507 124.0505 Schiff base of CH 
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Figure 3.14. MS/MS spectrum of Acetyl-GEGG(C-CH2-dA)GAA. 
m/z obs m/z calc Ion 
810.2938 810.2948 MH - dR 
663.2400 663.2403 (Ac-GEGGCGAA)H+ 
645.2287 645.2297 − H2O 
574.1926 574.1926 b7 
564.2062 564.2082 y7 
556.1818 556.1820 b7 – H2O 
546.1971 546.1977 a7 
503.1551 503.1555 b6 
469.1674 469.1678 Ac-GEGG(Acr)-NH-CH-CO+ 
446.1337 446.1340 b5 
435.1652 435.1656 y6 
428.1231 428.1234 b5 – H2O 
418.1399 418.1391 a5 
412.1431 412.1463 Ac-GEGG-NH-C(=CH2)-CO+ 
378.1442 378.1442 y5 
343.1250 343.1248 b4 
321.1223 321.1227 y4 
264.1091 264.1091 Schiff base of dA 
148.0613 148.0618 Schiff base of A 
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Figure 3.15. MS/MS spectrum of Acetyl-GEGG(C-CH2-dG)GAA. 
m/z obs m/z calc Ion 
826.2883 826.2897 MH − dR 
737.2441 737.2420 Ac-GEGGC(-CH2-Gua)G-NH-CH(CH3)CO+ 
663.2390 663.2403 (Ac-GEGGCGAA)H+ 
645.2283 645.2297 − H2O 
574.1921 574.1926 b7 
564.2083 564.2082 y7 
556.1806 556.1820 b7 – H2O 
546.1964 546.1977 a7 
503.1556 503.1555 b6 
485.1453 485.1449 b6 – H2O 
469.1670 469.1678 Ac-GEGG-(Acr)-NH-CH2-CO+ 
446.1338 446.1340 b5 
435.1654 435.1656 y6 
428.1233 428.1234 b5 – H2O 
418.1388 418.1391 a5 
412.1431 412.1463 Ac-GEGG-NH-C(=CH2)-CO+ 
378.1429 378.1442 y5 
343.1239 343.1248 b4 
321.1230 321.1227 y4 
164.0557 164.0567 Schiff base of G 
152.0558 152.0567 G 
Acr = α-amidoacrylic acid
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 Figure 3.16. MS/MS spectrum of Acetyl-VEGG(TPHA-1)GAA. 
m/z obs m/z calc Ion 
742.3735 742.3730 (Ac- VEGG-(NH-CH-CH2)4-CH=NH)-
GAA)+  
(Schiff base of peptide) 
724.3620 724.3624 − H2O 
653.3255 653.3253 b7 
635.3141 635.3148 b7 − H2O 
625.3296 625.3304 a7 
601.2939 601.2940 y7 
582.2885 582.2882 b6 
554.2932 554.2933 a6 
536.2823 536.2827 a6 − H2O 
525.2671 525.2667 b5 
513.2639 513.2667 b5  (no Schiff base) 
97.2722 497.2718 a5 
472.2512 472.2514 y6 
415.2295 415.2300 y5 
385.1716 385.1718 b4 
358.2085 358.2085 y4 
328.1516 328.1503 b3 
243.1445 243.1339 a2 
164.0561 164.0567 N2-Schiff base of G 
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Figure 3.17. MS/MS spectrum of Acetyl-VEGG(TPHA-2)GAA. 
m/z obs m/z calcd ion 
917.4220 917.4224 MH – dR − OH 
905.4206 905.4224 MH – dR – CH2OH 
828.3736 828.3747 MH – dR – CH2OH – NH2Ac – 
H2O 
754.3727 754.3730 source ion 
742.3727 742.3730 source ion 
724.3622 724.3624 − H2O 
653.3252 653.3253 b7 
613.2940 613.2940 y7 
601.2937 601.2940 y7 
582.2882 582.2882 b6 
537.2672 537.2667 b5 
525.2670 525.2667 b5 
497.2716 497.2718 a5 
484.2515 484.2514 y6 
427.2298 427.2300 y5 
370.2082 370.2085 y4 
358.2080 358.2082 y4 
327.1656 327.1663 z4 
280.1030 280.1040 Schiff base of dG 
178.0717 178.0723 8,9-dihydro-εG 
164.0560 164.0567 Schiff base of G 
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Figure 3.18. MS/MS spectrum of Acetyl-VEGG(H-CH2-dA)GAA. 
 
m/z obs m/z calcd Ion 
739.3361 739.3369 (Ac-VEGGHGAA)H+ 
721.3254 721.3264 -H2O 
650.2905 650.2893 b7 
598.2542 598.2580 y7 
579.2424 579.2522 b6 
522.2354 522.2307 b5 
469.2102 469.2154 y6 
355.1724 355.1724 y4 
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Figure 3.19. MS-MS spectrum of Lys-CH2-Dg 
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Figure 3.20. MS-MS spectrum of TPHA-1 
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Figure 3.21. MS-MS spectrum of TPHA-2 
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Figure 3.22. MS-MS spectrum of Cys-CH2-dG 
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Figure 3.23. MS-MS spectrum of Cys-CH2-dA 
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Figure 3.24. MS-MS spectrum of Cys-CH2-dC 
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Figure 3.25. MS-MS spectrum of His-CH2-dA 
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Figure 3.26. MS-MS spectrum of Trp-CH2-dG 
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Figure 3.27. SIM of Lys-dG coupling induced by formaldehyde over 48 h: 
(A: 5 mM formaldehyde; B: 50 mM formaldehyde) 
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Figure 3.28. Trace (254 nm) of semi-preparative HPLC of the reaction mixture from the 
formaldehyde-induced coupling of Lys and dG. The peaks at 17.2 and 26.5 min were 
characterized by NMR. Peaks at 7.3 and 10.2 min are dG and N2-CH2OH-dG, 
respectively. 
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Figure 3.29. HMBC spectrum (DMSO-d6) of TPHA-1 mixture, indicating C,H 
connectivities establishing structure of triazino linkage and C,H signals tentatively 
assigned to formaldehyde. Unsuppressed 1-bond couplings are indicated by brackets. 
 
 112
 
 
 
 
 
 
Figure 3.30. HSQC spectrum (DMSO-d6) of the mixture containing TPHA-1, identifying 
the C,H cross-peaks discussed in the text. 
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Figure 3.31. ROESY spectrum (500 MHz, DMSO-d6) of TPHA-1. NOESY cross-peaks 
between methylene protons at C6 and C8 of the triazino ring and Cε hexanoic acid and 
between the methylene protons at C6 and N5H are consistent with the HMBC analysis 
and support the triazino structure for the linkage. Red cross-peaks are positively phased 
and blue cross-peaks are negatively phased.  
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Figure 3.32. HMBC spectrum (DMSO-d6) of TPHA-2 mixture, indicating C,H 
connectivities establishing structure of triazino linkage and C,H signals tentatively 
assigned to formaldehyde. Unsuppressed 1-bond couplings are indicated by brackets. 
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Figure 3.33. Expansion of HMBC spectrum of TPHA-1between 2.0 and 5.2 ppm on the 
1H-axis and 15 and 166 ppm on the 13C-axis . Key signals are identified on the marginal 
1H and 13C traces. Unsuppressed 1-bond couplings are indicated by brackets. 
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Figure 3.34. Expansion of HMBC spectrum of TPHA-2 between 2.0 and 5.2 ppm on the 
1H-axis and 40 and 160 ppm on the 13C-axis . Key signals are identified on the marginal 
1H and 13C traces. Unsuppressed 1-bond couplings are indicated by brackets. 
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Figure 3.35. HSQC spectrum (DMSO-d6) of the mixture containing TPHA-2, identifying 
the C,H cross-peaks discussed in the text. 
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Figure 3.36. ROESY spectrum (500 MHz, DMSO-d6) of TPHA-2. NOESY cross-peaks 
are present between protons of the three formaldehyde-derived methylene groups and Cγ, 
Cδ and Cε of hexanoic acid. The methylene at N5 also has NOESY interactions with H1′ 
and H3′. The NOESY interactions are consistent with the proposed tricyclic structure. 
Red cross-peaks are positively phased and blue cross-peaks are negatively phased.  
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Figure 3.37. HMBC spectrum (DMSO-d6) of Cys-CH2-dG, indicating C,H connectivities 
establishing structure of the linkage. Unsuppressed 1-bond coupling between the linker 
methylene carbon and attached protons is indicated by a bracket. 
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Figure 3.38. ROESY spectrum (500 MHz, DMSO-d6) of Cys−CH2−dG. NOESY 
connectivity is observed between linker methylene protons, Cys β-methylene protons and 
between linker methylene protons and H1′. Red cross-peaks are positively phased and 
blue cross-peaks are negatively phased. 
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Figure 3.39. HMBC spectrum (DMSO-d6) of dA−CH2−Cys, indicating C−H 
connectivities between the linker methylene group and CβH2 of Cys and C6 of dA. 
Unsuppressed one-bond coupling is indicated by bracket.  
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Figure 3.40. ROESY spectrum (500 MHz, DMSO-d6) of dA−CH2−Cys, showing 
NOESY interaction between the linker methylene protons and Cys CβH2. The positive 
phase of the cross-peaks between the linker methylene protons represents COSY 
interactions. Red cross-peaks are positively phased and blue cross-peaks are negatively 
phased.  
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Figure 3.41. HMBC spectrum of dC−CH2−Cys indicating C−H connectivities between 
the linker methylene, Cys CβH2 and C4 of dC.  
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Figure 3.42. ROESY spectrum (500 MHz, DMSO-d6) of Cys−CH2−dC, indicating 
NOESY interactions between the bridging methylene protons, N4H, and CH2 of Cys. 
Arrows in red indicate signals from a minor species related by exchange (red cross 
peaks). Red cross-peaks are positively phased and blue cross-peaks are negatively 
phased.  
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Figure 3.43. HMBC spectrum of His−CH2−dA, shows C,H connectivities within 
nucleoside and His, but no connectivity through the linker.  
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Figure 3.44. 1H NMR (500 MHz, DMSO-d6) of His−13CH2−dA, identifying the linker 
methylene signal at 5.59 ppm by 13C splitting (1JC−H = 153.2 Hz). In this trace, NBocH is 
resolved from H1′ and CαH from H4′.  
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Figure 3.45. ROESY spectrum (500 MHz, DMSO-d6) of His−CH2−dA. The linker CH2 
exhibits NOESY cross-peaks only with the imidazole C−H protons. Connectivity 
between the nucleoside and His is indicated by a NOESY cross-peak between the His 
Hδ1 and H4′ of dA. Red cross-peaks are positively phased and blue cross-peaks are 
negatively phased.  
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Figure 3.46. HSQC spectrum (DMSO-d6) of Trp−CH2−dG identifying the 1H and 13C 
signals of the bridging CH2 and Trp CβH2 and demonstrating that four of the indole 
carbons of Trp have attached hydrogens.  
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Figure 3.47. HMBC spectrum of Trp−CH2−dG (DMSO-d6), establishing C,H 
connectivity between linker CH2 and Trp. Additional C,H connectivities are indicated on 
the spectrum. Unsuppressed 1-bond couplings are indicated on data by brackets. 
Numbering convention is according to citation [*]. 
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Figure 3.48. ROESY spectrum (500 MHz, DMSO-d6) of Trp−CH2−dG, indicating 
NOESY interactions of the linker CH2 with Trp (and the deoxyribose). Red cross-peaks 
are positively phased and blue cross-peaks are negatively phased.  
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Table 3.1. Relative yielda of formaldehyde-induced cross-links formed over 48 h by 
reaction between 5 mM amino acid and 50 mM formaldehyde. 
 
 dA dT dC dG 
Lys - - - 1.0b 
Cys 0.05 - 0.02 0.53 
His 0.04 - - - 
Trp - - - 0.03 
aRelative yields based on integration of HPLC peaks in UV traces acquired at a 
detector wavelength of 254 nm. 
bSum of three cross-linked products. 
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Table 3.2. Exact masses for the reaction products of trinucleotides and Nα-Boc-protected 
amino acids cross-linked by formaldehyde, determined by negative ion ESI-QTOF-MS. 
 
Cross-links Experimental Mass ([M-H]-) 
Calculated 
Mass ([M-H]-) Composition 
Δ 
(ppm) 
TGT—CH2—Lys 1132.3360 1132.3395 C42H60N11O22P2- –3.1 
T(TPHA-1)T 1144.3373 1144.3395 C43H60N11O22P2- –1.9 
T(TPHA-2)T 1174.3494 1174.3501 C44H62N11O23P2- –0.6 
TGT—CH2—Trp 1190.3264 1190.3239 C47H58N11O22P2- 2.2 
TGT—CH2—Cys 1107.2526 
1107.2537 C39H53N10O22P2S
- 
–1.0 
TAT—CH2—His 1125.3048 1125.3085 C42H55N12O21P2- 3.3 
TAT—CH2—Cys 1091.2556 
1091.2588 C39H53N10O21P2S
- 
–2.9 
TCT—CH2—Cys 1067.2464 1067.2476 C38H53N8O22P2S- –1.1 
 133
 
 
 
 
 
Table 3.3. Exact masses of protonated 8-mers cross-linked to deoxynucleosides by 
formaldehyde determined by positive ion ESI-QTOF-MS. 
 
Cross-links Experimental Mass ([MH]+) 
Calculated 
Mass ([MH]+) Composition 
Δ 
ppm 
Acetyl-VEGG(K-CH2-
dG)GAA  1009.4687 
1009.4697 C41H65N14O16+ –1.0 
Acetyl-VEGG(TPHA-1) 
GAA 1021.4702 
1021.4697 C42H65N14O16+ 0.5 
Acetyl-VEGG(TPHA-
2)GAA  1051.4805 
1051.4803 C43H67N14O17+ 0.2 
Acetyl-GEGG(W-CH2-
dG)GAA  1025.4048 
1025.4071 C43H57N14O16+ –2.2 
Acetyl-GEGG(C-CH2-
dG)GAA  942.3372 
942.3370 C35H52N13O16S+ 0.2 
Acetyl-VEGG(H- CH2-
dA)GAA  1002.4383 
1002.4388 C41H60N15O15+ –0.5 
Acetyl-GEGG(C-CH2-
dC)GAA  902.3304 
902.3309 C34H52N11O16S+ –0.6 
Acetyl-GEGG(C-CH2-
dA)GAA  926.3427 
926.3421 C35H52N13O15S+ 0.6 
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Table 3.4.  Exact masses of formaldehyde-induced deoxynucleoside-amino acid cross-
links by FTICR-MS. 
 
 
Cross-links Experimental Mass ([MH]+) 
Calculated 
Mass ([MH]+) Composition Δ (ppm) 
Lys- CH2-dG 526.2622 526.2619 C22H35N7O8 0.6 
TPHA-1 538.2623 538.2619 C23H35N7O8 0.7 
TPHA -2 568.2726 568.2725 C24H37N7O9 0.2 
Trp- CH2-dG 584.2465 584.2463 C27H33N7O8 0.3 
Cys-CH2-dG 501.1763 501.1762 C19H28N6O8S 0.2 
His- CH2-dA 519.2312 519.2310 C22H30N8O7 0.4 
Cys- CH2-dA 485.1813 485.1813 C19H28N6O7S 0 
Cys- CH2-dC 461.1701 461.1700 C19H28N6O8S 0.2 
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Scheme 3.1. The formation of formaldehyde-induced DPCs originating from the initial 
attack of formaldehyde on protein residues (A) and from the initial attack of 
formaldehyde on DNA (B). 
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Scheme 3.2. Fragmentation of AcVEGGC(-CH2-dG)GAA. 
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Scheme 3.3. Fragmentation of AcVEGG(TPHA-1)GAA. 
 
 
 
 
 138
 
 
 
 
 
Scheme 3.4. Fragmentation of AcVEGG(TPHA-2)GAA. 
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Scheme 3.5. Mechanism proposed for formation of cross-linked formaldehyde adducts. 
A: initial attack by the amino acid-formaldehyde adduct; B: initial attack by the 
nucleoside adduct. 
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Charts 
 
 
 
 
Chart 3.1. Structures of cross-linked adducts between amino acids and nucleosides 
identified in this study. Formaldehyde-derived linkages are shown in red. 
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Chart 3.2. Nomenclature of ions after the fragmentation of trinucleotides 
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CHAPTER 4 
4. THE FORMATION OF S-[1-(N2-
DEOXYGUANOSINYL)METHYL]GLUTATHIONE BETWEEN 
GLUTATHIONE AND DNA INDUCED BY FORMALDEHYDE 
 
This paper has been published and therefore is reproduced with permission from 
[Kun Lu, Wenjie Ye, Avram Gold, Louise M. Ball and James A. Swenberg. Formation of 
S-[1-(N2-Deoxyguanosinyl)methyl]glutathione between Glutathione and DNA Induced 
by Formaldehyde.  J. Am. Chem. Soc., 2009, 131 (10), pp 3414–3415] Copyright [2009] 
American Chemical Society.  
 
4.1 Introduction 
Formaldehyde, an essential metabolic intermediate generated endogenously from 
serine, glycine, methionine and choline and also produced from some metabolites and 
proteins by demethylation(1), is present  in human blood at about 0.1 mM(2). 
Formaldehyde can also enter the body through environmental exposures. Formaldehyde 
forms DNA and protein adducts and DNA-protein crosslinks, and its toxicity has been the 
object of intensive investigation(3-13). Previous studies have shown that formaldehyde is 
genotoxic(14). Although N6-dA, N2-dG and N4-dC adducts of formaldehyde are found in 
vitro(15-18), no exogenous formaldehyde-induced DNA adducts have ever been detected 
in animals exposed by  inhalation. This inability to detect DNA adducts may result from 
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rapid binding of formaldehyde by the tripeptide glutathione (GSH), which significantly 
decreases the chance that exogenous formaldehyde will attack DNA directly.  
GSH is a major reducing thiol present in all human cells at a concentration around 
5 mM. Formaldehyde (1; Scheme 4.1) reacts spontaneously with GSH (2) to form S-
hydroxymethylglutathione (3). Formaldehyde dehydrogenase (ADH3) oxidizes 3 to S-
formylglutathione, which is then hydrolyzed to formate by S-formylglutathione 
hydrolase, regenerating free glutathione (1). The S-hydroxymethyl group of 3 is a 
reactive target for nucleophilic substitution. Recent work in our laboratory on 
formaldehyde-induced DNA-protein crosslinks shows that the thiol groups of cysteine 
residues can readily crosslink with DNA bases in the presence of formaldehyde, raising 
the possibility that 3 can conjugate with DNA as shown in Scheme 4.1. 
 
4.2 Materials and Methods 
4.2.1 Chemicals and Enzymes  
Glutathione, deoxyguanosine, calf thymus DNA, potassium phosphate, Tris-HCl, 
MgCl2, formic acid, methanol, acetonitrile, HPLC grade water were all purchased from 
Sigma (St. Louis, MO). 20% formaldehyde in water was procured from Tousimis 
(Rockville, MD). DNase I was purchased from New England Biolabs (Ipswich, MA). 
Alkaline phosphatase and phosphodiesterases were ordered from Fisher Scientific 
(Pittsburgh, PA).  All chemicals were used as received unless otherwise stated.  
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4.2.2 Instrumentation  
High Performance Liquid Chromatography (HPLC). The purification of S-[1-
(N2-deoxyguanosinyl)methyl]glutathione was carried out on an Agilent 1200 series 
HPLC system equipped with a diode-array detector (Santa Clara, CA). Analytes were 
separated by reverse phase chromatography using a 250 mm × 2.5mm 218MS52 
analytical column from Grace Vydac (Hesperia, CA). A linear gradient was run from 2% 
methanol in 0.1% aqueous formic acid to 60% methanol over 15 min, at a flow rate of 
200 µL/min and monitored at 254 nm.  25 µl of mixture from the small scale reaction was 
injected to determine retention times.  S-[1-(N2-deoxyguanosinyl)methyl]glutathione 
eluted at 11.8 min in this system. For the large scale reaction, 100 µl of reaction mixture 
was used for each injection to collect S-[1-(N2-deoxyguanosinyl)methyl]glutathione for 
NMR characterization.  
Liquid Chromatography-Mass Spectrometry (LC-MS). LC-MS analyses were 
performed on a triple quadrupole mass spectrometer TSQ-Quantum (Thermo Electron, 
Waltham, MA) operating in selected reaction monitoring (SRM) mode to detect and 
quantify S-[1-(N2-deoxyguanosinyl)methyl]glutathione. A 150 mm × 2.5mm Hypersil 
Gold column (3 µm particle size) from Thermo Scientific (Pittsburgh, PA) was used. A 
linear gradient was run from 2% methanol in 0.1% aqueous formic acid to 60% methanol 
over 10 min, at 200 µL/min. The electrospray ionization (ESI) source was set as follows: 
spray voltage, 4.0 kV; capillary temperature, 300 °C; sheath gas pressure, 40 au; aux gas 
pressure, 10 au. S-[1-(N2-deoxyguanosinyl)methyl]glutathione was detected at 7.10 min.  
The accurate mass and MS/MS were acquired on an Agilent 6500 Series Quadrupole 
Time-of-Flight (Q-TOF) LC/MS (Santa Clara, CA) with an ESI source. A linear gradient 
was run from 2% acetonitrile in 0.1% formic acid to 98% acetonitrile in 10 min at 200 
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µL/min. The ESI source was set as follows: gas temperature, 350 °C; drying gas, 10 
L/min; Vcap, 4000 V; Nebulizer, 35 psig; fragmentor, 100 V; skimmer, 65 V. A 150 mm 
× 2.5mm Hypersil Gold column (3 µm particle size) was used and S-[1-(N2-
deoxyguanosinyl)methyl]glutathione was detected at 4.8 min. For  fragmentation of S-[1-
(N2-deoxyguanosinyl)methyl]glutathione, the collision energy was set at 20 V.   
Quantitation of S-[1-(N2-deoxyguanosinyl)methyl]glutathione from DNA 
Samples. The adduct was quantified by a triple quadrupole mass spectrometer TSQ-
Quantum (Thermo Electron, Waltham, MA)  using SRM mode (587m/z→308 m/z). The 
collision energy was set at 20 V after optimization.  The calibration curve for quantitation 
was obtained using the integrated peak area and amount of injected standard. 
 
NMR. NMR spectra were recorded on a Varian INOVA 500 NMR spectrometer 
(Palo Alto, CA) at 500 MHz for 1H and 125 MHz for 13C spectra.  HMBC data were 
acquired using the standard Varian program gHMBC, with a mixing time of 62.5 msec. 
 
4.2.3 Experimental Methods 
Glutathione (5 mM) was incubated with formaldehyde (2.5 mM) in 40 µl of 10 
mM potassium phosphate buffer (pH=7.2) for 4 hours at 37 °C. Then, 10 µl of 10 mM 
deoxyguanosine was added and further incubated for 8 hours. The resultant reaction 
mixtures were either separated by reverse phase chromatography or analyzed by mass 
spectrometry. To prepare larger quantities of product for NMR characterization and for 
use as a standard, 92 mg of glutathione were treated with 100 mM formaldehyde in 3.5 
ml of 100 mM potassium phosphate buffer (pH=7.2) for 4 hours at 37°C, followed by 
incubation with 8 mg of deoxyguanosine for 6 hours at 37°C. The resultant reaction 
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mixture was purified by HPLC using a C18 reverse phase column. HPLC fractions 
corresponding to S-[1-(N2-deoxyguanosinyl)methyl]glutathione were collected and dried 
by lyphilization, followed by 1D and 2D NMR analysis.   To measure  adduct formation 
between DNA and GSH, 5 mM GSH solution was first treated with different 
concentrations of formaldehyde (0.1, 0.5, 1, 5, 50 mM) in 100 µl of 10 mM potassium 
phosphate buffer (pH=7.2) for 4 hours at 37°C, followed by incubation with 100 µg of 
calf thymus DNA for another 12 hours. The resultant modified DNA was washed with 
water 5 times using a Millipore Microcon YM-10 spin column. Then, DNA was treated 
by DNaseI (50U) for 30 min in the digestion buffer (80mM Tris-HCl 20mM MgCl2 
pH=7.2), followed by the addition of alkaline phosphatase (2U) and phosphodiesterases 
(1U) for additional 1 hour. Enzymes were removed by a Millipore Microcon YM-10 spin 
column and the resultant solution was separated by HPLC. The fraction containing S-[1-
(N2-deoxyguanosinyl)methyl]glutathione was dried with speed vacuum, followed by 
detection with mass spectrometry.  
 
4.2.4 Stability test  
S-[1-(N2-deoxyguanosinyl)methyl]glutathione standard (100 µL, 4.14 nmol) was 
dissolved in 900 µL of water containing 0.1% formic acid (pH=4) or DNA digestion 
buffer (80mM Tris-HCl 20mM MgCl2 pH=7.2). Solutions were stored at room 
temperature, 100 µL aliquots were analyzed at specified time points (0, 2, 4, 6, 8 and 16 
hour) by HPLC. Stability was calculated from the integrated peak area for each injection, 
relative to time = 0 hour.  
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4.2.5 NMR data  
1H NMR (500 MHz, DMSO-d6): δ = 8.51 (bt, 1H, NH-Gly), 8.45 (bs,1H, N2H-
dG), 8.30 (bd, 1H, J = 8.5 Hz, NH-Cys), 7.90 (s, 1H, H8-dG), 6.15 (ψt, 1H, J ~ 7 Hz, 
H1′-dG), 4.49-4.4 (m, 3H, Cys-Hα, formaldCH2 overlapping), 4.35 (td,1H, J = 6.0, 3.2, 3.0 
Hz, H3′-dG), 3.81 (m, 1H, J = 4.9, 4.8, 3.1 Hz, H4′-dG), 3.71 (d, 2H, J = 6.7 Hz, Gly-
CH2), 3.56 (dd, 1H, J = 11.6, 4.9 Hz, H5′ or H5′′-dG), 3.49 (dd, 1H, J = 11.6, 4.8 Hz, H5′′ 
or H5′-dG), 2.99 (dd,1H, J = 14.0, 5.0 Hz, Cys-Hβ), 2.87 (dd,1H, J = 14.0, 7.4 Hz, Cys-
Hβ'), 2.63 (ddd, 1H, J = 13.3, 7.3, 6.0 Hz, H2′-dG), 2.36 (m, 2H, Glu-CH2γ), 2.22 (ddd, 
1H, J = 13.3, 6.3, 3.2 Hz, H2′′-dG), 1.95 (m, 2H, Glu-CH2β). 
 
4.3 Results 
To characterize potential cross-linked products, excess GSH (5 mM) was allowed 
to react with formaldehyde in 10 mM potassium phosphate buffer (pH=7.2) for 4 hours at 
37°C, followed by incubation with deoxyguanosine (dG) (4) for another 8 hours. A single 
coupling product eluted at 11.9 min on a C18 reverse phase column, giving a UV 
spectrum similar to that of dG, with an absorbance maximum at 260 nm (shown in Figure 
4.1). The exact mass of the protonated molecule was 587.1896 Da (Figure 4.2), consistent 
with elemental composition C21H30N8O10S expected for S-[1-(N2-deoxy-
guanosinyl)methyl]glutathione (5).   
The ESI-MS/MS of the protonated molecule (Figure 4.3) shows major product 
ions corresponding to loss of deoxyribosyl and deoxynucleoside fragments, in accord 
with structural assignment 5. Definitive structural characterization was provided by 1D 
(Figure 4.4) and 2D NMR (Figure 4.5) analysis of product isolated from a larger-scale 
reaction, which also served as standard for subsequent quantitation. The formaldehyde-
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derived methylene linkage between the β methylene carbon of the Cys residue and the 
exocyclic N2 of dG is established by C-H connectivities in the HMBC spectrum (Figure 
4.6), which shows the expected cross peaks between the diastereotopic Cys β-methylene 
protons and the formaldehyde-derived carbon of the methylene linker and between the 
protons of the methylene linker C2 of dG. Adduct 5 was stable in aqueous solution at 
room temperature over 16 hours at pH 4, approximately 40% loss was observed at pH 7.2 
(see Figure 4.7), supporting the hypothesis that if formed, this adduct would be detectable 
in DNA.  
In order to test this hypothesis, DNA was incubated with GSH in the presence of 
formaldehyde. GSH (5 mM) in 10 mM potassium phosphate buffer (pH=7.2) was treated 
with different concentrations of formaldehyde (0.1, 0.5, 1, 5, 50 mM) for 4 hours at 37°C, 
followed by incubation with 100 µg of calf thymus DNA for 12 hours. After extensive 
washing, DNA was digested with DNaseI (50U) for 30 min at 37°C in 80mM Tris-HCl 
20mM MgCl2 (pH=7.2), followed by addition of alkaline phosphatase (2U) and 
phosphodiesterases (1U) for an additional hour. The resultant adduct 5 was collected by 
HPLC and quantified by triple quadrupole mass spectrometer using selected reaction 
monitoring (SRM) mode (587m/z→308 m/z) and the previously-generated 5 from the 
large scale reaction as a standard (the calibration curve is shown in Figure 4.8). Figure 
4.9 shows that production of 5 rises with increasing formaldehyde concentration from 0.1 
mM to 5 mM, then declines when the formaldehyde concentration is further increased to 
50 mM. It was shown previously that when formaldehyde is in excess in the reaction 
mixture, GSH traps two formaldehyde molecules to form a bicyclo[4.4.1]undecane 
structure (6)(19;20), which is not able to react with DNA. Mass spectrometry analysis of 
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6 was consistent with the previously identified compound (Figure 4.10). This evidence 
further supports the involvement of 3 in the formation of 5. 
 
4.4 Conclusions 
We have demonstrated that 5 is formed as a consequence of formaldehyde attack 
in vitro. Both formaldehyde and GSH are ubiquitous cellular components, thus, this DNA 
adduct is expected to form endogenously in cells. The involvement of the cysteine 
residue of GSH in coupling suggests that other thiols may participate in the formation of 
this type of DNA damage arising from formaldehyde.  
The formation of 5 from exogenous formaldehyde may serve as a biomarker to 
evaluate formaldehyde exposure. Concentrations of formaldehyde in the blood of humans 
and of rats after formaldehyde exposure (1.9 ppm for 40 min and 14.4 ppm for 2 hours) 
were not different from the pre-exposure concentration(2), consistent with extensive 
formation of 3. It has also been shown that formaldehyde exposure depletes GSH levels 
in cells and tissues(1), suggesting that GSH was not completely regenerated. Therefore, 
the scavenging of formaldehyde-induced 3 by ADH3 may be limited, which allows 
opportunity for reaction between 3 and DNA to form 5. Also, adduct 5 is of potential 
importance for investigating effects of formaldehyde at distal sites. This issue remains 
one of the biggest challenges for understanding formaldehyde toxicity, carcinogenicity 
and epidemiology, which have been controversial for many years(21-23). Formaldehyde 
exposure by inhalation resulted in decreases in cellular GSH concentration in the 
liver(24), a remote site that inhaled formaldehyde is unlikely to reach by simple 
diffusion. Detection of 5 in distal tissues will shed light on the intriguing question of 
whether formaldehyde exhibits systemic toxicity. 
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In conclusion, we have demonstrated that formaldehyde can cross-link between 
GSH and DNA by forming S-[1-(N2-deoxyguanosinyl)methyl]glutathione. This adduct 
may form endogenously since formaldehyde and GSH are ubiquitous in human cells.  
This adduct is unique because of the involvement of the reactive S-
hydroxymethylglutathione intermediate that normally serves for formaldehyde 
detoxication.  Since S-hydroxymethylglutathione is relatively abundant and highly 
reactive, and the adduct S-[1-(N2-deoxyguanosinyl)-methyl]glutathione is reasonably 
stable, this adduct may serve as a biomarker to understand formaldehyde toxicity and to 
evaluate formaldehyde exposure if coupled with the application of isotope-labeled 
formaldehyde to differentiate between endogenous and exogenous formaldehyde-derived 
adducts. 
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Figure 4.1. HPLC analysis of the products of reaction between glutathione, 
formaldehyde and deoxyguanosine.  Panel A, chromatogram (254 nm) of the complete 
reaction mixture.  Panel B, UV-Vis spectrum (diode array detector) of the peak at 11.9 
minutes, identified as S-[1-(N2-deoxyguanosinyl)methyl]glutathione.  
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Figure 4.2. Exact mass of S-[1-(N2-deoxyguanosinyl)methyl]glutathione 
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Figure 4.3. ESI-MS/MS of the protonated molecular ion of S-[1-(N2-
deoxyguanosinyl)methyl]glutathione. 
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Figure 4.4.  1H NMR spectrum [Varian INOVA 500 NMR spectrometer (Palo Alto, CA), 
at 500 MHz] of S-[1-(N2-deoxyguanosinyl)methyl]glutathione 
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Figure 4.5. HMBC spectrum of S-[1-(N2-deoxyguanosinyl)methyl]glutathione. 
Unsuppressed 1J splittings are indicated on the spectrum by brackets 
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Figure 4.6.  Expansion of the HMBC spectrum of 5 to show the Cys-β-methylene-
formaldehyde linker-N2-dG connectivity. 
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Figure 4.7. Stability of S-[1-(N2-deoxyguanosinyl)methyl]glutathione in aqueous 
solutions (pH=4 and pH=7.2).  
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Figure 4.8. Calibration curve used for the quantitation of S-[1-(N2-
deoxyguanosinyl)methyl]glutathione  from DNA.  Adduct 5 isolated from large-scale 
reaction and quantitated by HPLC served as the standard. 
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Figure 4.9. The influence of formaldehyde concentration on the formation of 5 in DNA.    
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Figure 4.10. Exact mass of  bicyclo[4.4.1]undecane induced by normal formaldehyde 
and [13CD2]-formaldehyde  (50mM). 
 
 165
Schemes 
 
 
 
 
Scheme 4.1. Formation of S-[1-(N2-deoxyguanosinyl)-methyl]glutathione induced by 
formaldehyde. 
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CHAPTER 5 
5. DNA ADDUCTS CAUSED BY INHALED FORMALDEHYDE ARE FOUND IN 
NASAL EPITHELIUM, BUT NOT BONE MARROW 
 
5.1 Introduction  
Formaldehyde is a known human and animal carcinogen according to the 
International Agency for Research on Cancer (IARC) (1), causing nasopharyngeal cancer 
in humans and squamous cell carcinomas in the nose of rats(2).  Limited evidence for an 
association between formaldehyde exposure and the induction of leukemia was published 
in several epidemiology studies on professional workers and industrial workers(3;4), 
however, this finding was not consistent across studies. A large study of British industrial 
workers failed to find excess mortality among workers exposed to formaldehyde(5). 
Overall, IARC considered that there was strong, but not sufficient evidence for a causal 
association between leukemia and occupational exposure to formaldehyde. A recent 
follow-up of the epidemiology study of industrial workers in USA also found an 
association between peak exposure to formaldehyde with the induction of leukemia, 
especially myeloid leukemia(6). However, whether or not formaldehyde causes leukemia 
is still very debatable because there are no experimental data that provide any 
mechanistic insight related to how formaldehyde could induce leukemia, although several 
possible mechanisms have been proposed(7).  There is wide spread human exposure to 
formaldehyde that has raised public concern over its safety. 
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Formation of DNA adducts and increased cell proliferation secondary to 
cytotoxicity are well established key events that drive the induction of nasal cancer in rats 
by formaldehyde (1). Formaldehyde readily induces DNA protein cross-links (DPC) in 
nasal epithelial DNA of rats(8), the site of contact following inhalation exposure, 
however, DPC have not been demonstrated in distant tissues(9). DPC measurements have 
utilized non-chemical-specific methods, primarily based on physical chemistry. However, 
no chemical-specific DNA biomarkers have been evaluated following inhalation 
exposure to formaldehyde, a primary route of exposure.  
Formaldehyde can directly enter into the body through environmental exposure 
such as vehicle emissions, building materials, food, tobacco smoke and indoor air such as 
living in FEMA trailers (http://www.cdc.gov/nceh/ehhe/trailerstudy). Formaldehyde can 
also be indirectly generated through metabolism of a variety of compounds including 
nutrients, drugs and proteins by demethylation. Of equal importance, formaldehyde is an 
essential metabolic intermediate in all living cells and is endogenously produced from 
serine, glycine, methionine and choline.  The endogenous concentration of formaldehyde 
in the blood of human subjects is about 0.1mM (1). Therefore, the presence of both 
endogenous and exogenous formaldehyde makes developing chemically-specific 
biomarkers to monitor formaldehyde exposure and to understand its toxicity especially 
challenging.   
Several previous in vitro studies demonstrated that N6-hydroxymethyl-dA (N6-
HOCH2-dA) was a primary formaldehyde-DNA monoadduct(10;11).  Recently, the 
Hecht laboratory reported increased amounts of N6-HOCH2-dA in multiple tissues of rats 
treated with N-nitrosodimethylamine (NDMA) or 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK) (12;13), which were attributed to the production of formaldehyde during 
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the metabolism of NDMA and NNK. Thus, N6-HOCH2-dA may serve as a good 
biomarker for formaldehyde exposure after inhalation. In preliminary cell culture 
experiments, we found that N2-hydroxymethy-dG was also a suitable DNA biomarker for 
formaldehyde exposure.  Therefore, in the present study, we measured both N2-
hydroxymethy-dG and N6-hydroxymethyl-dA in tissues of rats exposed by inhalation to 
10 ppm [13CD2]-formaldehyde for 6 hr or for 5 days (6h/day). The use of [13CD2]-
formaldehyde permitted the simultaneous measurement of both endogenous and 
exogenous formaldehyde DNA adducts in any tissue.  We also developed sensitive LC-
ESI-MS/MS-SRM methods to detect and quantify formaldehyde-induced DNA adducts 
and DNA-DNA cross-links.   
Our results show that N2-hydroxymethyl-dG is a suitable DNA biomarker for 
inhalation exposure to formaldehyde. Surprisingly, there were no detectable exogenous 
formaldehyde induced N6-HO13CD2-dA in 1 day or 5 day-exposed rat nasal DNA. In 
addition, we demonstrated that exogenous [13CD2]-formaldehyde-DNA adducts and 
DNA-DNA cross-links occurred only in nasal DNA, the site of contact for inhaled 
formaldehyde, whereas endogenous dA and dG monoadducts were present in DNA of all 
tissues examined. This suggests that distant site genotoxic effects of inhaled 
formaldehyde are highly implausible. 
 
5.2 Experiment and methods.  
5.2.1 Chemicals and Materials.   
Deoxyguanosine, deoxyadenine, potassium phosphate, Tris-HCl, MgCl2, formic 
acid, NaCNBH3, methanol, acetonitrile, HPLC grade water and 10X PBS were all 
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purchased from Sigma (St. Louis, MO). 20% formaldehyde in water was procured from 
Tousimis (Rockville, MD). DNase I, alkaline phosphatase and phosphodiesterases were 
purchased from Sigma (St. Louis, MO). [15N5]-dA and [13C1015N5]-dG were ordered from 
Cambridge Isotope Lab (Cambridge, MA). N6-CH3-dA and N2-CH3-dG were obtained 
from Sigma (St. Louis, MO) and Berry & Associates (Dexter, MI), respectively.  All 
chemicals were used as received unless otherwise stated.  
 
5.2.2 High Performance Liquid Chromatography (HPLC).  
The purification of formaldehyde-DNA adducts was carried out on an Agilent 
1200 series HPLC system equipped with a diode-array detector (Santa Clara, CA). 
Analytes in 40-200 μg DNA hydrolysate were separated by reverse phase 
chromatography using a 150 mm × 2.5mm T3 analytical column from Waters (Milford, 
MA). The mobile phases were 0.1% formic acid (A) and methanol (B). A linear gradient 
was run from 2% methanol to 30% methanol over 30 min, at a flow rate of 200 µL/min 
and monitored at 254 nm.  N6-Me-dA and N2-Me-dG eluted at 22.2 and 25.2 min on the 
column in this system, respectively.  dG-dG cross-links eluted at 34.3 min with a linear 
gradient from 2% methanol to 60% methanol over 60 min, at a flow rate of 200 µL/min.  
 
5.2.3 Liquid Chromatography-Mass Spectrometry (LC-MS).  
LC-MS analyses were performed on a triple quadrupole mass spectrometer Ultra 
TSQ-Quantum (Thermo Electron, Waltham, MA) operating in selected reaction 
monitoring (SRM) mode to detect and quantify formaldehyde-DNA adducts. The mass 
spectrometer was interfaced with a Ultra Performance Liquid Chromatography (UPLC) 
system from Waters (Milford, MA).  A 150 mm × 1.0 mm T3 column (3 µm particle 
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size) from Waters was used. A linear gradient was run from 2% methanol in 0.1% 
aqueous formic acid to 60% methanol over 10 min, at 40 µL/min. For the analysis of 
monoadducts, the electrospray ionization (ESI) source was set as follows: spray voltage, 
4.0 kV; capillary temperature, 300 °C; sheath gas pressure, 40 au; aux gas pressure, 10 
au.  For the analysis of dG-CH2-dG, the mass spectrometer was coupled with a Waters 
nano-Acquity LC system. A 100 mm × 100 µm nanoAcquity UPLC HSS T3 column was 
used. A linear gradient was run from 2% acetonitrile in 0.1% acetic acid to 50% in 10 
min, at a flow rate at 0.6 or 1 µL/min. The ESI source was set as follows: spray voltage, 
2.2-2.5 kV; capillary temperature, 280 °C.  
 
5.2.4 Preparation of Internal Standards.   
10 mM [13C1015N5]-dG and [15N5]-dA solution was treated by 100 mM 
formaldehyde in phosphate buffer (pH=7.2) overnight at 37 °C. The reaction mixture was 
separated by HPLC using a 150 mm × 2.5mm C18 T3 analytical column. N2-
hydroxymethyl-dG and N6-hydroxymethyl-dA eluted at 20.5 and 24.3 min, respectively. 
N2-hydroxymethyl-dG and N6-hydroxymethyl-dA were collected and incubated with 50 
mM NaCNBH3 (pH=7.1) overnight at 37°C, followed by further separation using HPLC. 
[13C1015N5]-N2-CH3-dG and [15N5]-N6-CH3-dA eluted at 27.2 and 33.5 min on a 150 mm 
× 2.5mm T3 column using 10 mM ammonium acetate in 0.1% acetic acid and methanol 
as mobile phases, separately. The concentration of [13C1015N5]-N2-CH3-dG and [15N5]-N6-
CH3-dA was determined by HPLC with unlabelled N6-CH3-dA and N2-CH3-dG as 
references. The usual conversion rate from hydroxymethyl group to methyl group was 
65% to 85%.  The internal standard of dG-dG cross-links was prepared by incubating 10 
mM [13C1015N5]-dG with 100 mM formaldehyde in phosphate buffer (pH=7.2)  for 96 h at 
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37 °C. dG-dG cross-links eluted at 34.3 min using a linear gradient from 2% methanol in 
0.1% formic acid to 60% methanol over 60 min, at a flow rate of 200 µL/min.  
 
5.2.5 Animal Exposures.   
 Animal use in this study was approved by the Institutional Animal Use and 
Care Committee of The Hamner Institutes for Health Sciences and was conducted in 
accordance with the National Institutes of Health guidelines for the care and use of 
laboratory animals. Animals were housed in fully accredited American Association for 
Accreditation of Laboratory Animal Care facilities. F344 rats were nose-only exposed to 
10 ppm formaldehyde atmospheres generated by the thermal depolymerization of solid 
[13CD2]-paraformaldehyde for 1 or 5 days (6h/day), sacrificed within two hours of 
exposure for tissue collection and immediate freezing on dry ice, followed by storage at -
80°C. The atmospheric concentration of formaldehyde was continuously monitored 
during exposure , using a calibrated infrared analyzer.  
 
5.2.6 DNA Isolation and Digestion.   
DNA was isolated from the tissues of rats using a NucleoBond DNA Isolation Kit 
(Bethlehem, PA), as instructed by the manufacturer with small modifications. The 
resultant DNA was quantified and stored at -80°C for further analysis. DNA isolated 
from each nose sample (approximately 30~50 µg) was incubated with 50 mM NaCNBH3 
at 37°C for 6 hour in phosphate buffer (pH=7.1). Then, DNA was treated by DNaseI 
(200U) for 10 min in the digestion buffer (80mM Tris-HCl 20mM MgCl2 pH=7.2), 
followed by the addition of 25 µl of alkaline phosphatase and 25 µl of phosphodiesterases 
for additional 1 hour. Enzymes and undigested DNA were removed by a Millipore 
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Microcon YM-10 spin column for 45 min at 23 °C and the resultant solution was 
separated by HPLC to collect the fractions containing the corresponding DNA adducts. 
For monoadduct analysis of other tissues, 200 µg of DNA was usually used for digestion 
using the same methods. Typically, 10 µl of hydrolysate was used to quantify dG and dA 
generated from DNA enzymatic digestion.  
 
5.2.7 Sample workup for DNA-DNA cross-links.   
For the analysis of dG-dG cross-links in nose samples, 30-50 µg isolated nasal 
DNA was digested enzymically as described above in Tris buffer for 70 min at 37°C, 
followed by a cleaning procedure with a Millipore Microcon YM-10 spin column for 45 
min at 23 °C. NaCNBH3  was not used in DNA isolation for dG-dG cross-link analysis, 
as it labilized the cross-links.  The hydrolysate, after removing 10 µl for dG quantitation, 
was frozen at -20°C and separated by HPLC after 12 h storage. A parallel control 
experiment was carried out, to determine the extent of artifact. We spiked an equal 
amount of isotope labeled [13C1015N5]-dG as was produced from DNA digestion 
(determined by HPLC with UV detector using a small aliquot of DNA solution) into the 
sample before hydrolysis. Thus, the signal corresponding to cross-links dG-CH2-
[13C1015N5]-dG accounted for ~half of the artifacts formed during sample workup and 
storage, which demonstrated the amount of artifactual dG-CH2-dG formed during sample 
workup and storage.  The extent of artifact was determined using the integrated peak area 
of dG-CH2-[13C1015N5]-dG divided by the peak area of dG-CH2-dG. For the analysis of 
dG-dG cross-links in other tissues, 200 µg DNA was digested for 70 min at 37°C, 
followed by a cleaning procedure with a Millipore Microcon YM-10 spin column for 60 
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min at 4 °C. The resultant solution was frozen on dry ice immediately, followed by the 
storage in -80°C.  
 
5.2.8 Quantitation of formaldehyde-DNA adducts.  
The adducts were quantified by a triple quadrupole mass spectrometer Ultra TSQ-
Quantum (Thermo Electron, Waltham, MA) using SRM mode. N2-HOCH2-dG was 
quantified as N2-CH3-dG after reduction with NaCNBH3 using the transition of m/z 
282.2→m/z166.1 and N2-HO13CD2-dG was quantified as N2-13CD2H-dG with the 
transition of m/z 285.2→m/z 169.1. N6-HOCH2-dA was detected as N6-CH3-dA after 
treatment by NaCNBH3 with the transition of m/z 266.2 to m/z 150.1. The collision 
energy was set at 17 V after optimization. dG-CH2-dG and dG-13CD2-dG was detected 
and quantified using the transition of m/z 547.5 to m/z 152.1 and m/z 550.5 to m/z 152.1, 
with the collision energy set at 23V. The calibration curves for quantitation were obtained 
using the integrated peak area and amount of injected analytical standard and internal 
standard. 
 
5.2.9 Statistical analysis of data.   
Data represent mean ± standard deviation (SD). Unpaired Student’s t tests were 
performed using the SAS statistical package (SAS Institute, Cary, NC) with the sample 
size ranging from 5 to 8 for monoadduct analysis. Differences were considered 
statistically significant if p < 0.05. 
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5.3 Results  
5.3.1 Method development for formaldehyde-induced monoadducts.  
A highly sensitive method for the analysis of N2-hydroxymethyl-dG was 
developed. Briefly, DNA was incubated with 50 mM NaCNBH3 to convert moderately 
stable N2-hydroxymethyl-dG to stable N2-methyl-dG. The resultant DNA was digested by 
multiple enzymes, followed by fraction collection using HPLC. The fractions containing 
N2-Me-dG were dried and analyzed by capillary LC-ESI-MS/MS in SRM mode.  As 
shown in Scheme 5.1, both endogenous and exogenous formaldehyde can contribute to 
the formation of formaldehyde-DNA adducts. Therefore, the mass spectrometer was set 
up to monitor different transitions: m/z 282.2→166.1 for N2-CH3-dG; m/z 285.2→m/z 
169.1 for N2-13CD2H-dG and m/z 297.2→m/z 176.1 for the internal standard [13C1015N5]-
N2-CH3-dG.  The method for N6-HOCH2-dA was essentially the same as that for N2- 
HOCH2-dG with appropriate transitions in SRM.  
Figure 5.1 A shows a typical LC-ESI-MS/MS-SRM chromatogram of N2-CH3-dG 
and its corresponding internal standard. 0.8 fmol of N2-CH3-dG and 80 fmol of 
[13C1015N5]-N2-CH3-dG internal standard were loaded on the column, with a retention 
time at 7.58 min.  The limit of detection was ~240 amol on the column (S/N=3). Figure 
5.1 B shows a typical LC-ESI-MS/MS-SRM chromatogram of 0.15 fmol N6-CH3-dA and 
37.5 fmol internal standard [15N5]-N6-CH3-dA with a retention time of 8.55 min. The 
limit of detection was ~75 amol on the column (S/N=3). The calibration curves used to 
quantify formaldehyde-dG and dA adducts are presented in Figure 5.1 C and Figure 5.1 
D, respectively. Satisfactory accuracy and precision of this assay were shown by adding 
known amounts of N2-CH3-dG and N6-CH3-dA analytical standards to 50 µg of DNA, as 
shown in Table 5.1.  
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5.3.2 N2-hydroxymethyl-dG in tissues of exposed rats.  
Figure 5.2 A shows the LC-ESI-MS/MS SRM chromatogram of N2-Me-dG in 
nasal DNA from a 1 day-exposed rat using the methods just described.  The peak 
corresponding to the specific transition of m/z 282.2→ m/z166.1 and the same retention 
time with [13C1015N5]-N2-CH3-dG internal standard unambiguously identified the 
formation of N2-HOCH2-dG from endogenous formaldehyde, as shown by the peak at 
7.55 min in the top panel of Figure 5.2A. In addition to the peak of endogenous adducts, 
a new peak corresponding to the transition of m/z 285.2→m/z 169.1 coeluted with the 
internal standard, which is consistent with N2-HO13CD2-dG formed from exogenous 
[13CD2]-formaldehyde. Similarly, both endogenous and exogenous dG adducts could be 
clearly identified and quantified in 30-50 μg of nasal epithelial DNA after 5 days of 
exposure, as shown in Figure 5.2 B. Compared with Figure 5.2A, the amount of 
exogenous N2-HO13CD2-dG in nasal DNA increased as a consequence of extended 
exposure. In all other tissues including liver, lung, thymus, bone marrow and spleen of 1 
or 5 day-exposed rats, only endogenous formaldehyde-induced N2-HOCH2-dG could be 
observed in 200 μg DNA. As shown by the middle panels of Figure 5.2C and Figure 
5.2D, no signal corresponded to the transition of m/z 285.2→m/z 169.1 of exogenous 
adducts. Therefore, there were no detectable amounts of N2-HO13CD2-dG in distant site 
tissues after 1 or 5 days of exposure, despite the utilization of 5-fold more DNA for these 
tissues. These data strongly indicate that formaldehyde does not reach distant sites in an 
active form to cause detectable amounts of DNA adducts. 
 
 179
5.3.3 N6-hydroxymethyl-dA in tissues of exposed rats.  
N6-hydroxymethyl-dA has been reported to be induced by formaldehyde resulting 
from the metabolism of nitroso compounds(12;13). Therefore, we examined the 
formation of N6-hydroxymethyl-dA in rats exposed to 10 ppm [13CD2]-formaldehyde, as 
shown in Figure 5.3. Figure 5.3 A and B illustrate the LC-ESI-MS/MS-SRM 
chromatograms of N6-Me-dA in noses of rats exposed to [13CD2]-formaldehyde for 1 or 5 
days. The peak corresponding to the specific transition of m/z 266.2→m/z 150.1 and the 
same retention time as the internal standard identified the formation of N2-HOCH2-dA 
from endogenous formaldehyde. However, there was no signal for N6-HO13CD2-dA (m/z 
269.2→m/z 153.1). This result indicates that N2-hydroxymethyl-dA did not form in 
detectable amounts in the noses of rats exposed to 10 ppm formaldehyde for either 1 or 5 
days.  Figure 5.3C and 5.3D show the chromatograms of N6-Me-dA in bone marrow and 
spleen of 5 day-exposed rats. We did not detect a peak for N6-HO13CD2-dA after [13CD2]-
formaldehyde exposure, while we clearly observed the peak of N6-HOCH2-dA from 
endogenous formaldehyde.   
 
5.3.4 Monoadduct amounts in tissues of exposed rats.  
Table 5.2 summarizes the number of adducts in all the tissues measured in this 
study. For 1 day-exposed samples, endogenous N2-HOCH2-dG ranged from 1.05-2.66 
adducts/107 dG depending on tissues, while endogenous N6-HOCH2-dA was from 1.85 to 
3.95 adducts/107 dA. For 5 day-exposed rats, the numbers of endogenous N2-HOCH2-dG 
and N6-HOCH2-dA were 1.17-3.24 adducts/107 dG and 2.23-3.61 adducts/107 dA, 
respectively.  The exogenous [13CD2]-formaldehyde only induced DNA adducts with dG 
and this adduct was only detected in nasal epithelium from 1 or 5 day-exposed rats.  The 
 180
mean amounts of exogenous N2-HO13CD2-dG in 1 or 5 day-exposed nasal epithelium 
samples were 1.28±0.49  and 2.43±0.78 adducts/107 dG, respectively.  
Figure 5.4 illustrates statistical analyses of the data from 1 day-exposed and 5 
day-exposed nose samples. Figure 5.4 A shows that the number of exogenous   N2-
hydroxymethyl-dG adducts was significantly greater for 5 day-exposed noses (p < 0.05), 
with almost double the amount in 5 day samples, suggesting that some N2-
hydroxymethyl-dG accumulated with the longer exposure. The ratio of endogenous 
versus exogenous N2-hydroxymethyl-dG is shown in Figure 5.4 B. There was a 
significant difference between 1 day and 5 day-exposed samples (p < 0.05). The former 
had a ratio of 0.57±0.28, while the ratio of 5 day-exposed sample was 1.06±0.40.  These 
results suggest that the exogenous formaldehyde adducts increased during exposure.  
 
5.3.5 DNA-DNA cross-links in tissues of exposed rats.  
A sensitive nano-LC-MS/MS-SRM method was also developed, with a limit of 
detection of ~60 amol on column, to detect dG-dG cross-links in the tissue samples 
(Scheme 5.1). Some typical chromatograms are shown in Figure 5.5. Similar to the 
monoadducts, the exogenous dG-13CD2-dG only could be detected in nasal DNA (Figure 
5.5A and 5.5B) and not in DNA from any distant tissue (Figure 5.5C and 5.5D). These 
data demonstrate that no detectable amounts of exogenous dG-dG cross-links were 
induced at distant sites in rats by inhalation exposure to formaldehyde.   
 The numbers of dG-dG cross-links in individual tissues are summarized in Table 
5.3. The amount of endogenous cross-links ranged from 0.09–0.21 adducts/107 dG across 
all tissues. In contrast, the amounts of exogenous dG-13CD2-dG were 0.14±0.06 and 
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0.26±0.07 adducts/107 dG in DNA from nasal epithelium of 1 day and 5 day-exposed 
rats, respectively, but were not detectable in other tissues. These numbers were roughly 
10% of the amount of corresponding monoadducts. Since N2-hydroxymethyl-dG can 
further react with dG, potential artifacts could form during sample workup and storage. 
Therefore, we carried out a parallel control experiment adding amounts of [13C1015N5]-dG 
equal to the amount of dG in the sample and determined that up to 65% of the cross-links 
were artifact by calculating the peak ratio under the conditions used to analyze nose 
samples ( Figure 5.6). The data in Table 5.3 were corrected to remove such artifact. 
 
5.4 Discussion 
This study addressed several critical issues related to formaldehyde toxicity and 
carcinogenicity. Exogenous N2-HO13CD2-dG was only detected in DNA from nasal 
epithelium of rats after inhalation. The same was true for exogenous dG-dG cross-links.  
The absence of exogenous formaldehyde-induced DNA adducts and cross-links in other 
tissues supports the conclusion that distant genotoxic effects of inhaled formaldehyde are 
highly implausible. Endogenous formaldehyde-induced N6-HOCH2-dA was detected in 
all tissues, but N6-HO13CD2-dA was not detectable in DNA from any tissue examined in 
rats following inhalation exposure. It is important to note that previous methods used to 
measure DPC (8;9) and specific DNA adducts (12;13)could not differentiate between 
endogenous and exogenous DNA damage. It was only through the use of the [13CD2]-
formaldehyde and mass spectrometry that endogenous and exogenous adducts could 
specifically be measured in the same tissue. 
 Formaldehyde was first identified as a carcinogen when rats exposed to 15 ppm 
for 12-18 months developed squamous cell carcinomas of the nasal passages(2). This 
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study was continued through 24 months of exposure, with nasal carcinomas developing 
in 50% of the 15 ppm rats, but only 1% of the rats exposed to 6 ppm formaldehyde. No 
malignant tumors of the nose occurred in rats exposed to 2 ppm, or in controls(14) . A 
second carcinogenicity study was conducted that expanded the exposure response to 
include 0.7, 2, 6, 10 and 15 ppm formaldehyde. Formaldehyde induced nasal squamous 
cell carcinomas in a highly nonlinear fashion, with no neoplasms at the lowest two 
concentrations, and 1, 22 and 47% carcinomas at 6, 10 and 15 ppm formaldehyde. Cell 
proliferation was also greatly increased at 10 and 15 ppm exposures(15). Exposures for 
the present study were modeled after the 10 ppm exposure data from this expanded 
cancer bioassay because it was clearly carcinogenic, induced marked increases in 
sustained cell proliferation, yet was less cytotoxic than15 ppm formaldehyde.  
 IARC recently classified formaldehyde as a known human carcinogen based on 
sufficient evidence for nasopharyngeal carcinoma(1).  Extensive research has 
demonstrated that both genotoxicty and cytoxicity contribute to the carcinogenesis of 
formaldehyde in nasal tissues(1). As mentioned above, marked and sustained increases in 
cell proliferation in the noses of rats have been observed after exposure to ≥10 ppm 
formaldehyde (15;16). In this study, we found that exogenous formaldehyde-induced N2-
hydroxymethyl-dG adducts and corresponding dG-dG cross-links, a generally more 
mutagenic species, formed in noses of rats after 10 ppm [13CD2]-formaldehyde exposure. 
These findings provide new mechanistic insight regarding how exposure to formaldehyde 
may cause nasal cancer. Several guanine point mutations have been identified by DNA 
sequence analysis of p53 cDNA from formaldehyde-induced squamous cell carcinomas 
in nasal passages of rats, including 398G→T, 638G→T, 812G→A and 842G→C(17). Earlier 
studies of Heck and Casanova demonstrated a linear response for DPC between 6, 10 and 
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15 ppm formaldehyde exposures associated with depletion of glutathione in the nasal 
epithelium at ≥6 ppm formaldehyde, but reduced numbers of DPC per ppm formaldehyde 
at 2 and 0.7 ppm (9). The present study quantitated endogenous dG and dG-dG cross-
links in numerous tissues, including the nasal epithelium. It also quantitated the number 
of endogenous dA adducts in these tissues. Surprisingly, the number of endogenous 
formaldehyde adducts was greater than the number of exogenous adducts in nasal DNA 
following exposures to 10 ppm [13CD2]-formaldehyde.  
 The number of endogenous formaldehyde adducts was similar across tissues. This 
suggests that the marked increases in cell proliferation induced by exposure to 10 and 15 
ppm plays a critical role in converting both endogenous and exogenous labile, but 
promutagenic adducts into mutations. At low exposures (<0.1 ppm), minimal numbers of 
exogenous formaldehyde adducts will be formed relative to the high number of 
endogenous formaldehyde adducts. Likewise, no increase in cell proliferation will be 
associated with such low exposures. Nasal squamous cell carcinomas are rare in non 
exposed rats, but were very prominent in rats exposed to 10 or 15 ppm formaldehyde. 
This improved understanding of the mechanisms involved strengthens the role of 
cytotoxicity-induced cell proliferation in the mutagenesis and carcinogenesis of 
formaldehyde.   
 We have demonstrated that exogenous [13CD2]-formaldehyde only induced DNA 
lesions at the site of contact, but not in DNA of distant organs. This result offers new 
insight regarding the plausibility of formaldehyde causing leukemia. Limited evidence 
for an association between leukemia and formaldehyde exposure have been identified in 
several epidemiology studies, but were not present in others (5). Leukemia was increased 
in the U.S. formaldehyde worker cohort only when the highest vs lowest peak exposure 
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were compared, but not when cumulative exposure was the metric (6). Likewise, a meta 
analysis found an increase in lymphohematopoietic malignancies, with the highest 
relative risk for myeloid leukemia (7). In contrast, Coggon found no association with 
leukemia in the British cohort, even though 28% of the workers had exposures >2.0 ppm 
(5). The IARC Working Group considered the association between formaldehyde 
exposure and leukemia as strong, but less than causal. They also noted that it was not 
possible to identify a mechanism for the induction of myeloid leukemia in humans. For 
example, no increase has been found in the formaldehyde concentration in the blood of 
exposed humans and animals, there were no detectable protein adducts or DPC in the 
bone marrow of rats exposed to as high as 15 ppm formaldehyde, no DPC were 
detectable in the bone marrow of Rhesus monkeys exposed to formaldehyde as high as 6 
ppm, and no chromosomal aberrations were found in the bone marrow of rats exposed to 
as high as 15 ppm formaldehyde (18). Zhang hypothesized three possible mechanisms for 
the induction of leukemia by formaldehyde (7). First, formaldehyde may act directly on 
the bone marrow. This study demonstrated that that does not occur. He then suggested 
that hematopoietic stem cells/early progenitor cells in the circulation, or residing in the 
nasal passages, could be exposed in the nose, travel to the bone marrow and be 
transformed into leukemia cells. There are no data supporting this mechanism for 
leukemia induced by any chemical. Furthermore, the exogenous formaldehyde DNA 
adducts are labile and would not be expected to persist for more than a day or so, based 
on our data for 1 versus 5 days of exposure. The cells containing labile adducts would 
need to travel to the bone marrow and undergo cell division shortly after being adducted. 
Therefore, these hypotheses remain highly speculative. The possibility that formaldehyde 
induces leukemia cannot be ruled out by this study, however, our finding that exogenous 
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N2-HO13CD2-dG adducts were only formed in nasal DNA, that the adducts are labile and 
that high numbers of endogenous formaldehyde adducts are always present indicate that 
formaldehyde is unlikely to cause leukemia.  
In this study, rats were exposed to formaldehyde for 1 or 5 days (6 hours/day). 
Compared to the 1 day group, the 5 day group nearly doubled the amount of exogenous 
N2-hydroxymethyl-dG in nasal DNA. These data indicate that formaldehyde adducts can  
modestly accumulate with increased exposure. Previous research compared the acute 
yields of DPC in pre-exposed and naive rats after 3-h exposure and found that the acute 
yields of DPC in pre-exposed rats were about half those of naive rats at 6 and 15 ppm 
(19). This difference was attributed to an increase in total DNA in the noses secondary to 
cell proliferation. In addition, cumulative yields of DPC were also compared between 
pre-exposed and naive rats and the yield was not higher in pre-exposed than in those 
naive rats, which  was attributed to the rapid repair of DPC in the rat nasal mucosa (19). 
Even though increased cell proliferation has been demonstrated in noses of rats exposed 
to 10 ppm formaldehyde (15;20), we found significantly increased numbers of exogenous 
N2-hydroxymethyl-dG in the 5 day-exposed group, suggesting that N2-hydroxymethyl-dG 
is a sensitive specific DNA biomarker of formaldehyde exposure. From this limited time 
course, it is not clear if the exogenous N2-hydroxymethyl-dG level had attained steady 
state. Additional exposures will be needed to clarify this issue.  
 We detected both endogenous dG and dA adducts, but only exogenous dG 
adducts were observed in the nasal DNA of rats exposed to 10 ppm formaldehyde. What 
is different between dG and dA toward exogenous formaldehyde during exposure?  Since 
the in vitro reactivity of dG and dA toward formaldehyde is quite similar, the formation 
of exogenous DNA adducts should not be different from direct reaction between 
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formaldehyde and the DNA bases, so dA adducts would be expected to occur.  We 
hypothesize that the difference could be a consequence of different involvement of dG 
and dA in the formation of DPC and suggest that exogenous dG adducts are actually 
formed through DPC intermediates. Lysine-dG cross-links are the primary DPC formed, 
however, they are very labile (21). Decomposition of the labile lysine-dG cross-links 
could yield dG monoadducts. We suggest that this does not occur with dA since it is 
much less involved in the formation of DPC. Exogenous formaldehyde first targets 
neighboring proteins due to the high reactivity of lysine residues (22) , followed by the 
further condensation with DNA to form DPC. Thus, there is little chance for exogenous 
formaldehyde to directly react with DNA to form adducts. In contrast, endogenous dA 
and dG monoaducts may arise from the direct attack of higher concentrations of 
intracellular formaldehyde, estimated to be present in µM concentrations (23). As shown 
by our results, the number of endogenous dA adducts is similar, but slightly higher than 
that of endogenous dG adducts, which is consistent with their reactivity in vitro.  
We found that formaldehyde induces N2-hydroxymethyl-dG as the primary DNA 
monoadduct in rats exposed to formaldehyde via inhalation.  However, a previous study 
demonstrated that formaldehyde lead to increased amounts of N6-HOCH2-dA in multiple 
tissues from rats exposed to NDMA and NNK (13). Well characterized pathways support 
that formaldehyde is released during intracellular metabolism of carcinogenic NDMA 
and NNK (13).  Thus, increased amounts of N6-HOCH2-dA were the consequence of 
formaldehyde from the metabolism of these compounds (13). It is of interest to note that 
endogenous N6-HOCH2-dA was present in control rat liver at 1.96±1.86 adducts/107 dA 
(13), which is similar to our 1 day (2.62±0.46) and 5 day (2.87±0.65) endogenous N6-
HOCH2-dA rat liver DNA. However, in our study, there was no detectable N6-HO13CD2-
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dA in nasal epithelial DNA following exposure to 10 ppm [13CD2]-formaldehyde for 1 or 
5 days.  N2-hydroxymethyl-dG was not measured in the previous study (13), but we 
would predict that it will also be increased. The way formaldehyde enters the tissue (from 
inhalation or intracellular metabolism) may influence the formation of specific DNA 
adducts in metabolically active tissues.  
 Little is known about the biological consequence of formaldehyde-induced DNA 
monoadducts, including N2-hydroxymethyl-dG and N6-hydroxymethyl-dA. Both of these 
adducts could interfere with base-pairing. In addition, they can serve as precursors of 
DNA-DNA cross-links. In rats treated with NDMA and NNK, it has been shown that the 
number of N6-HOCH2-dA and dA-CH2-dA cross-links increased as a consequence of 
formaldehyde generated during the metabolism of NDMA and NNK (13). This suggests 
that monoadducts are the precursor of the corresponding DNA-DNA cross-links.  We 
have detected both endogenous and exogenous dG-dG cross-links in noses, but only 
endogenous dG-CH2-dG cross-links were found in distant tissues. However, the reactivity 
of N2-hydroxymethyl-dG also can contribute to the formation of artifactual cross-links 
during sample processing and storage, as shown in our experiment with [13C1015N5]-dG, 
where up to 65% of the cross-links were artifactually formed during sample workup and 
storage. Although use of lower temperature (4°C) in the sample workup and storage (-
80°C) can significantly reduce artifact, special caution is needed when generating or 
using any quantitative data on formaldehyde-induced dG-dG cross-links. Nevertheless, 
no exogenous dG-dG cross-links were detected in distant tissues, even though we utilized 
5-fold more DNA which could amplify true cross-link formation and formation from 
artifact.  
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 Anatomical differences between rat and human nasal structures could also affect 
the molecular dose. Previous studies have demonstrated that formaldehyde is absorbed 
almost completely in the nasal passage of rats, while formaldehyde is also absorbed in 
adjacent tissues like nasopharynx, trachea and proximal regions of the major bronchi of 
monkeys (1). When using DPC as an endpoint, the yield of DPC in the noses of monkeys 
was about an order of magnitude lower than in the noses of rats. This was attributed to 
species differences in minute volume and quantity of exposed tissue(24). A 
pharmacokinetic model has been developed, predicting that the number of DPC in the 
human nose would be lower than those in the noses of monkeys and rats (24). This would 
predict that lower molecular doses of formaldehyde DNA adducts would be formed in 
humans relative to animal models, reducing the risk in human populations exposed to 
formaldehyde.  
 The use of [13CD2]-formaldehyde provided a unique opportunity to distinguish the 
DNA adducts from different sources. However, it is well documented that deuterium is 
not a stable isotope and can exchange with hydrogen. The unambiguous identification 
and accurate quantitation of specific DNA adducts may be interfered if H-D exchange 
occurs in the analyzed samples. We set up the mass spectrometer to monitor all the 
transitions, including no H-D exchange and loss of 1 or 2 deuterium atoms. Based on the 
ratio of integrated peaks, we found that no H-D exchange occurred in either 1 day or 5 
day exposures.  
 In summary, the results of this study clearly demonstrated that endogenous and 
exogenous formaldehyde-induced DNA adducts and DNA-DNA cross-links could be 
unambiguously differentiated utilizing [13CD2]-formaldehyde exposures and mass 
spectrometry. This approach allowed us to quantitatively examine the molecular dose of 
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endogenous and exogenous formaldehyde DNA adducts in a multitude of tissues 
following inhalation exposure. Moreover, we demonstrated that exogenous 
formaldehyde-induced N2-HO13CD2-dG is the primary DNA monoadduct in rats exposed 
to 10 ppm [13CD2]-formaldehyde for 1 day or 5 days. This provides clear evidence that 
inhaled formaldehyde induced exposure-specific DNA adducts at the target site for 
carcinogenesis. It also demonstrated that N2-hydroxymethyl-dG serves as an excellent 
biomarker to evaluate specific formaldehyde exposures through inhalation. This approach 
should also be suitable for other routes of exposure. More importantly, we have shown 
that exogenous formaldehyde-induced DNA monoadducts and dG-dG cross-links only 
occur in rat nasal mucosa, providing clear evidence that distant genotoxic effects of 
inhaled formaldehyde are highly implausible. The data generated in this study add greatly 
to our understanding of the toxicity and carcinogenicity of formaldehyde, a high volume 
chemical of intense public health concern.  
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Figure 5.1. Typical LC-ESI-MS/MS SRM chromatograms standards and calibration 
curves. 0.8 fmol of N2-CH3-dG and 80 fmol of internal standard [13C1015N5]-N2-CH3-dG 
loaded on the column (A). 0.15 fmol of N6-CH3-dA and 37.5 fmol of internal standard 
[15N5]-N6-CH3-dA (B). Typical calibration curve used for the quantitation of N2-Me-dG 
adducts (C). Typical calibration curves used for the quantitation of N6-Me-dA adducts 
(D). 
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Figure 5.2. LC-ESI-MS/MS SRM chromatograms of N2-Me-dG in typical tissues: 
1 day-exposed nasal epithelium (A), 5 day-exposed nasal epithelium (B), 
bone marrow (C) and spleen (D). 
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Figure 5.3.  LC-ESI-MS/MS SRM chromatograms of N6-Me-dA of typical tissues of rats: 
nasal epithelium of a 1 day-exposed rat (A); nasal epithelium of a 5 day-exposed rat (B) 
bone marrow of a 5 day-exposed rat (C); spleen of a 5 day-exposed rat (D). 
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Figure 5.4. The amount of exogenous N2-HO13CD2-dG in nasal epithelial DNA of rats 
exposed to 10 ppm formaldehyde for 1 day or 5 days (A). The ratio of exogenous versus 
endogenous N2-hydroxymethyl-dG for 1 day and 5 day-exposed nose samples (B). 
A. B.
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Figure 5.5.  LC-ESI-MS/MS SRM chromatograms of dG-dG cross-links in typical tissues of rats: 
nasal epithelium of a 1 day-exposed rat (A); nasal epithelium of a 5 day-exposed rat (B); 
liver of a 5 day-exposed rat (C);  spleen of a 5 day-exposed rat (D). 
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Figure 5.6. Formation of artifacts under the conditions used to analyze dG-dG cross-links 
in nasal DNA samples. The extent of artifacts (~65%) was determined by the area ratio of 
peak 562.5→152.1 (middle panel) versus peak 547.5→152.1 (top panel) in parallel 
control experiments by adding amounts of [13C1015N5]-dG equal to the amount of dG in 
the sample during sample workup and storage. 
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Table 5.1. Accuracy and precision of the LC/MS/MS-SRM analysis of monoadducts of 
formaldehyde*  
 
N2-CH3-dG  N6-CH3-dA  
Added 
(fmol) 
Detected 
(fmol) 
Accuracy 
(%) 
CV 
(%) 
Added 
(fmol) 
Detected 
(fmol) 
Accuracy 
(%) 
CV 
(%) 
10 10.8±0.7+ 108 6 10 10.2±0.5 102 5 
20 22.5±0.9 112 4 20 21.6±1.2 108 5 
40 42.3±0.4 105 0.1 40 40.9±1.4 102 3 
*Rat hepatic DNA samples were spiked in triplicate with the indicated amounts of N2-CH3-dG 
or N6-CH3-dA 
+ Mean±SD 
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Table 5.2.  Formaldehyde-induced monoadducts amounts in rats exposed to 10 ppm formaldehyde for 1 day and 5 days 
 
N2-HOCH2-dG N6-HOCH2-dA 
Exposure 
period 
Tissues exogenous 
(adduct/107 dG) 
endogenous 
(adduct/107 dG) 
exogenous 
(adduct/107 dA) 
endogenous 
(adduct/107 dA) 
Nose* 1.28±0.49+ 2.63±0.73 n.d. 3.95±0.26 
Lung‡ n.d.§ 2.39±0.16 n.d. 2.62±0.24 
Liver n.d. 2.66±0.53 n.d. 2.62±0.46 
Spleen n.d. 2.35±0.31 n.d. 1.85±0.19 
Bone marrow n.d. 1.05±0.14 n.d. 2.95±1.32 
1 day 
Thymus n.d. 2.19±0.36 n.d. 2.98±1.11 
Nose 2.43±0.78 2.84±1.13 n.d. 3.61±0.95 
Lung n.d. 2.61±0.35 n.d. 2.47±0.55 
Liver n.d. 3.24±0.42 n.d. 2.87±0.65 
Spleen n.d. 2.35±0.59 n.d. 2.23±0.89 
Bone marrow n.d. 1.17±0.35 n.d. 2.99±0.08 
5 day 
Thymus n.d. 1.99±0.30 n.d. 2.48±0.11 
*n=5-8 nose samples for the analysis of monoadducts in 30-50 μg of DNA; data represent mean ± SD; 
                                                  + not detectable in 200 μg of DNA; ‡n=4-5 for distant tissues; 
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Table 5.3. Formaldehyde-induced dG-dG cross-links in rats exposed to 10 ppm formaldehyde for 1 day and 5 days 
 
dG-dG Cross-links 
Exposure period Tissues exogenous 
(adduct/107 dG) 
endogenous 
(adduct/107 dG) 
Nose* 0.14±0.06+ 0.17±0.05 
Lung‡ n.d.§ 0.20±0.04 
Liver n.d. 0.18±0.05 
Spleen n.d. 0.15±0.06 
Bone Marrow n.d. 0.09±0.01 
1 day 
Thymus n.d. 0.10±0.03 
Nose 0.26±0.07 0.18±0.06 
Lung n.d. 0.20±0.03 
Liver n.d. 0.21±0.08 
Spleen n.d. 0.16±0.08 
Bone Marrow n.d. 0.11±0.03 
5 day 
Thymus n.d. 0.19±0.03 
§ n=4-5 nose samples for the analysis of cross-links, artifacts have been subtracted from the data; 
The data on dG-dG cross-links were considered less rigorous than monoadduct data due to the issue of potential artifacts (Figure 5.6); 
¶ n=3 for distant tissue 
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Schemes 
 
 
Scheme 5.1. The formation of N2-hydroxymethyl-dG (A) and dG-dG cross-links (B) 
originating from both endogenous and exogenous formaldehyde.  
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CHAPTER 6 
6. CONCLUSION AND PERSPECTIVES 
 
In this dissertation, we have addressed several critical issues necessary to improve 
our understanding on formaldehyde toxicity and carcinogenesis by designing an 
integrated bottom-up approach. Specifically, we have shown that lysine residues of 
histone are highly reactive toward formaldehyde; we have elucidated the structures of 
DPC; we have identified a novel DNA adduct induced by formaldehyde; we have 
quantified endogenous and exogenous formaldehyde adducts in tissues following 
inhalation exposure of rats to 10 ppm [13CD2]-formaldehyde, and we have demonstrated 
that it is highly implausible that inhalation exposure of rats to formaldehyde has distant 
genotoxic effects. The primary conclusions from this research is summarized as follows. 
 
6.1 Conclusions 
6.1.1 Formaldehyde binding sites of histone 
We started with the attempt to evaluate accessibility of histone residues to 
formaldehyde, since histone was reported to be involved in the formation of DPC in 
which the epsilon-amino groups of lysine and exocyclic amino groups of DNA were 
thought to be cross-linked through multiple step reactions. Using mass spectrometry, the 
N-terminus of histone and lysine residues located in both the histone N-terminal tail and 
the globular fold domain were identified as binding sites for formaldehyde in the current 
study. The observation that only lysine residues without post-translational modification 
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can be attacked by formaldehyde indicates that PTM blocks the reaction between lysine 
and formaldehyde. Remarkably, we found that formaldehyde-induced Schiff bases on 
lysine residues could inhibit the formation of PTM on histone, raising the possibility that 
formaldehyde might alter epigenetic regulation.  
 
6.1.2 Structure elucidation of DPC 
The identification of lysine residues on histone as binding sites of formaldehyde 
implies that lysine may be involved in the formation of DPC. Although DPCs are 
biologically important as a primary genotoxic effect and eight amino acids have been 
reported to form stable adducts with formaldehyde, the structures of these cross-links 
have not yet been elucidated. We have demonstrated that Lys, Cys, His and Trp form 
detectable formaldehyde-induced cross-links with dG, dA and dC. Detailed 
characterization of the formaldehyde-derived linkage of single amino acids with 
nucleosides by NMR and mass spectrometry established that these amino acids all form 
cross-links involving formation of a formaldehyde-derived methylene bridge. Lys yields 
two additional products with dG in which the linking structure is a 1,N2-fused triazino 
ring. We further investigated cross-linking reactions between the four amino acids and 
the trinucleotides d(T1B2T3) where B2 is the target base G, A or C. We also examined the 
cross-linking reactions between dG, dA and dC and 8-mer peptides containing a single 
reactive residue at position 5.  Our results also demonstrated that Lys-dG cross-links are 
the primary DPC induced by formaldehyde. In addition, Lys-dG cross-links are not 
stable, which is consistent with previous reports on the lability of histone-DNA cross-
links.  
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6.1.3 Identification of a novel dG-CH2-GSH adduct 
The finding that Cys-dG cross-links could be initiated by either S-hydroxymethyl 
group of cysteine residue or N2-hydroxymethyl-dG highlighted the reactivity of S-
hydroxymethyl group during cross-linking reaction. This finding further lead to the 
identification of a novel dG-CH2-GSH adduct. Previous research has demonstrated that 
formaldehyde is genotoxic, causing mutations in multiple genes. However, no exogenous 
formaldehyde-induced DNA adducts have been detected in animals after inhalation 
exposure, although formaldehyde can result in N6-deoxyadenosine, N2-deoxyguanosine 
and N4-deoxycytidine adducts in vitro. This can be partially attributed to the rapid 
metabolism of formaldehyde by glutathione-dependent enzyme systems.  Among the 
intermediates in the pathway of formaldehyde detoxification, S-
hydroxymethylgultathione is a reactive species and has the potential to further conjugate 
with DNA bases. We demonstrated the formation of S-[1-(N2-
deoxyguanosinyl)methyl]glutathione between glutathione and DNA in the presence of 
formaldehyde. This adduct is unique because of the involvement of S-
hydroxymethylglutathione which is a key player during the detoxification of 
formaldehyde.  
 
6.1.4 Distant genotoxic effects of formaldehyde  
After our extensive work on biomarker discovery and validation involving DNA 
monoadducts and DNA-DNA cross-links, we applied these methods to analyze DNA 
samples from rats exposed to formaldehyde, trying to answer whether or not 
formaldehyde has distant genotoxic effects. Both genotoxicty and cytotoxicity are key 
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events in formaldehyde nasal carcinogenicity in rats, but no mechanistic data exist for 
leukemia. Highly sensitive LC-MS/MS-SRM methods were developed and [13CD2]-
formaldehyde exposures utilized, allowing differentiation of DNA adducts and DNA-
DNA cross-links originating from endogenous and inhalation-derived formaldehyde 
exposure. The results show that exogenous formaldehyde induced N2-hydroxymethyl-dG 
monoadducts and dG-dG cross-links in DNA from rat nasal mucosa, but did not form 
[13CD2]-adducts in distant tissues. Furthermore, no N6-HO13CD2-dA adducts were 
detected in nasal DNA, but high amounts of endogenous formaldehyde dG and dA 
monoadducts were present in all tissues examined. The number of exogenous N2-
HO13CD2-dG in 1 day and 5 day nasal DNA samples from rats exposed to 10 ppm 
[13CD2]-formaldehyde was 1.28±0.49 and 2.43±0.78 adducts/107 dG, respectively, while 
2.63±0.73 and 2.84±1.13 N2-HOCH2-dG adducts/107 dG and 3.95±0.26 and 3.61±0.95 
N6-HOCH2-dA endogenous adducts were present. No N2-HO13CD2-dG adducts were 
detected in lung, liver, spleen, bone marrow or thymus, despite analyzing 5 times more 
DNA than for nasal epithelium, while endogenous dG and dA adducts were present in 
amounts similar to nasal DNA. This study provides the first quantitation of both 
endogenous and exogenous formaldehyde adducts. There is strong evidence supporting a 
genotoxic and cytotoxic mode of action for inhaled formaldehyde in the target tissue for 
carcinogenesis, but does not support the biological plausibility that inhaled formaldehyde 
causes leukemia.   
 
6.2 Further directions 
As mentioned before, we have generated data to address many of the critical 
challenges raised in the chapter 1. We provided mechanistic insight on the ability of 
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formaldehyde inducing leukemia by performing molecular dosimetry for both 
endogenous and inhaled formaldehyde. The results, we believe, substantially improve our 
knowledge on formaldehyde carcinogenesis.  However, there are still some intriguing 
questions to be further investigated, which will bridge the current gaps and our better 
understanding on formaldehyde.  
 
6.2.1 Time course experiment on the repair of formaldehyde-induced DNA adducts 
We have demonstrated that inhaled formaldehyde induced N2-hydroxymethyl-dG 
monoadducts and dG-dG cross-links in DNA from rat nasal mucosa, but not other distant 
tissues. These results support that formaldehyde is not able to travel to bone marrow to 
cause genotoxic effects there following exposure to rats. Tthis finding strongly refutes the 
first proposed mechanism by Zhang et al. We can not rule out the possibility that 
damaged cells can migrate to bone marrow after being exposed to inhaled formaldehyde 
in either blood or nasal/oral passage, although the biological plausibility of such 
mechanisms is slim. Under these scenarios, inhaled formaldehyde-induced DNA damage 
needs be stable enough to remain during the migration back to bone marrow, as well as 
remain there and cause further mutation during cell replication. Previous research and our 
current work indicate that formaldehyde-induced DNA adducts are extremely unstable in 
vitro. Therefore, the lability of these DNA lesions further casts a question on the validity 
of the second and third proposed mechanisms for leukemia. So far, we do not have data 
to demonstrate a short half-life of these adducts in animals after exposure. Therefore, 
time course experiment on the repair and half-life of these adducts in vivo should be 
performed to further shed light on the ability of formaldehyde inducing leukemia.  
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6.2.2 Dose response after exposure 
Our current quantitative data on inhaled formaldehyde-induced DNA adducts are 
generated using rats exposed to 10 ppm formaldehyde for 1 day and 5 days.  This high 
dose results in a 22% incidence of nasal cancer in rats after exposed for a lifetime. 
Presently, there are no available data on exposure-response of chemical specific adducts 
in rats , except previous work on DPC. Previous studies using DPC as an endpoint did 
show a linear response between 6, 10 and 15 ppm formaldehyde exposures for DPC, with 
reduced numbers of DPC per ppm formaldehyde at 2 and 0.7 ppm due to depletion of 
glutathione in the nasal epithelium at 6 ppm and higher exposures to formaldehyde.  As 
we discussed before, DPC is not a chemical-specific biomarker and may not be an 
appropriate one for risk assessment purpose due to potential artifacts, which is a major 
driving force of the present study on developing specific DNA biomarker.  As we 
demonstrated in this study, N2-hydroxymethyl-dG is a superior specific DNA biomarker 
to evaluate formaldehyde exposure through inhalation.  We have demonstrated the 
formation of this adduct in nasal epithelium of rats after exposed to 10 ppm for both 1 
day and 5 days. Our next effort will focus on generating the exposure-response in rats 
after exposure to 0.7 ppm, 2 ppm, 6 ppm, 10 ppm and 15 ppm, [13CD2]-formaldehyde, 
which is expected to provide further critical data for science-based risk assessment of 
formaldehyde exposure.    
 
6.2.3 Mechanism of the formation of dG adduct after exposure 
As we have demonstrated in this study, inhaled formaldehyde induced N2-
hydroxymethyl-dG adducts as primary DNA monoadducts, while N6-hydroxymethyl-dA 
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adducts were not formed as a consequence of exposure. However, both endogenous dG 
and dA adducts were observed in cells or tissues we examined.  Why were only dG 
adducts induced after inhalation? Why were dA adducts formed endogenously but not 
exogenously. The observed difference between the formation of dA and dG adducts 
suggests that the underlying mechanisms through which dG and dA adducts are formed 
may be different. We hypothesized that endogenous dA and dG adducts could be the 
consequence of direct reaction between intra-cellular formaldehyde with neighboring 
DNA. The ratio of endogenous dA versus endogenous dG adducts in the analyzed tissues 
is consistent with their in vitro reactivity toward formaldehyde and stability (dA is a little 
more reactive and dA adducts are more stable).  However, the observation that only dG 
adducts could be induced by exogenous formaldehyde indicates that dG adducts are not 
formed by direct reaction with exogenous formaldehyde. Otherwise, dA adducts should 
be also detected considering a relatively higher reactivity of dA. We hypothesize that dG 
addcuts are formed through certain intermediates, primarily DPC. As we showed in 
Chapter 3, dG instead of dA is highly involved in the formation of DPC and the primary 
cross-links, Lys-CH2-dG, are extremely labile.  Our preliminary in vitro data suggests 
that dG adducts could be produced after DPC decompose. Therefore, we hypothesized 
that exogenous dG adducts could be formed through the following steps, as illustrated in 
Figure 6.1: First, exogenous formaldehyde reacts with prevalent protein in cytoplasm 
after entering into cells; Then, formaldehyde-modified protein migrates into the nucleus 
and further cross-links with interacting DNA sequences to cause DPC; DPC decompose 
to form dG adducts.   
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6.2.4 Exposure routes and specific DNA biomarkers 
In this study, we have clearly demonstrated N2-hydroxymethyl-dG, rather than N6-
hydroxymethyl-dA, is the primary DNA biomarker after inhalation exposure to 
formaldehyde. The Hecht laboratory previously reported increased amounts of 
formaldehyde-induced N6-HOCH2-dA in multiple tissues of rats treated with NDMA or 
NNK due to the release of formaldehyde from these compounds. Thus, it is very likely 
dA adducts could be formed after indirect exposure to formaldehyde generated in cells,    
although the Hecht’s study did not unambiguously demonstrate that formaldehyde was 
produced from the metabolism of NDMA and NNK.  More recently, the Hecht Lab 
reported a clear difference in N6-HOCH2-dA adducts between smokers and non-smokers 
in leukocyte DNA samples.  This clear difference (approximately 6 times higher in 
smokers) could be either the result of direct exposure to formaldehyde in the smoke or 
indirect exposure to formaldehyde produced after metabolism of  various nitrosamines 
found in tobacco. Therefore, this study added further mystery to the critical issue whether 
or not specific DNA biomarkers are associated with exposure routes.  We hypothesized 
that the formation of specific DNA biomarkers was dependent on exposure routes, as 
illustrated in Figure 6.2.  Under direct exposure through inhalation, only dG adducts is 
formed with DPC being intermediates, as we explained before. However, if formaldehyde 
is generated in cells following exposure to certain compounds, both dA and dG are 
formed as the consequence of reaction between formaldehyde and DNA bases. Under this 
scenario, there is no evidence to support the formation of dG adducts, but we would 
predict the formation of dG adducts considering a similar reactivity of dA and dG toward 
formaldehyde. The answer to this question is of importance to rule out confounding 
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factors for the risk assessment of formaldehyde inhalation exposure. In addition, the 
finding on this issue will also add a new dimension on investigating the carcinogenesis of 
a variety of compounds and drugs if formaldehyde is released inside cells after 
metabolism.  
 
6.2.5 Primate studies are needed to address oro-nasal breathing versus obligatory 
nasal breathing 
Another important relevant issue is species differences between rats and humans. 
We did not detect the formation of dA adducts, but the Hecht Lab has demonstrated a 
clear increase of dA adducts in smokers. Although this adduct could be the consequence 
of formaldehyde released from the metabolism of nitrosamines present in tobacco, it also 
could arise from well known species differences in inhalation. Humans could be 
differentially exposed to formaldehyde through oro-nasal breathing, while rats are 
exposed through obligatory nasal breathing. Therefore, more studies are needed in order 
to develop data based on breathing patterns similar to human populations exposed to 
inhaled formaldehyde.  This can be accomplished by exposing monkeys to 6 ppm 
[13CD2]-formaldehyde and measuring [13CD2]-formaldehyde DNA adducts in tissues and 
blood. Such studies are clearly required to establish distant site exposure.   
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Figures 
 
Figure 6.1. Formation of formaldehyde-DNA adducts through endogenous and 
exogenous pathway 
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Figure 6.2. Formation of DNA adducts arising from formaldehyde generated through 
metabolism (indirect exposure) and exogenous formaldehyde (direct exposure). 
 
 
 
